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The European Society for Translational Medicine 
defined Translational Medicine as “interdisciplinary branch of the 
biomedical field supported by three main pillars: benchside, 
bedside and community. The goal of TM is to combine disciplines, 
resources, expertise, and techniques within these pillars to 
promote enhancements in prevention, diagnosis, and therapies” 
(Cohrs et al., 2015). 
 
  
“If [something] works in the pig, then it has a high 
possibility of working in the human.” - Michael Swindle, author of 
"Swine in the Laboratory" 
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1 Translational medicine  
 
 
 
 
(“Die Abwehr besser verstehen,” n.d.) 
 
 
In the 1950s, clinical systems were structured such that clinical studies, 
patient care and theoretical research were all done in the same place and 
members of research teams worked in all these areas. Developments in the 
decades that followed and the specialization of research areas led to a 
separation of clinical research (e.g. internal medicine and surgery) and 
theoretical studies (e.g. biology and molecular biology in particular) (“History of 
translational medicine | CENTRE FOR TRANSLATIONAL MEDICINE,” n.d.). It 
was this separation of types of research that brought about one of the greatest 
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challenges in medicine in the late 20th century and introduced the concept of 
translational medicine for the first time.  
There is not a clear and univocal definition for translational medicine as it 
assumes different meanings for different people.  
The concept of translational medicine as the science to test, in humans, 
novel therapeutic strategies developed through experimentation was so popular 
that Bench to Bedside (BtB)  Awards was developed within the NIH in 1998 to 
encourage collaboration between clinicians and basic scientists across institutes 
(“NIH Clinical Center,” n.d.).  
Some confusion may occur when we consider the term translational 
research. 
For many, the term refers to the “bench-to-bedside” concept that 
considers the knowledge coming from the basic sciences a way to assess new 
drugs, devices, and treatment options for patients. For this area of research the 
end point is the production of a promising new treatment, and has been 
characterized as follows: “effective translation of the new knowledge, 
mechanisms, and techniques generated by advances in basic science research 
into new approaches for prevention, diagnosis, and treatment of disease is 
essential for improving health.”(Fontanarosa and DeAngelis, 2002)  
For others translational research refers to translating research into 
practice; i.e., ensuring that new treatments and research knowledge actually 
reach the patients or populations for whom they are intended and are 
implemented correctly. The production of a new drug, an end point for “bench-
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to-bedside” translational research, is only the starting point for this second area 
of research which works to improve the quality of treatments helping clinicians 
and patients to change behaviors and make more informed choices, providing 
reminders and point of- care decision support tools, and strengthening the 
patient clinician relationship.  
In 2003 the Institute of Medicine’s Clinical Research Roundtable  
described 2 “translational blocks” to explain the differences between the two 
definitions of translational research (Sung et al., 2003), which some now label as 
T1 and T2. The first roadblock (T1) was described by the roundtable as “the 
transfer of new understandings of disease mechanisms gained in the laboratory 
into the development of new methods for diagnosis, therapy, and prevention 
and their first testing in humans.” The roundtable described the second 
roadblock (T2) as “the translation of results from clinical studies into everyday 
clinical practice and health decision making.” 
Referring to T1 and T2 both as translational medicine has become a 
source of confusion. (Kerner, 2006) 
Their goals, settings, study designs, and investigators differ. T1 research 
requires mastery of molecular biology, genetics, and other basic sciences; 
appropriately trained clinical scientists and a supportive infrastructure within 
the institution. 
In contrast, the “laboratory” for T2 research is the community and 
ambulatory care settings, where population-based interventions and practice-
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based research networks (Mold and Peterson, 2005) bring the results of T1 
research to the public.  
In 2009, the American Association for the Advancement of Science 
announced the publication of a new journal, Science Translational Medicine; to 
try to fill the deep gaps in our fundamental understanding of biology that often 
have been highlighted in clinical human studies. The Founding Chief Scientific 
Advisor Elias A. Zerhouni declared: “Never before have scientists had access to 
the remarkable tools that are available today and that allow rigorous 
translational investigations to be conducted. However, the creation of a 
redefined discipline of translational medicine will require the emergence of a 
new and vibrant community of dedicated scientists, collaborating to fill 
knowledge gaps and dissolve or circumvent barriers to improved clinical 
medicine.” 
In parallel with the WHO's call for translational research (TR) to be 
applied to much more than just clinical medicine (“WHO | World Report on 
Knowledge for Better Health,” n.d.), it has been recognized in the US that the 
need for TR extends beyond the areas covered by types T1 and T2.  
A variety of four-type models have been proposed, including the one 
proposed by Khoury and colleagues. In 2010 indeed, highlighting the role of 
epidemiology in translational medicine, Muin J. Khoury presented the 
application of translational epidemiology (TE) through four phases designated 
T1–T4.  
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The phases and the role of epidemiology are synthetized in table 1. In T1 
epidemiology explores the role of a basic scientific discovery (e.g., a disease risk 
factor or biomarker) in developing a “candidate application” for use in practice 
(e.g., a test used to guide interventions). In T2, epidemiology can help to 
evaluate the efficacy of a candidate application by using observational studies 
and randomized controlled trials. In T3, epidemiology can help to assess 
facilitators and barriers for uptake and implementation of candidate 
applications in practice. In T4, epidemiology can help to assess the impact of 
using candidate applications on population health outcomes. (Khoury et al., 
2010) 
Table 1. T0–T4, designated phases of translational research and the role of 
epidemiology. From Khoury et al., 2010 
Phase  Details  Role of Epidemiology  Examples From Genomics  
T0  Description and 
discovery  
Describing patterns of 
health outcomes by 
place, time, and person; 
finding determinants of 
health outcomes by use 
of observational studies  
Describing patterns of health 
outcomes in relation to 
inbreeding, migration, and 
family history to generate 
hypotheses about genetic 
factors; genome-wide 
association studies as a tool 
for gene discovery  
T1  From discovery to 
health 
applications 
(tests, 
interventions)  
Characterizing discovery 
and assessing potential 
health applications by 
using clinical and 
population studies  
Assessing prevalence, 
associations, interactions, 
sensitivity, specificity, and 
predictive value of testing for 
genetic risk factors  
T2  From health 
application to 
evidence 
guidelines  
Assessing the efficacy of 
interventions to improve 
health and prevent 
disease by using 
observational and 
experimental studies  
Assessing the clinical utility 
of genetic risk factors in 
improving health outcomes  
T3  From guidelines 
to health practice  
Assessing the 
implementation and 
dissemination of 
guidelines into practice  
Assessing the factors 
associated with 
implementation of BRCA 
testing in practice  
T4  From health 
practice to 
population health 
outcomes  
Assessing the 
effectiveness of 
interventions on health 
outcomes  
Assessing the effectiveness of 
newborn screening 
programs  
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The typology suggested by the Harvard Catalyst, a consortium headed by 
Harvard University, is very similar, but its impact at a population level is clearly 
stated as relating to public health rather than the application of clinical practice 
to maximize its impact at a population level (“Pathfinder | Harvard Catalyst,” 
n.d.). The Harvard typology acknowledges the importance of the 'social 
determinants of health' in considering health at a population level, but the 
extent to which these and the other determinants of health are addressed in 
their T4 TR it is not clear.  
In 2009 Ogilvie and colleagues noted public and population health TR 
required more fundamental and wide-ranging societal response than those that 
were offered through the established systems of delivering health care, so they 
develop a framework for translational health research at a population level. 
(Ogilvie et al., 2009)  
The complexity of interventions implied by the Ogilvie framework 
revealed the need for TR to go beyond the impact of specific public health 
interventions on population-level health outcomes. The addition of T5, as 
shown in table 2, was proposed by Thomson n in 2012 (“Translational research 
« What we do « Our work « About « Australian Indigenous HealthInfoNet,” n.d.). 
Unlike the other types of TR, attention to the social and other determinants of 
health is an essential aspect of T5 TR.  
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Table 2. Translational research, by type, area of translation, attention to social and 
other determinants of health, and complexity of synthesis. Source: Khoury et al., 
2010,“Pathfinder | Harvard Catalyst,” n.d. and Ogilvie et al., 2009  
Type Area of translation 
Attention to social and 
other determinants of 
health 
T1 Basic research to clinical effect No 
T2 Clinical effect to clinical intervention No 
T3 Clinical intervention to clinical practice Some 
T4 
Specific public health intervention at a population 
level 
Some 
T5 
Clinical, public health and determinants-related 
interventions applied to the population or specific 
sub-populations 
Yes 
 
Analyzing the 4-phase in translational research the T0 phase has given 
rise to claims that research is translational when, in fact, it is translatable and 
often quite a distance away from translational medicine. 
In 2014 Frank Gannon proposed a classification scheme that aimed to 
help to define the steps in pre-clinical research from discovery to translation 
(T0). As the four phases of translational research, Gannon distinguished four 
phases of discovery D1 to D4. (Gannon, 2014) 
D1 is pure basic research to gain knowledge. It is essential and the basis 
for the following stages, but does not itself focus on clinical use or any other 
application. D2 is disease-related research or oriented/strategic research: the 
context is defined by a disease, and the work is designed to obtain new insight 
or a starting point for diagnosis, treatment or prevention. D3 is the phase when 
the initial outcome of D2 research, such as a target molecule or a metabolic 
pathway, has been identified and when its link to the disease is being 
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investigated. D4 describes the phase when the target from D3 is manipulated in 
some way to confirm its disease association.  
After successfully completing D4, the path to “real” translation or T1 is 
evident and the product, treatment or diagnostic test can be moved into clinical 
research. The 4 phases of discovery (D1-D4), T0 and T1 phases are often 
characterize by the use of animals. The animals are used to model a diseases o 
to model how a new device/therapy will work on humans. The use of animals is 
therefore fundamental as the complexity of the human physiology cannot be 
explained without. 
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1.1 Historical considerations 
 
 
Figure 1. AVICENNA Liber canonis de medicina - Pavia, Giacomo Pocatela, 1510-
1512: detail of the front page. 
 
Animal experimentation has played a central role in biomedical research 
throughout history and for centuries it has also been an issue of heated public 
and philosophical discussion. Animal use in the life sciences and its moral and 
social implications in a historical point of view are important to understand the 
key issues and to evaluate present principles and practices in animal research. 
(Franco, 2013) 
Humans have been using animals as models of their anatomy and 
physiology since the dawn of medicine, physicians in ancient Greece dissected 
animals for anatomical studies (Von Staden, 1989). 
14 
 
Galen of Pergamon (2nd–3rd century CE) developed the techniques for 
dissection and vivisection of animals and on which he based his many treatises 
of medicine (Guerrini, 2003). These remained canonical, authoritative, and 
undisputed until the Renaissance (Fig. 1). 
Beginning with the decline of the Roman Empire and continuing 
throughout the Middle Ages, physiological experiments and scientific activity in 
general would fall almost entirely into disuse and medical knowledge would 
become dogmatic. 
The use of animals for scientific activity restart when the Flemish 
anatomist Vesalius (1514–1564) and Francis Bacon (1561–1626), examined the 
similarities and differences between the internal structure of humans and other 
animals, thus setting the foundations of modern comparative anatomy.  
Physiological experiments on animals carried on throughout the 
seventeenth century, in the period favorable to scientific progress now known 
as the Age of Enlightenment. 
In this period the controversy on animal rights began to take hold, some 
philosophers, like Baruch Spinoza (1632–1677), though that animals had the 
ability to feel but that humans could “use them as we please, treating them in a 
way which best suits us; for their nature is not like ours” (Spinoza, 1677). 
 John Locke (1632–1704), on the other hand, recognized that animals 
could feel and stated that “children should be brought up to abhor the killing or 
torturing of any living thing in order to prevent them from later becoming 
capable of cruel actions to fellow humans” (Franco, 2013). 
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Immanuel Kant (1724–1804) regarding animal use in research, stated 
that “Vivisectionists can justify their cruelty, since animals must be regarded as 
man’s instruments; but any such cruelty for sport cannot be justified”(Kant, 
1997). 
In 1628 William Harvey (1578–1657), physician to kings James I and 
Charles I and one of the founders of modern science, published Exercitatio 
Anatomica de Motu Cordis et Sanguinis in Animalibus (“An Anatomical Exercise 
on the Motion of the Heart and Blood in Living Beings”) in which he provided 
the most accurate description of blood circulation and heart function of his time 
(Fig. 2). 
Figure 2. William Harvey, using a live deer, explains to Charles I the circulatory 
system of blood. From El Museo Popular published Madrid, 1889 
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In the eighteen century philosophers like Voltaire, Jean-Jacques 
Rousseau, Jeremy Bentham and Arthur Schopenhauer began to challenge the 
anthropocentric view on human duties to animals. Bentham famously state: 
“The question is not, Can they reason? Nor, Can they talk? But, Can they suffer?” 
(Bentham, 1907). While knowledge of bodily functions and pathology was still 
incipient at that time, eighteen-century physiologists differed from their 
seventeenth-century predecessors, as they believed that medical improvements 
could one day be achieved through advancing knowledge by the means of 
animal experimentation. 
The idea of inducing disease in model animals was first suggested by 
Claude Bernard in 1865, when he published the Introduction to Experimental 
Medicine (Bernard, 1957). It was the first time animal models were used for 
experimental research, rather than for visualization and understanding of 
biological systems. 
Pasteur began hypothesizing that microbes could be responsible for 
many diseases affecting humans and other animals. Together with his disciples, 
most notably Emile Roux (1853–1933), he would go on to 
identify Staphylococcus, Streptococcus, the “septic vibrio” (now Clostridium 
septicum), the causative agents of anthrax (Bacillus anthracis) and chicken 
cholera (Pasteurella multocida), being the first to develop vaccines for these 
zoonotic diseases, as well as for Swine Erypselas,  thus setting the foundations 
of modern immunology (Bazin, 2011). In his studies Pasteur used dogs, 
chickens, rabbits, rodents, pigs, cows, sheep, and non-human primates  and was 
the first to introduce the concept of Humane Endpoint by stating that: “The 
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rabbit should begin to show symptoms on the sixth or seventh day, and die on 
the ninth or tenth. Usually the rabbit is not allowed to die, but is chloroformed 
on the last day in order to avoid terminal infections and unnecessary suffering”. 
 Emil von Behring (1854–1917) and Paul Ehrlich (1854–1915) 
developed the first antitoxin for treatment of diphtheria from horse serum, for 
which von Behring received the Nobel Prize in 1901. 
The twentieth century would witness astonishing advances in medical 
knowledge and the treatment of disease. The advances of biomedical research 
to human health since the dawn of the past century are countless, with animal 
research playing a role in many important discoveries. Of the 103 Nobel Prizes 
in physiology or medicine given since 1901, in more than 80 the results were 
obtained from animals. 
Consideration towards animals began to change with Regan and Singer 
works on animal ethics (Regan, 1987) and with  the development of   the “Three 
Rs”—Replacement, Reduction, Refinement—principles by Russell and Burch in 
1959.  
Animals are part of the translational process and the importance of 
animal welfare is emerging thanks to awareness of its fundamental importance 
in producing data able to establish translation. 
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1.2 The need for animal model and translational 
value   
 
Undoubtedly, the greatest achievements in medicine in the 19th and 20th 
centuries were possible due to the use of animals. There is a strong relationship 
between a rapid progress in experiments on animals and evident progress in 
clinical medicine. 
The role of the animal model is neatly explained in “The Animal Research 
War”, by Conn and Parker (Conn and Parker, 2008) : 
“If you are going to study a human disease you can’t, for ethical 
reasons, perform the initial work in humans; you have to develop a model. 
Some models may be in vitro – literally, in glass tubes – but as you learn 
more and more, you must eventually test ideas in vivo– in living animals. 
That means you have to have a way of producing the disease that allows 
you to study it. 
Let’s consider AIDS, one of Podell’s interests. You could take its 
causative agent, the Human Immunodeficiency Virus (HIV), grow it in a test 
tube, and kill it by pouring bleach on it. Do you now have a way to kill HIV? 
Yes, you do. Do you have a treatment that can be used in humans? 
Absolutely not: bleach is toxic. Killing HIV in a test tube and killing it in a 
living animal are two very different accomplishments. 
To complicate things further, viruses grow differently in test tubes 
than in humans. Humans have an immune system: test tubes do not. A virus 
growing in a test tube is not a good model for the human disease, but drugs 
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that don’t kill the test tube virus probably won’t work in humans either – 
and these might be eliminated from further consideration. 
Animal models allow closer approximation to a human response. 
They are not perfect, of course; animals host different diseases and 
different responses. While the fundamentals of life are the same – there is a 
67 percent similarity between the DNA of humans and earthworms – there 
are differences in species and even in individual animals. Some animals are 
good human-like models for one thing and some for another; some have a 
cardiovascular system that is similar to humans while others have similar 
skin.” 
We can distinguish three main groups when we talk about types of 
animal models: (I) normal animals,  used in the past and are still used today to 
investigate physiological situation and to assess the safety/toxicology risk of a 
putative therapeutic; (II) animals with naturally occurring deficits, i.e. 
spontaneous and endogenous occurring conditions or  mutations, selection and 
genetic lines; (III) animals with experimentally induced deficits like transgenic 
and knockout animals, chromosomal substitution strains and chemical/physical 
induced  models. 
Another way to defined animal models is by nine categories 
based on  the use of the animals in science and research (Greek and 
Menache, 2013): 
1. Animals are used as predictive models of humans for research into such 
diseases as cancer and AIDS. 
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2. Animals are used as predictive models of humans for testing drugs or other 
chemicals. 
3. Animals are used as “spare parts”, such as when a person receives an aortic 
valve from a pig. 
4. Animals are used as bioreactors or factories, such as for the production of 
insulin or monoclonal antibodies, or to maintain the supply of a virus. 
5. Animals and animal tissues are used to study basic physiological principles. 
6. Animals are used in education to educate and train medical students and to 
teach basic principles of anatomy in high school biology classes. 
7. Animals are used as a modality for ideas or as a heuristic device, which is a 
component of basic science research. 
8. Animals are used in research designed to benefit other animals of the same 
species or breed. 
9. Animals are used in research in order to gain knowledge for knowledge sake. 
In both the categorizations, the assumption that animal models are 
predictive of human outcomes is fundamental for much of their use in 
biomedical research. 
The ideal animal model should replicate, to a major extend, both a human 
disease phenotype and its underlying causality (McGonigle and Ruggeri, 2014) 
but one ideal animal model for all human condition does not exist. Some animal 
models are however capable of predicting a particular human condition or 
define a specific question.  
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Most medical therapies in use today are initially developed and tested in 
animals, yet animal experiments often fail to replicate when tested in rigorous 
human trials (Hackam and Redelmeier, 2006). 
To fight this trend is important to validate and improve the translational 
value of animal models. 
It can be done by proper design, conduction and reporting of experiment, 
as the best validated model is not able to yield conclusive data when the 
experimental design is flawed or the execution of the study is not well 
controlled (Denayer et al., 2014).  
There are different criteria to validate a model, a more general criteria is 
the definition of face validity, the similarity in biology and symptoms between 
the animal model and the human disease; predictive validity, demonstration 
that clinically effective interventions demonstrate a similar effect in the model 
and target validity, the target under investigation should have a similar role in 
the disease model as in the clinical situation.  
Another criteria is the one proposed by Sams-Dodd (Sams-Dodd, 2006), a 
model validity scoring system upon five criteria (Tab. 3). 
Table 3. Proposed validity scoring system. From Denayer et al.  
Criterion Value Score 
Species Human 4 
Non-human primate 3 
Non-human mammal 2 
Non-mammal 1 
Disease simulation True 4 
Complex 3 
Pharmacological 2 
No 1 
Face validity >1 core symptom 4 
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1 core symptom 3 
1 symptom 2 
No 1 
Complexity In vivo 4 
 Tissue 3 
 Cellular 2 
 Sub-cellular/molecular 1 
Predictivity Graded for all pharmacology principles 4 
 Graded for certain pharmacology principles 3 
 All or none for certain pharmacology principles 2 
 No or not shown 1 
 
This scoring system can help to assemble a screening 
cascade/combination of models which altogether has maximal validity. 
Improving the quality of animal models involves three things: improving 
the performance quality of existing models (e.g. proper design and execution of 
experiments), improving the way in which animal models are used in the 
decision making process and investing in the development of more 
sophisticated and clinical relevant and predictive models (Denayer et al., 2014). 
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2 The pig model  
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The pig was first used in biomedical research in ancient Greece and over 
the past few decades has quickly grown into an important biomedical research 
tool, table 4 shows the major landmark of the use of pig in biomedical science 
from Erasitratus to the current day (Schook et al., 2015). 
Table 4. Timeline of the use of pigs in biomedical science. Table from Schook et al. 
2016.  
Date Event 
302–258 BC Erasistratus: studied the circulatory system of pigs 
129–200 AD Galen: studied the respiratory and nervous system of pigs 
1578–1657 William Harvey: established principles of circulation 
1865 Claude Bernard: conducted first experimental research on animals 
1915–1949 Porcine thyroid extract used to treat hyperthyroidism 
1921–1982 Porcine insulin used to treat diabetes 
1930–Present Porcine heparin only FDA-approved source 
1960s Thyrotropin releasing factor and luteinizing hormone releasing factor 
isolated from porcine hypothalami (Nobel Prize 1978) 
1969 First porcine aortic valve implanted 
1981 First transgenic mouse (microinjection) 
1982 Genentech introduced recombinant human insulin 
1986 First transgenic pig (microinjection) 
1989 Pig generated by transfer of embryonic cell (blastomere) nucleus into 
enucleated oocyte 
1991 Tao injected cultured fetal fibroblast cells into enucleated oocytes 
1996 Dolly born; first clone from adult somatic cell nuclear transfer 
1997 Retinitis pigmentosa (Rhodopsin, mutant P347L) 
2000 Pigs cloned by nuclear transfer from adult somatic cells 
2001 Huntington’s disease porcine model 
2002 Porcine sequencing initiative white paper submitted 
2003 Pig Project Sequencing initiated 
 The Encyclopedia of DNA Elements (ENCODE) 
2004 Pilot human epigenome project published 
2008 Cystic fibrosis porcine model 
2009 Porcine 60k single nucleotide polymorphism chip 
2010 Huntington’s disease porcine model 2 
2012 Pig genome sequence published 
Neonatal pig brain MRI atlas online (http://pigmri.illinois.edu/) 
Retinitis pigmentosa porcine model (Rhodopsin, mutant P23H) 
A porcine model of familial adenomatous polyposis 
2013 Genome-edited pigs born (TALEN and ZNF injected into zygote) 
2014 Inducible P53/Kras porcine cancer model 
 
The great spread of pig farming made a large quantity of tissues available 
as source of many therapeutic biomedical products. One great example is the 
production of insulin. Insulin was discovered in 1924 and porcine insulin 
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became the treatment of choice (Harington, 1926) until 1982 when Genentech 
produced the first recombinant human insulin (Evens, 2016). 
Another example is the porcine thyroxin that was isolated in 1915 
(Kendall, 1983) and is still available today (Slater, 2011) .  
Heparin, which acts as an anticoagulant, blocking the blood clotting 
cascade was first isolated from porcine intestines in the 1930s (Pritchard, 1964) 
and today is still the only Federal Drug Administration–approved source of 
heparin. Currently, the global use of this product is 1.5 billion doses yearly 
which production consumes tissue from 700 million pigs (Oduah et al., 2016). 
In the 1960s, porcine hypothalami were used for Nobel Prize–winning 
work that identified, isolated, and determined the structure of the first brain 
hormones (Schook et al., 2015).  
In addition to the extracted biological, porcine tissues are used routinely 
for replacement heart valves and patches. The bioprosthetic heart valves, first 
introduced in the 1960s, are made of porcine or bovine pericardium preserved 
with glutaraldehyde (Manji et al., 2012). Patients receiving these valves do not 
require anticoagulation therapy. However, these glutaraldehyde-treated 
implants do pose some risk of deterioration in young patients, which can 
necessitate additional replacements (Fig. 3). 
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Figure 3. Comparison of an unused glutaraldehyde-fixed bioprosthetic heart valve 
(GBHV; “off the shelf”) with a GBHV removed from a patient for structural valve 
deterioration. From Manji et al., 2012 
A. Porcine bioprosthetic heart valve prior to implantation in patient. There is no 
calcification and the valve leaflets are thin and clean. B. Porcine bioprosthetic heart valve 
removed for structural valve deterioration, showing calcification (C), stenosis of the valve 
orifice (S), and cusp tears (T). 
 
 
The authors suggested that the production of genetically engineered pigs, 
such as α1,3-galactosyltransferase gene-knockout pigs, that do not express this 
protein would provide a potential source of non- or less-immunogenic valves to 
meet worldwide demand.  
Pigs are used in the field of pharmacology and toxicology for their 
similarities with humans in terms of anatomy and physiology.  
Many authors deeply analyzed the role of pig and in particular minipig in 
toxicology, Swindle et al. provided an overview of the common use of these in 
research and toxicology testing providing a review of the anatomic and 
histopathologic characteristic (Swindle et al., 2012). 
A B 
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Thanks to the RETHINK project the use of minipig in this field was 
validated and the minipig model was assumed to be a better non-rodent model 
than the dog (Forster et al., 2010) bringing benefits in terms of 3Rs (life-cycle 
analysis) compared to dogs and non-human primates. Finally the minipig 
(unlike the dog) is well positioned to take advantage of genomics and gene 
manipulation technologies (Yum et al., 2016). 
In general it can be stated that toxicology studies performed in minipigs 
are acceptable to regulatory authorities (Bode et al., 2010).  
In 2002 a group of scientist submitted the porcine sequencing initiative 
paper to the National Human Genome Research Institute to provide scientific 
justification for sequencing the porcine genome to identify new genes and novel 
regulatory elements in the pig and in humans, mice and rats (“Porcine Genomic 
Sequencing Initiative,” n.d.). The proposal set the stage for the worldwide 
collaborative effort to develop and publish a high-quality draft genome 
sequence for a female domestic Duroc pig (Groenen et al., 2012). The initiative 
had a big impact on scientific world (Fig. 4) leading to the identification of 
natural mutations, which increase the potential for additional pig biomedical 
models. In addition, the pig mitochondrial genome was sequenced (Lin et al., 
1999) providing support for pig models of mitochondrial diseases. 
One hundred and twelve positions have been observed where the 
porcine protein has the same amino acid that is implicated in a human disease. 
These include genes implicated in multifactorial diseases, such as obesity, 
diabetes, Parkinson’s, and Alzheimer’s disease (Groenen et al., 2012). In 
addition, the sequencing of the genomes of 48 individual pigs has revealed 
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32,548 no synonymous SNPs, 6 known to be associated with human disease and 
11 that have been linked to human disease phenotypes. Identification of these 
porcine variants allowed further study of these diseases in a suitable pig model. 
Figure 4. A high-quality draft genome sequence for a female domestic Duroc pig 
is published in this issue of Nature, under the auspices of the Swine Genome 
Sequencing Consortium. Cover: Mike Kemp, Rubberball,Getty Images/ Pompeii: René 
Mattes, Hemis, Corbis. 
 
 
 
In the post-genomic era the interesting on the pig model increased 
exponentially. The pig was developed to be a model for multigenetic and 
monogenic disease, but also to model cancer and lifestyle diseases.  
The availability of the pig genome sequence provided an important 
resource for improving strategies to generate genetically engineered biomedical 
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models and transgenic animals are now commonly used worldwide as models of 
human disease.  
For example pig proved excellent models for human atherosclerosis 
(Skold et al., 1966), so that in 2010 Jensen TW et al. demonstrated that cloned, 
genetically defined ApoE4 (apolipoprotein associated with increased risk of 
atherosclerosis in humans) pigs fed high-fat, high-cholesterol diets had 
increased total and low-density lipoprotein cholesterol plasma levels within 60 
days, thus providing a model in which the earliest stage in atherosclerosis can 
be induced and mitigated (Jensen et al., 2010). 
Due to recent advances in the sequencing of domestic animal genomes 
and the development of new organism cloning technologies, it is now very 
feasible to utilize pigs as a malleable species, with similar anatomic and 
physiological features with humans, in which to develop cancer models. Recent 
advancements in porcine tumor modeling and genome editing will bring 
porcine models to the forefront of translational cancer research (Schook et al., 
2016).  
Pigs are also very useful as model in surgery new techniques 
development and training field due to their similar anatomy and human 
comparable dimensions (Gessaroli et al., 2012). 
The pig is an extremely useful biomedical model for improving our 
understanding of the pathophysiology and for investigating potential 
treatment/prevention strategies under rigorously controlled conditions for 
many human diseases and ailments. The optimum porcine model to use is often 
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dependent on the specific disease being studied. In a review of 2010 Little-
Brown and collaborators defined the minipig the best breed for investigation on 
the metabolic syndrome. The author provide an overview of the use of pig as 
biomedical model (Litten-Brown et al., 2010).  
Due to the considerations above the swine species provide a valuable 
translational model to bridge the gap between classical rodent models and 
humans in developing new therapies to aid human health. 
These features of the pig combined with an increasing availability of 
biological tools and reagents for use to study porcine tissue make the pig 
arguably the best model available for translational biomedical research (Ziegler 
et al., 2016). 
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2.1 Gastro-intestinal and metabolic applications 
 
 
Because of the limitations of data on human gastrointestinal disease in a 
clinical environment, the use of animal models to clarify the mechanisms of 
gastrointestinal disease is of great importance. 
Rodent models remain the most commonly used animal model for the 
study of human disease because of their relatively low cost and maintenance 
requirements, rapid reproduction rates, and availability of research tools such 
as murine antibodies (Low, 2012). However, rodent models frequently do not 
mimic clinical signs and significant pathologic hallmarks of human diseases.  
Pigs have significant anatomic and physiological similarity with humans, 
for example, when investigating gastric disease, the pig has a glandular-type 
stomach similar to that of human beings, whereas the murine stomach has both 
glandular and non-glandular regions (Fig. 5) (T. T. Kararli, 1995). 
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Figure 5. Schematic diagrams for comparison of murine, porcine, and human 
gastrointestinal tract anatomy and histology. Derived from (Ziegler et al., 2016) 
 
 
Humans and pigs shares similarities in the structure of intestine that 
contribute to the comparable transit time and analogous digestive and 
absorptive processes reported for these species (Graham and Aman, 1987). 
Shared microscopic features also exist, including the structure of the villi 
and the types of cells that constitute the intestinal epithelium (Fig 6).  The 
villous projection of the small intestine are finger shaped for both humans and 
pigs and the intestinal epithelium cells, their phenotypic appearance, and their 
expression of unique protein biomarkers used for cellular identification are 
similar (Tugrul T. Kararli, 1995). Moreover the morphologic appearance of 
crypt base columnar stem cells is consistent with the ones described for humans 
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(Gonzalez et al., 2013). Taken together, these features contribute to 
fundamental digestive processes such as mucosal transport and motility that 
are similar between pigs and humans.  
The pig serves as a valuable model for studies of human intestinal injury, 
repair, and efficacy of novel therapeutics, some direct clinical applications are 
summarized in table 5 (Gonzalez et al., 2015). 
Table 5. Direct clinical application of porcine models. Modify version from Gonzalez 
et al. 2015. 
Abbreviations: CF, cystic fibrosis; CRF, corticotropin-releasing factor; FDA, Food and Drug 
Administration; GLP-2, glucagon-like peptide 2; NEC, neonatal necrotizing 
enterocolitis; SBS, short bowel syndrome. 
Clinical impact Research support using porcine models 
 
Understanding role of 
early life stress on the 
onset and exacerbation of 
clinical symptoms of 
human gastrointestinal 
diseases 
-Early life stress induces a marked increase in serum 
and intestinal CRF that plays a critical role in intestinal 
permeability and diarrhea. 
-Administration of CRF receptor antagonists and mast 
cell stabilizers to pigs prevented stress-induced 
increases in intestinal permeability 
 
Treatment of reperfusion 
injury 
-Activation of xanthine oxidase plays less important 
role than initially postulated in inciting injury 
-Injury is mediated by neutrophil release of oxygen 
metabolites and transmigration through epithelial 
tight junctions creating physical damage 
 
Treatment of NEC patients 
-Oral probiotics reduce the incidence and severity of 
NEC in very low birth weight infants148 
 
Dietary considerations 
after massive bowel 
resection 
-GLP-2 hastens intestinal adaptation; FDA drug 
approval 
 
Successful intestinal 
transplantation 
-Simultaneous liver transplant does not decrease the 
risk of bowel graft rejection and is no longer 
recommended in patients with SBS with normal liver 
function 
 
Cause and treatment of 
gastrointestinal 
dysfunction associated 
with CF 
-Pig model of CF accurately displays clinical 
manifestations of human disease permitting study of 
pathogenesis of intestinal obstruction 
 
Diagnosis of familial 
adenomatous polyposis 
-Porcine transgenic model accurately represents 
disease manifestation, including location and 
histologic appearance of lesions 
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The pig model has also been used extensively to study esophageal 
diseases due to the characteristic of the mucosa (Abdulnour-Nakhoul et al., 
2007). In pigs, the esophageal and gastroesophageal junction anatomy and 
physiology are comparable with that of humans, both sharing the existence of 
large, dissectible sub mucosal glands, making the pig a preferred model for 
analogous clinical applications (Ziegler et al., 2016). In particular, for what 
concern the esophagus, pigs are used commonly to test new surgical procedures 
but also as model for regenerative and protective treatments (Di Simone et al., 
2012).  
Additionally, pigs, like humans, are true omnivores, whereas other 
potential mammalian models such as dogs, cats, ruminants, rabbits, and rodents 
have evolutionarily developed alternative digestive strategies, moreover both 
pigs and humans are colon fermenters and have similar colonic microbiota 
composition. 
The gut microbiota has been the subject of study for many decades 
because of its importance on the health and wellbeing of animals.  Two types of 
microbial populations have been described in mammals: autochthonous and 
allochthonous (Dubos et al., 1965). Autochthonous bacteria are the resident 
stable microbes that were described by DuBos as co-evolving within a 
mammalian habitat. The allochthonous bacteria are considered to be non-
resident microbes that are ‘passing through’ a habitat or that represent 
microbes that are opportunistic colonizers of a habitat and may be associated 
with disease states or other perturbations.  
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The gut microbiota is then closely associated with the health of the host 
and there is a strong interaction between host physiology, nutrition, microbiota 
and health. The role of gut microbiota is today well recognized from the 
scientific world, but also from the community and animals breeders as shown in 
figure 6. The role of microbiota on zootechnical parameters as growth rate and 
food conversion rate is indeed well correlated. 
Figure 6 Figure showing the intestinal tract of a piglet. The picture is the advertising 
of a pig diet based on Lactobacillus acidophilus fermentation technology. From “SynGenX 
| Diamond V,” n.d. 
 
 
 Animals develop an intestinal microbiome over time and space. During 
the growth and development of the pig, the microbiome changes in composition 
in a process known as the microbial succession, for example the microbiome is 
an important contributor to the development of the host’s immune system 
(Isaacson and Kim, 2012). There are clear and distinct differences in the 
composition of the pig intestinal microbiome moving from the proximal end of 
the intestinal tract to the distal end, the comparative composition of humans 
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and pigs’ microbiota is summarized in table 6. Perturbations to the microbiome 
occur in response to many factors including stresses, treatment with antibiotics, 
and diet (Leser et al., 2000; Phillips et al., 2004; Dowd et al., 2007).  
Table 6. Bacteria Phyla in order of dominance in human and pig gut microbiota. 
Data from (Isaacson and Kim, 2012; Tremaroli and Bäckhed, 2012) 
Human gut microbiota Pig gut microbiota 
Firmicutes 
Bacteroidetes 
Actinobacteria 
Proteobacteria 
Verrucomicrobia 
Euryarchaeota 
Cyanobacteria 
Fusobacteria 
Lentisphaerae 
Spritochaetes 
Firmicutes 
Bacteroidetes 
Proteobacteria 
Cyanobacteria 
Actinobacteria 
Spirochaetes 
 
The link between the microbes in the human gut and the development of 
obesity, cardiovascular disease and metabolic syndromes, such as type 2 
diabetes, is becoming clearer (Fig 7). However, because of the complexity of the 
microbial community, the functional connections are less well understood 
(Tremaroli and Bäckhed, 2012). 
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Figure 7. Alterations to the composition and metabolic capacity of gut microbiota 
in obesity promote adiposity and influence metabolic processes in peripheral 
organs, such as the control of satiety in the brain; the release of hormones from the 
gut (shown as PYY and GLP-1); and the synthesis, storage or metabolism of lipids in 
the adipose tissue, liver and muscle. Microbial molecules also increase intestinal 
permeability, leading to systemic inflammation and insulin resistance. From 
Tremaroli et al. 2010. 
 
A Human microbiota-associated (HMA) swine have been developed using 
inocula from infants , children and adult to investigate the role of microbiota on 
normal development, but also to study microbiota associated disease, like those 
mentioned above, and microbiota targeted therapies (Wang and Donovan, 
2015). 
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In their review on the pig model for appetite, metabolic syndrome and 
obese type 2 diabetes, Koopmans and Schurman take in consideration different 
papers. It emerges that both humans and pigs are prone to the development of 
obesity and related cardiovascular diseases such as hypertension and 
atherosclerosis and that bad (LDL) is high and good cholesterol (HDL) is low in 
pigs, like in humans. Diet-induced obese pigs show a phenotype related to the 
human metabolic syndrome including high amounts of visceral fat, fatty 
organs, insulin resistance and high blood pressure. To accelerate the induction 
of obese type 2 diabetes, obese pigs have been titrated with streptozotocin, a 
chemical agent which selectively damages the insulin-producing pancreatic 
beta-cells at such a level that hyperglycaemia was induced but lipolysis was still 
inhibited due to the fact that inhibition of lipolysis is more sensitive to insulin 
compared to stimulation of glucose uptake (Koopmans et al., 2006; Larsen et al., 
2006).   
All the characteristic displayed make the pig one of the most important 
model in the field of nutrition and microbiota investigation associated with 
human health (Leulier et al., 2017). 
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2.2 Visual science applications 
 
As described before in this paper the pig is an excellent model due to its 
similar anatomy and physiology with humans. For the eyes the situation does 
not differ, the porcine eye indeed displays many similarities with the human 
eye. 
Anatomic parameters of the porcine eye are summarized in table 7 
(Middleton, 2010) 
Table 7. Measurements of anatomic parameters of the porcine eye. Modified from 
Middleton, 2010. 
Parameter Measurement Notes References 
Globe Size (mm) [±SD] 
20.1 [0.74] × 23.5 [0.85] 
× 24.9 [0.87]  
(McMenamin 
and Steptoe, 
1991) 
22–24 × 25 × 26–27 
 
(Prince, 1960) 
Globe Volume (ml) 
[±SD] 6.5 [0.3]  
(McMenamin 
and Steptoe, 
1991) 
Number of Ciliary 
Processes 95 main processes 
Smaller processes 
between each pair of 
larger ones 
(Prince, 1960) 
Intraocular pressure 
(mm Hg) [±SD] 
15.2 [SEM 1.8] Data from anesthetized 
animals 
(Ruiz-Ederra et 
al., 2005) 
14.1 [2.2] Data from anesthetized 
animals 
(Castejon et al., 
2010) 
27.3 [3.45] OD   26.3 
[3.14] OS 
Data from minipigs (not 
anesthetized) 
(Rosolen et al., 
2003) 
Mean scleral surface 
area (cm
2
) [±SD] 
7.78 [0.66], small pigs 
9.66 [0.75], medium pigs 
11.92 [1.57], large pigs  
(Olsen et al., 
2002) 
Mean corneal surface 
area (cm
2
) [±SD] 
1.09 [0.07], small pigs 
1.15 [0.09], medium pigs 
1.4 [0.19], large pigs  
(Olsen et al., 
2002) 
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Corneal dimensions 
(mm) 
17–19 × 14–16.5 
 
(Prince, 1960) 
14–16 × 13–14 
 
(Sisson, 1914) 
Corneal thickness (mm) <1 
 
(Prince, 1960) 
 
Due to the characteristic of the eye the pig is a validated animal model of 
glaucoma, it has been used in cataract surgery research (Machuk et al., 2016; 
Nishi et al., 2008; Sugiura et al., 1999), corneal transplant studies (Choi et al., 
2011; Kim et al., 2016) and aberrometry studies (Sanchez et al., 2011).  
More in detail a pig model of glaucoma based on the occlusion of the 
episcleral vein method, was produced; the damage was considered to be 
glaucomatous due to the presence of elevated intraocular pressure, altered eye 
fundus morphology and retinal ganglion cell loss (Ruiz-Ederra et al., 2005). 
To solve the shortage of donor corneas, Choi and colleagues suggested 
that decellularized porcine cornea could be a promising substitute for human 
corneal allograft (Choi et al., 2011). Kim proposed Seoul National University 
(SNU) miniature pig cornea for xenocorneal transplantation using the same 
preservation protocol as human with respect to biophysical and functional 
properties; they found that with this protocol the corneas could be stored for up 
to 7 days for transplantation in human clinical trials (Kim et al., 2016). 
When we think of human vision diseases we have to consider retinal 
degenerations. 
Retinal degenerations (RDs) are a family of inherited retinal 
degenerative diseases (dystrophies) that lead to vision loss. Although 
phenotypically very different, the RDs have several characteristic in common. 
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They are all caused by gene mutations and lead to photoreceptor dysfunction 
and often to the death of both rod and cones cells. It is estimated that more than 
fifteen million people around the world have vision loss due to an inherited RD 
(Chader, 2002). 
The principal RDs are dry and wet age-related macular degeneration 
(AMD), retinitis pigmentosa (RP) and Leber congenital amaurosis.      
Human vision is based on three systems of photosensitivity: rod 
photoreceptors, cone photoreceptors and melanopsin-expressing retinal 
ganglion cells (Fig. 8) (Kimbrel and Lanza, 2015) .  
Figure 8. The eye and the cell types of the retina.  
From (Kimbrel and Lanza, 2015) 
 
 
Rod photoreceptor cells are responsible for the detection of stimuli in 
dim light, whereas cone photoreceptor cells transmit visual information in 
bright light conditions. Melanopsin-expressing retinal ganglion cells are also 
sensitive to bright light, and are implicated in non-image-forming visual 
functions such as circadian synchronization or pupillary light reflexes (Nasir-
42 
 
Ahmad et al., 2017). Cones also provide colour vision and high visual acuity, 
allowing precise tasks such as reading or facial recognition.  
The loss of the cone system is dramatic in our highly technological world, 
where reading and visual communication are extremely important for social 
interactions. Moreover,in patients suffering from rod deficiency, a secondary 
death of cones is observed which definitely worsens their quality of life.  
To date, no molecular therapy has been successful in stopping cone 
degeneration, thus, the study of cone degeneration mechanisms and the 
examination of innovative therapeutic strategies are a major field of research in 
ophthalmology (Kostic and Arsenijevic, 2016). 
It is very important to find and charactrize animal models to study cone 
dystrophy, in figure 9 there is a schematic rapresentation of cone distribution in 
different species. 
Figure 9. Schematic representation of cone distribution in the central retina of 
different species. Both sections of the outer nuclear layer and visualization of the eye 
fundus were schematically represented to highlight the specific cone distribution of the 
retina of zebrafish, chick, mouse, sheep, pig, dog and human. Photoreceptor types are 
arbitrarily coloured to represent the different categories of cones (L, M, S, and double 
cones) and rods. The wavelength of each photopigment is also indicated. (A) In zebrafish, 
in addition to S- and UV-cones, a double cone is observed with fusion at the level of the IS 
of two OSs containing either L- or M-opsin. The four classes of cones are then laid out in a 
regular mosaic pattern. (B) The chick retina contains five types of cones comprising a 
double cone (in yellow) as well. The different types of cones are homogeneously arranged 
in the retina. A particular vascular extension, the pecten (red rectangle), is apposed at the 
inner part of the retina. (C) The mouse retina is composed of only 3% cones, distributed 
throughout the retina. A dorso-ventral gradient of cone expression is observed, with S-
opsin mainly expressed in the inferior hemisphere and M-opsin in the superior 
hemisphere. However, both opsins are observed in single cells in the overlapping gradient. 
(D) The sheep retina includes two types of cones, with higher densities of cones in the 
central streak and in the dorso-temporal region. S-cones are enriched in this particular 
peripheral region. Sheep have a tapetum, a membrane reflecting the light in the superior 
hemisphere (yellow area) except in the dorso-nasal periphery. (E) The pig retina features 
two types of cones, with densities higher in the central streak. (F) The dog retina is also 
characterized by two types of cones and a central streak, but recently a fovea-like region 
was identified with an increased number of cones and a longer OS. Dogs also have a 
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tapetum in the superior hemisphere (yellow area). (G) The human central retina is 
characterized by a region with exclusively cones named the fovea, containing mainly L- 
and M-cones. S-cones are distributed in the perifovea region and in the periphery. ONL: 
outer nuclear layer; OS: outer segment; black circle: optic nerve head; red lines: vessels; S: 
superior; I: inferior; N: nasal; T: temporal. 
Source: (Kostic and Arsenijevic, 2016) 
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Pig retina maintains the structure of ten layers, the same as in the human 
retina because embryonic development is similar (Gu et al., 2007; Sanchez et al., 
2011). The outer plexiform layer contains the synapses between the 
photoreceptors and second-order neurons, bipolar and horizontal cells. The 
inner plexiform layer is the other synaptic zone and connects third-order 
neurons, like amacrine and ganglion cells, with the bipolar cells. Müller cells are 
the main retinal glial cells that extend through most of the retina from the outer 
segments, where their finger-like processes form the outer limiting membrane 
to their basement membrane, which makes up the inner limiting membrane 
(Beauchemin, 1974; Beattie et al., 2007). The retina structure is schematically 
represented in figure 10. 
Figure 10. Layers of the retina. Light impinging on the retina comes from the top of the 
figure and passes through all the superficial layers to reach the photoreceptor rods and 
cones. From (Koeppen and Stanton, 2017) 
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Chandler M.J. and Hendrickson Anita studied the distribution and the 
density of the domestic pig retina finding an overall high density of cones and a 
large horizontal band running across the retina that contains the highest cone 
density  (Chandler et al., 1999; Hendrickson and Hicks, 2002). This band was 
found to be free of large blood vessels indicating that the pig has an central area 
which is similar to the human fovea  (De Schaepdrijver et al., 1992). 
The cone density in the horizontal band is between 20 and 40 thousand 
cells/mm2, moreover the total number of cones in the pig retina is between 17 
and 20 million while in the human retina there are around 5 million cones 
(Curcio et al., 1990). Given that the human and pig retina are about the same 
size the pig retina can be considered a higher dense cone retina compared with 
human retina (Hendrickson and Hicks, 2002). The pig retina has also a higher 
cones/rods ratio, 1:3 to 1:10 from the streak to periphery with a medium of 1:7-
8 while the ratio in human is 1:20 and in Macaca monkeys is 1:15 (Chandler et 
al., 1999; Curcio et al., 1991). Both medium (m) – and short (s) – wavelength 
sensitive cones  were detected in the domestic pig retina, with S cone 
percentage ranging from 7,4 to 17,5% (Hendrickson and Hicks, 2002). 
The color of the optic streak and fundus is orange to pale gray with 
pigmented epithelial cells, which is very similar to the human eye, and there is 
no retinal tapetum in the porcine eye (Ollivier et al., 2004; Ng et al., 2008). 
Due to the similarities with the human the pig was chosen as model by 
many scientists and several models of retinal dystrophies have been created 
(table 8). 
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Table 8. Pig models of cones dystrophies. Modified from (Kostic and Arsenijevic, 2016) 
Model Gene Method of 
generation 
Human 
condition 
Reference 
Pig TgP347L, Pig-
Tg N1Pet 
RHO Pronuclear 
injection and 
homologous 
recombination 
RP (Petters et al., 
1997) 
Pig TgP23H, line 
53-1 
RHO Somatic cell 
nuclear transfer 
RP (Ross et al., 2012) 
Pig ELOVL4-
790e794delAACTT 
ELOVL4 Pronuclear 
injection and 
homologous 
recombination 
STDG3 (Sommer et al., 
2011, p. 4) 
Pig ELOVL4-
Y270terEYFP 
ELOVL4 Somatic cell 
nuclear transfer 
STDG3 (Sommer et al., 
2011, p. 4) 
Pig GUCY2D-
E837D;R838S 
GUCY2D Lentiviral-
directed 
transgenesis 
CORD6 (Kostic et al., 
2013) 
IAA Pig Na 12mg/kg 
systemic 
iodoacetc acid 
(IAA) 
PR 
degenerat
ion 
(Scott et al., 2011; 
Wang et al., 2011; 
Noel et al., 2012) 
  
The first transgenic (Tg) pig to model a retinal dystrophy was generated 
by pronuclear microinjection to mimic a severe form of retinitis pigmentosa 
caused by the dominant rhodopsin (RHO) gene mutation p.P347L (Petters et al., 
1997).  
This work was then followed by the generation of TgP23Hpigs (Ross et 
al., 2012) using stable transfected pig fibroblasts, the NIH miniature pig (SLA C/C 
haplotype) was used. Although these mutations affect specifically rod function 
and survival, these models are also interesting for cone studies as cone death is 
observed following rod loss (Kostic and Arsenijevic, 2016). This secondary 
wave of photoreceptor death is hypothesized to be related to a deficit in a 
survival factor secreted by rods, the rod-derived cone viability factor (RdCVF) 
which is an inactive thioredoxin secreted by rod photoreceptors that protects 
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cones from degeneration (Aït-Ali et al., 2015). RdCVF was found to act through 
binding to Basigin-1 (BSG1), a trans membrane protein expressed specifically 
by photoreceptors. BSG1 binds to the glucose transporter GLUT1, resulting in 
increased glucose entry into cones promoting cone survival by stimulation of 
aerobic glycolysis. The mechanism that lead to cones death during the late 
phase of retinitis pigmentosa remain obscure, both TgP347L and TgP23H pigs 
could help to understand it.  
The most severely affected TgP23H animals were investigated at 14 days 
of age, showing an absence of the scotopic response, the cone response had 
declined at 2 months and had decreased to 50% at 3 months of age (Fernandez 
de Castro et al., 2014). The photopic (cones) response then remained at 
approximately 30% of the wild type WT response until 18–24 months. These 
two models clearly reveal that cone degeneration rapidly follows rod loss, 
indicating that cone protection needs to be performed at an early stage of rod 
dystrophies (Kostic and Arsenijevic, 2016). 
A juvenile form of macular degeneration termed Stargardt-like macular 
dystrophy type 3 (STGD3) is associated with mutations in the elongation of the 
very long-chain fatty acids-4 gene (ELOVL4), which is mainly expressed in rods 
and cones (Zhang et al., 2001). The cones in the macula are particularly affected 
in comparison to rods; the presence of truncated ELOVL4 proteins recapitulates 
different figures of the STGD3 disease in pigs, thus proposing interesting models 
to study pathophysiology of this disease. 
CORD6 is the most frequent dominant cone dystrophy form in humans. 
The p.E837D and p.R838S variants of the GUCY2D gene product are associated 
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with disease appearance (Gregory-Evans et al., 2000). By using a lentiviral 
vector encoding the mutated GUCY2D cDNA controlled by the cone arrestin 
promoter and injected in fertilized oocytes, Kostic and colleagues generated 
three cohorts of transgenic pigs (Kostic et al., 2013).  
Although the response variability was high in the transgenic pigs, 
changes in the behavior tests were observed in several transgenic animals and a 
significant alteration of transgenic cone activity was noticed by ERG in 
comparison to WT littermates. Moreover, histology revealed that all transgenic 
pig eyes had displaced cone nuclei that localized to the OS region, indicating a 
degenerative process (Kostic et al., 2013). 
A rapid inducible swine model of photoreceptors degeneration was 
generating using the iodoacetic acid IAA by three different scientists.  Scott et al. 
investigated whether IAA produced a damage preferentially for rods or cones 
and whether IAA induced remodeling of the inner retina using four doses of the 
chemical (5; 7,5; 10 and 12 mg/kg) (Scott et al., 2011). The author found that 
systemic IAA administration induces rapid and robust degeneration to 
photoreceptors and in particular rods. The inner retina was largely spared, 
exhibiting only subtle changes including dendritic retraction of rod bipolar cells 
and hypertrophy and swelling of Müller cells. 
Wang found the IAA model very similar to the RHO transgenic pig model, 
they also evaluated ERG signals, finding that the signals from rods were 
diminished at 2 weeks after IAA injection, and they remained diminished until 
12 weeks. By contrast, cone ERG signals dipped at 2 weeks after IAA injection 
but rebounded significantly by 5 weeks, and this recovery was maintained to 12 
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weeks. Wang suggested that the dip in response at 2 weeks reflected the initial 
covalent modification to GAPDH and the resultant block of glycolysis when IAA 
was injected (Graymore and Tansley, 1959), probably after the injection cones 
could resynthesize GAPDH and restore glycolysis and that the cone defects was 
a secondary result of the surrounding rod loss. 
Noel and colleagues compared the effectiveness of IAA with Sodium 
iodate (NaIO3), finding the second one ineffective in swine (Noel et al., 2012). 
The authors tested the same concentrations of IAA of the previous work 
published by Scott et al., 5, 7.5, 10 and 12 mg/kg. The data confirm the 
preferential damage in rods compare to cone due to IAA administration and the 
damage is concentration-dependent. The mfERG was performed only in 
7.5mg/kg IAA treated pigs, but as the light adapted ERG for the same IAA 
concentration showed an increase of cones responds 5-6- weeks after 
treatment. This data confirm Wang theory of cones ability to resynthesize 
GAPDH and restore glycolysis. The trend is not maintained for the higher IAA 
concentration, thus moderate concentrations of IAA can mimic more initial 
stages of retinitis pigmentosa while the 12 mg/Kg concentration the late state of 
disease.  
This founding make the IAA pig model a rapidly and versatile model of 
retinitis pigmentosa for the study of different therapeutic approaches, from cell 
transplantation to neuroprosthetic devices (Zhang, 2016). 
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3 The role of veterinarians and 
legislative aspects 
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There is an increasing need for veterinarians worldwide. Areas of 
greatest need include translational medical research, veterinary pathology, 
laboratory-animal medicine, emerging infectious diseases, public health, 
academic medicine, and production-animal medicine. Veterinarians have unique 
skill sets that enable them to serve as leaders or members of interdisciplinary 
research teams involved in basic science and biomedical research with 
applications to animal or human health (Rosol et al., 2009). 
Translational medicine is connected with basic science and the use of 
animals and to improve the translational value of animal models is fundamental 
to “better know” the model itself.  
In addition to performing research themselves, veterinarians play crucial 
roles in the support of biomedical research. Laboratory animal veterinarians 
support the medical care and health of laboratory animals, promote animal 
well-being and humane care of laboratory animals, maintain barrier conditions 
against diseases to improve laboratory research, conduct collaborative 
research, provide technical instruction to scientists, monitor compliance with 
state and federal regulations, and serve on institutional animal research review 
panels.  
Veterinary and medical pathologists (that specialize in laboratory animal 
pathology) are central to the diagnosis of spontaneous diseases, understanding 
the mechanisms of disease induced by experimental procedures, and analyzing 
the phenotype of spontaneous or induced genetic modifications in animals. 
When there is a lack of expert pathology support on a research project 
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important information may be misinterpreted or go undiscovered, which 
reduces the impact of animal-based research.  
Laboratory animal veterinarians are professionals who by virtue of 
interest, experience, and training are specialized in working with and caring for 
laboratory animals. They are integral members of the research team and 
provide veterinary support for model development and implementation as they 
work to safeguard animal wellbeing. Although basic veterinary education 
imparts some of the specialized skills and information necessary to work with 
laboratory animals, the diversity and complexity of the laboratory environment 
and the species used within that environment generally require additional 
experience and training (Turner et al., 2009). 
The International Association of Colleges of Laboratory Animal Medicine 
(IACLAM) and the International Council for Laboratory Animal Science (ICLAS) 
support the efforts of regional organization and communities of laboratory 
animal science professionals as well as the development of local associations 
and professional colleges that promote the training and continuing education of 
research facility personnel and veterinary specialists (Turner et al., 2015). 
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3.1 The three R’s 
 
In 1959, William Russell and Rex Burch published "The Principles of 
Humane Experimental Technique". They proposed that if animals were to be 
used in experiments, every effort should be made to Replace them with non-
sentient alternatives, to Reduce to a minimum the number of animals used, and 
to Refine experiments which used animals so that they caused the minimum 
pain and distress (Russell and Burch, 1959).  
“Good welfare equals good science” has become the mantra ever since 
Trevor Poole first highlighted the relationship between research animal welfare 
and the quality of science, and, in the intervening decades, the evidence base for 
this relationship has been steadily growing (Prescott and Lidster, 2017). Animal 
welfare means how an animal is coping with the conditions in which it lives. An 
animal is in a good state of welfare if, as indicated by scientific evidence, it is 
healthy, comfortable, well-nourished, safe, able to express innate behavior, and 
if it is not suffering from unpleasant states such as pain, fear and distress. Every 
effort should be made to minimize unnecessary harm because animals with 
compromised welfare have disturbed behavior, physiology and immunology. 
This can lead to unreliable conclusions and/or unwanted variation in scientific 
output, affecting both the reliability and repeatability of experiments.  
Often, appropriately designed experiments that minimize variation, 
provide standardized optimum conditions of animals care and minimize 
unnecessary stress or pain yield better more reliable data (Flecknell, 2002)  
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The definitions of replacement, reduction, and refinement in the 
Principles were crafted with an overriding and clearly expressed aim: the 
reduction and, whenever possible, the elimination of animal distress consistent 
with the conduct of sound science. Put another way, it was not the use of 
animals in research that Russell and Burch found problematic, but the infliction 
on research animals of unnecessary or avoidable pain, fear, stress, anxiety, bodily 
discomfort and other significantly unpleasant feelings (Tannenbaum and Bennett, 
2015). 
Replacement 
Russell and Burch provide a detailed definition of replacement: 
“We shall use the term ‘replacement technique’ for any scientific method 
employing non-sentient material which may in the history of experimentation 
replace methods which use conscious living vertebrates. Among this non-sentient 
material, we include higher plants, microorganisms, and the more degenerate 
metazoan endoparasites, in which nervous and sensory systems are almost 
atrophied” (Russell and Burch, 1959). 
Non-animal research techniques have helped us to reduce the number of 
situations in which animal procedures are needed. These techniques include the 
use of statistical data already obtained from animal research, studies of isolated 
cells and tissues, new scanning methods, computer models that simulate an 
animal’s response to specific experiments, and studies of patients and 
populations. 
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Much safety testing can now be undertaken without the use of animals. 
For example, the Ames test uses bacteria instead of rodents to see whether a 
chemical is likely to damage DNA or has potential to cause cancer (Rodríguez et 
al., 2012). Similarly, some tests now use less complex animals than before: 
scientists can check injected medicines for most pyrogens (fever-causing 
bacterial contaminants) by using blood cells from the horseshoe crab, replacing 
tests on rabbits (Wachtel and Tsuji, 1977). More recently, the bovine whole 
blood assay (bWBA) reproducibly enabled sensitive detection of endotoxin and 
non-endotoxin pyrogens and may thus become a viable alternative for pyrogen 
testing (Wunderlich et al., 2014). 
Unfortunately, some non-animal research methods only give limited 
information about what happens in a whole, living animal. Despite the progress 
made as a result of attention to this principle, several major problems have been 
identified. When replacing animals with alternative methods, it has often 
proven difficult to formally validate the alternative. This has proven a particular 
problem in regulatory toxicology, especially when combined with the 
labyrinthine processes of the various regulatory authorities (Flecknell, 2002).  
Reduction 
The Principles defines reduction as “reduction in the numbers of animals 
used to obtain information of a given amount and precision” (Russell and Burch, 
1959). Like the other Rs, reduction serves the aim of reducing and when 
possible removing inhumanity or distress. 
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This can be achieved in many ways. Good experimental design and 
statistical analysis ensure that researchers use the optimum number of animals. 
Using inbred animals means researchers can get reliable results from fewer of 
them. Animals get fewer secondary infections or diseases, which might interfere 
with studies, if kept in clean environments. New scanning techniques mean that 
tumors can be tracked non-invasively, with more data collected from the same 
animal (Xing et al., 2014). Measures like freezing embryos mean that fewer 
rodents are needed for genetic modification breeding programs and in general 
the biobanking system reduce the number of animal and the waste of biological 
material (Artene et al., 2013). 
For ethical and economic reasons, it is important to design animal 
experiments well, to analyze the data correctly, and to use the minimum 
number of animals necessary to achieve the scientific objectives, but not so few 
as to miss biologically important effects or require unnecessary repetition of 
experiments. Investigators are urged to consult a statistician at the design stage 
and are reminded that no experiment should ever be started without a clear 
idea of how the resulting data are to be analyzed (Festing and Altman, 2002). 
The principle of Reduction would appear less contentious, but its 
application has highlighted the difficulties of providing appropriate expert 
statistical advice, especially in academic research facilities. In some instances, 
concern to implement Reduction strategies can result in the use of too few 
animals, which leads to inconclusive results, and wasteful experiments 
(Flecknell, 2002).  
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Refinement 
The Principles defines refinement as “any decrease in the incidence or 
severity of inhumane procedures applied to those animals which still have to be 
used” (Russell and Burch, 1959). Russell and Burch subsequently state that the 
“object [of refinement] is simply to reduce to an absolute minimum the amount 
of distress imposed on those animals that are still used” 
Paul Flecknell, the author of Laboratory Animal Anesthesia, highlighted 
the problems concerning the Refinement. He noticed that people tend to make 
assumptions about animals and their feelings that often have little scientific 
basis.  The problem is that these assumptions concerning an animal's likely 
experience of pain and distress may become incorporated into institutional or 
national policies, without any attempt to verify them. To give an example - it is 
reasonable to assure that animals will experience pain after a surgical 
procedure, so pain-relieving drugs should be given to prevent this. Requiring 
every animal to have the same dose of the same drug after any surgical 
procedure is not the best way of dealing with postoperative pain (Roughan and 
Flecknell, 2003). He suggest to focus on this area, not only to work on new 
methods of implementing the 3Rs, but also to disseminate current "Best 
Practice”, and to revise this advice as further progress is made. 
A good example of refinement is the new approach developed by Michael 
Emerson and colleagues for studying pulmonary embolism in mice (Moore and 
Emerson, 2012). Conventional modeling relies on injection of thrombogenic 
substances in conscious animals that often results in paralysis and death. In 
contrast, Emerson's refined model is performed under general anesthesia using 
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radiolabeled platelets and imaging to measure platelet function in real time 
during non-fatal thromboembolism. Not only is the new in vivo model a 
significant refinement, it also better mimics the physiology and biochemistry of 
the condition in man and models a broader spectrum beyond the extreme, fatal 
stage (Prescott and Lidster, 2017). 
The 4th R, Responsibility 
The 4th R of Research implies addition of ‘responsibility’ to the original 
three R's of Russell and Burch(Banks, 1995). It has grown into a new era of 
performance-based outcomes, which reflects integrity, honesty, and scientific 
correctness in appropriate and reasonable use of laboratory animals. This 
ensures that animal life is required and necessary for biomedical advancement. 
The concept of responsibility is being mobilized at both the individual 
level and with relation to good scientific practice more broadly at the 
organizational level. Institutions and industry that use animals in their research 
often make reference to the 3Rs, and it appears this is ‘used as evidence of the 
research community’s commitment to meet high ethical standards in the care 
and use of laboratory animals’ (Franco and Olsson, 2014). For example, the 
University of Oxford state on their website that they are ‘committed to pursue a 
policy of reduction, replacement, and refinement (3Rs) in all animal based 
research and to promote knowledge of the moral and legal responsibilities and a 
culture of care in all aspects of research’ (“University Policy on the Use of 
Animals in Scientific Research | University of Oxford,” n.d.). 
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At the broader governance and legislative level, the original embedding 
of the 3Rs principles within the 1986 EU legislation was clearly tied to 
expectations of ‘responsible animal research’, and more attention to ethical 
dimensions within animal research (Matthiessen et al. 2003). More recently, the 
National Centre for the Replacement, Refinement and Reduction of Animals in 
Research (NC3Rs), in collaboration with six other major UK funding bodies, has 
produced a set of guidelines entitled Responsibility in the Use of Animals in 
Bioscience Research (“Responsibility in the use of animals in bioscience research 
| NC3Rs,” n.d.). Within the guidelines, various responsibilities are set out for 
researchers, ethics committees, and peer reviewers to ensure implementation 
of the 3Rs. These responsibilities are mainly tied to legislative obligations, and it 
is notable that there is no mention of responsibility to the general public or 
wider society. 
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4 Aims 
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Scientists are becoming every day more aware that a deep 
knowledge of an animal used in biomedical science can lead to more 
reliable data. The role of the 3Rs in promoting health and welfare of 
laboratory animal models has improved in the last 50 years 
becoming a guide to the entire scientific and non-scientific 
community.  The translational value of animal models is becoming 
an important topic of debate due to the high frequency of fail when 
animal experiments are replicate on humans. 
The pig is a largely used and quite validated animal model for 
many human diseases. The role of the gut microbiota is well known 
and its impact on the host health is enormous; the pig has already 
been identified as a strong reliable model to study gut microbiota 
modulation. 
For this reasons the first aim of this work was to better 
characterize the role of nutrition on the gut microbiota in the pig 
model. More in detail we wanted to investigate the impact of einkorn 
flour, sourdough fermentation and iron fortification on the gut 
microbiota and inflammatory status using the pig as translational 
model. 
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Vision is the most precious among the five senses. 
Unfortunately degenerative retinal diseases that lead to vision 
decrease and blindness are extremely frequent with enormous 
social and economic costs. Many strategies have been applied 
worldwide to find a treatment for retinal degeneration, from gene 
therapy to bio-prosthetic devices. But new therapeutic approaches 
need to be tested on animal models.  
The pig due to anatomical and physiological similarities is 
often the gold standard model to test those strategies. The pig retina 
is indeed rich in cones, the cells responsible for daytime vision and 
visual acuity. Electrophysiological investigation is the tool to 
characterize and follow the progression of retinal diseases. It is very 
useful in clinic but also as preclinical investigation on animal model, 
for this reasons it is important to standardize and divulgate 
electrophysiological retinal responses of most commonly used 
animal models. 
The second aim of my work was to investigate a chemically 
inducible retinal degeneration pig model. This model is a rapidly 
inducible cost-effective model and the characterization of its visual 
pathways could help to spread its use in biomedical science.  
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5 The pig model to evaluate new 
bakery functional foods: the 
European project Bake4Fun 
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Nutritional iron deficiency (ID) is estimated to affect 1.5–2 billion people 
worldwide. In the Western society, consumers are increasingly adopting a 
preventive dietary strategy to reduce food intake or the consumption of specific 
foods, thus leading to the decrease of micronutrient intake correlated to ID. 
BAKE4FUN responds to the needs of food SMEs of innovating food formulations 
and technologies to overcome the negative effect of iron fortification of bakery 
products on their sensorial characteristics in order to produce bakery foods 
with an improved nutritional profile and health-promoting effects. 
Figure 11. The logo of the European project Bake4Fun 
 
In particular, BAKE4FUN (Fig. 11) aimed to provide, validate and develop 
innovative health-promoting bakery products based on a new iron 
microencapsulation technology and on the use of non-conventional high-added 
value whole grain flours, able to obtain healthy, sustainable and ethically 
correct products, to increase antioxidant intake and to improve the gut 
microbiota. 
Research activities carried out within BAKE4FUN were focused on i) the 
effect of bread obtained by the sourdough fermentation of non-conventional 
grains on the gut microbiota, the glycemic load, and the inflammatory and 
oxidative status; ii) the bioavailability of microencapsulated iron in fortified 
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breads, their effects on the iron status, on biomarkers of oxidation and 
inflammation.  
To respond to the need of developing safe, effective and validated 
functional bakery products three in vivo experiment were carried out on animal 
model. The pig was chose for its similarities with human gastro intestinal tract 
and microbiota. 
Ethical Statement  
The use of animals in the experiments 1, 2 and 3 was regulated by two 
protocols approved by the Italian Ministry of Health with D.Lgs 116/92.  
The experimental protocol was presented at the first section of Ethical 
Committee on Animal Experimentation available after the definition of the 
research plan. The experimental protocol was numbered 10-75-2013, discussed 
by the Committee in the session of 15 April 2013 and obtained the approval. 
Subsequently the protocol was sent to the Ministry of Health in 
communication regimen on the 7 June 2013, obtaining authorization by means 
of a tacit consent 30 days after the receipt.  
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5.1 Experiment 1. Evaluation of the impact of novel 
ancient flour bakery products on the intestinal 
microbiota, oxidative and inflammatory status  
 
Einkorn (Triticum monococcum L. ssp. monococcum) is a diploid (2n=2x 
=14) hulled wheat and a close relative of durum (Triticum turgidum ssp. durum) 
and bread (Triticum aestivum ssp. aestivum) wheats (Fig. 12). It was 
domesticated about 10 000 years ago in the Fertile Crescent, most probably in 
the Karacadağ mountains of Turkey, and spread to Europe during the 
Agricultural Revolution (Hidalgo and Brandolini, 2014). 
Figure 12. Spikes, hulled seeds and threshed seeds of Triticum monococcum ssp. 
monococcum. From(Hidalgo and Brandolini, 2014)  
 
The new interest in einkorn is based on its thrifty nature, particularly 
appropriate for low-input and organic managements, and on the perceived high 
nutritional value of its flour. Numerous recent studies confirm a consensus 
positive evaluation of the dietary merit of T. monococcum. Compared with the 
widespread durum and bread wheats, einkorn kernels are significantly richer in 
proteins, lipids (mainly PUFA and MUFA) and fructans; some trace elements, 
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including the ever-important zinc and iron, are also found in higher 
concentrations (37.2–62.6 mg/kg iron; 42.7–71.1 mg/Kg zinc) . Carotenoids, 
tocols, conjugated phenolics, alkylresorcinols and phytosterols, antioxidants 
with relevant healthful properties, are present in significant quantities; the low 
β-amylase and lipoxygenase activities of einkorn whole meal flours limit their 
degradation during food processing, largely maintaining the positive nutritional 
properties of this species. On the other hand, compared with bread wheat, 
einkorn has lower dietary fiber and insoluble bound polyphenol contents, along 
with higher PPO activity. For the above mentioned characteristic einkorn is a 
promising candidate for the development of new or special foods such as bakery 
products, baby foods or products with high contents of dietary fiber, 
carotenoids and tocols. 
The use of sourdough in baked and steamed bread production worldwide 
is increasing due to the improved sensory and nutritional quality of sourdough 
bread when compared to bread produced by straight dough processes (Gobbetti 
et al., 2014). Traditionally, sourdough has been used as leavening agent. The use 
of sourdough as baking improver in combination with baker's yeast also allows 
replacement of additives with “clean label” ingredients in industrial baking. 
Moreover, the fermentation of sourdough in the bakery is an alternative to the 
use of additives (Gänzle and Ripari, 2016). 
The species richness in a single batch of sourdough (α-diversity) is 
limited; typically, less than 6 different species or strains account for more than 
99% of microbial cells.  
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In contrast, the γ-diversity of sourdoughs, the number of species isolated 
from sourdoughs globally, encompasses more than 80 bacterial species, 
including mainly species of the Lactobacillaceae and Leuconostocaceae but also 
lactococci, enterococci, and streptococci (Gänzle and Ripari, 2016). 
The human intestinal microbial ecosystem plays an important role in 
maintaining health. A multitude of diseases including diarrhoea, gastrointestinal 
inflammatory disorders, such as necrotising enterocolitis (NEC) of neonates, 
and obesity are linked to microbial composition and metabolic activity. 
Therefore, research on possible dietary strategies influencing microbial 
composition and activity, both preventive and curative, is being accomplished. 
Heinritz reviewed the use of pig as a model to study the dietary 
modulation of the human gut microbiota (Heinritz et al., 2013), finding  the pig a 
validated model due to its similarities in terms of gastro-intestinal tract and 
body constitution and microbial fermentation and composition with humans. 
The aim of the present experiment was therefore to study the impact of 
novel ancient flour bakery products on the intestinal microbiota, oxidative and 
inflammatory status in a pig model.  
More specifically we wanted to investigate the role of einkorn flour and 
sourdough fermentation used to bake breads produced to improve the quality 
of human health. 
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5.1.1 Materials & Methods 
 
Animals 
36 commercial hybrid  pigs (LW x D) of 30 Kg, 18 female and 18 males, 
all coming from the same piggery were used in this study. The experiment was 
divided in two blocks in order to guarantee a better management of the animals. 
The animals were delivered to the ANFI-ASA Unit (Dipartment of Veterinary 
Medicine, University of Bologna) in two groups, five days before the beginning 
of the trial (acclimation period) and randomly divided in six groups. The 
animals were weighed at 0, 7, 14 and 30 days to control the growth 
performances. 
Diet 
The pigs were all fed with Swine Standard Diet (SSD) during the 
acclimation period. The standard diet was particularly formulated for pigs 
between 30 and 80Kg by CESAC s.c.a. Conselice (RA), and the diet composition is 
reported in table 9. At the beginning of the trial, each box (three animals per 
box) was randomly assigned to an experimental diet for 30 days: A, B, C, D, E 
and F (Tab. 10). From this point all animals and samples were indicated with the 
alphanumeric code keeping blind all the operators. The experimental bread was 
prepared and delivered (dehydrated and grinded) to the ASA Unit by Piekarnia 
W.W.K. Vini in Rogoźnik. The ancient flour was einkorn (Triticum monococcum 
L. ssp. monococcum) grown in Italy. The experimental diets were prepared by 
mixing, for at least 5 minutes, the SSD and one of the experimental bread in 1:1 
ratio. A horizontal mixer, single reel of 200 liters capacity with double 
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concentric coil was used for the mixing. Before and after each mixing session a 
sample of bread and a sample of the experimental diet were collected and 
analyzed to quantify total humidity. 
 
Table 9. Standard Swine Diet composition (Big 30-80 by CESAC s.c.a). 
Components 
Corn, soy flour, wheat bran, barley, white sorghum, calcium carbonate, vegetable oils and fats, 
sodium chloride 
Analytical components %  
Crude protein 16.50%, crude oils and fats 3.50%, crude cellulose 4.70%, crude ash 4.10%, 
calcium 0.50%, phosphorus 0.40%, sodium 0.10%, lysine 0.90%, methionine 0.30% 
Additives /Kg  
Vitamins and pro-vitamins 
Vit A E627 12500UI 
Vit D3 E671 2000UI 
Vit E 3°700 50mg 
Vit B1 2.0mg 
Vit B2 4.0 mg 
Vit B6 3.0 mg 
Vit B12 0.025mg 
Vit K 2.5 mg 
Vit PP 25mg 
Pantothenic acid 12.5mg 
Vit H 0.25mg 
Compounds of trace elements 
E 4 cupric sulfate, pentahydrate 79mg 
E 8 sodium selenite 0.55mg 
E 6 zinc oxide 155mg 
E1 ferrous sulfate monohydrate 456mg 
E5 manganous oxide 129mg 
E2 potassium iodide 2.0mg 
Antioxidants 
Ethoxyquin E324 34mg 
Butylated (BHA) E320 30mg 
 
Table 10. Experimental diets. 
 
Experimental Bread 
Experimental 
diet 
SFCF = Bread made with Standard Flour + Conventional 
Fermentation  
A 
AFCF = Bread made with Ancient Flour + Conventional Fermentation B 
SFSSF = Bread made with Standard Flour + Sourdough Standard 
Fermentation 
C 
AFSSF = Bread made with Ancient Flour + Sourdough Standard 
Fermentation 
D 
AFSAF = Bread made with Ancient Flour + Sourdough Ancient 
Fermentation 
E 
SFSAF = Bread made with Standard Flour + Sourdough Ancient 
Fermentation 
F 
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Sampling 
Fecal samples were collected at 0, 15 and 30 days for gut microbiota 
evaluation and to investigate differences among digestive process of tested 
breads by NMR technique. Blood samples (serum, Li-heparin and EDTA) were 
collected at the beginning and at the end of the trial for clinical evaluation 
(complete blood count) and to evaluate the impact of tested breads on the 
oxidative and inflammatory status 
For fecal sampling an operator was standing in the box with the animals. 
The samples were collected directly when spontaneous defecation occurred and 
immediately stored at -20°C. Samples were then stored at -80°C until the 
moment of analysis. Blood samples at the beginning and at the end of the trial 
were collected from jugular vein under general anesthesia with the following 
protocol: intramuscular (IM) administration of Azaperone (2mg/Kg), after 10 
minutes in dark and quite condition an IM bolus of Ketamine (40mg/Kg). 
Venosafe® Plastic Tubes for Serum Gel, K3EDTA and Li-heparin (Terumo, 
Tokyo, Japan) were used for blood sampling. Blood samples (K3EDTA) were 
analyzed at the Veterinary Clinical Pathology Service (SEPAC VET) for complete 
blood count (CBC). Serum Gel and Li-heparin tubes were centrifuged (100g x 
10min), then serum and plasma where stored at -80°C.  
Gut microbiota evaluation 
DNA extraction 
Total bacterial DNA was extracted from fecal material using QIAamp DN 
Stool Mini Kit (QIAGEN, Hilden, Germany) with a modified protocol (Salonen et 
al., 2010). Briefly, 250 mg of feces were suspended in 1 ml of lysis buffer (500 
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mM NaCl, 50 mM Tris-HCl pH 8, 50 mM EDTA, 4% SDS) and 3 times bead-beaten 
with four 3-mm glass beads and 0.5 g of 0.1-mm zirconia beads (BioSpec 
Products, Bartlesville, OK) in a FastPrep-24 Instrument (MP Biomedicals, Irvine, 
CA) at 5.5 m/s for 1 min. After incubation at 95°C for 15 min and centrifugation 
at full speed for 5 min to pellet stool particles, 260 μl of 10 M ammonium acetate 
were added to the supernatant, followed by incubation in ice for 5 min and 
centrifugation for 10 min. One volume of isopropanol was added to the 
supernatant and incubated in ice for 30 min. Precipitated nucleic acids were 
washed with 70% ethanol, resuspended in 100 μl of TE buffer and treated with 
2 μl of DNase-free RNase (10 mg/ml) at 37°C for 15 min. Each DNA sample was 
further treated with Proteinase K and purified with QIAamp Mini Spin columns 
(QIAGEN) following the manufacturer’s instructions. DNA concentration and 
quality was evaluated using NanoDrop ND-1000 spectrophotometer (NanoDrop 
Technologies, Wilmington, DE).  
16S rRNA gene sequencing and processing 
For each sample, the V3-V4 region of the 16S rRNA gene was PCR 
amplified, and the resulting single amplicons of approximately 460 bp were 
cleaned up and sequenced on Illumina MiSeq platform using a 2×300 bp paired 
end protocol, according to the manufacturer’s instructions (Illumina, San Diego, 
CA). In detail, PCR reactions were carried out in 25 μl volumes containing 12.5 
ng of microbial DNA, 2x KAPA HiFi HotStart ReadyMix (KAPA Biosystems, 
Resnova, Rome, Italy), and 200 nM of S-D-Bact-0341-b-S-17/S-D-Bact-0785-a-
A-21 primers (Klindworth et al., 2013) carrying Illumina overhang adapter 
sequences. Reaction conditions were as follows: initial denaturation at 95°C for 
73 
 
3 min, followed by 25 cycles of denaturation at 95°C for 30 sec annealing at 
55°C for 30 sec, and extension at 72°C for 30 sec, with a final extension step at 
72°C for 5 min. Amplicons were purified with a magnetic bead-based clean-up 
system (Agencourt AMPure XP; Beckman Coulter, Brea, CA). Indexed libraries 
were prepared by limited-cycle PCR using Nextera technology and further 
cleaned up with Agencourt magnetic beads. Final libraries were pooled at 
equimolar concentrations, denatured and diluted to 6 pM before loading onto 
the MiSeq flow cell. 
Raw sequences were processed using a pipeline combining PANDAseq 
(Masella et al., 2012) and QIIME (Caporaso et al., 2010). High-quality reads were 
binned into Operational Taxonomic Units (OTUs) at a 0.97 similarity threshold 
using UCLUST (Edgar, 2010). Taxonomy was assigned using the RDP classifier 
against Greengenes database. To filter out PCR errors and chimeras, all 
singleton OTUs were discarded. Alpha rarefaction was performed using the 
Faith’s phylogenetic diversity, Chao1, observed species, and Shannon index 
metrics. Beta diversity was estimated by computing weighted and unweighted 
UniFrac distances, which were used as input for principal coordinates analysis 
(PCoA). All statistical analyses were performed in R 3.1.3. P values were 
corrected for multiple comparisons using the Benjamini-Hochberg method 
when appropriate. A corrected P<0.05 was considered as statistically 
significant. 
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Oxidative and inflammatory status evaluation 
Total antioxidant capacity (TAC) 
TAC was measured in plasma as previously reported (Amaretti et al., 
2013). The method is based on the ability of the antioxidant molecules in the 
sample to reduce the radical cation of 2,2′-azinobis- (3-ethylbenzothiazoline-6-
sulfonic acid) (ABTS·+). TAC was determined in 10μl plasma by evaluating the 
decoloration of ABTS·+, measured as the quenching of the absorbance at 734 
nm. Values obtained were compared to the concentration–response curve of the 
standard Trolox solution and expressed as micromoles of Trolox equivalents 
(TE)/mL of plasma. 
Glutathione (GSH) content 
Plasma reduced GSH concentration was determined as previously 
described (Amaretti et al., 2013). One hundred μl of plasma were incubated for 
30 min in 100 μl reagent buffer (80 mM sodium phosphate, pH 8.0; 2 mM EDTA; 
2 % SDS; 250 μM DTNB), and GSH was measured spectrophotometrically by 
reading at 415 nm the absorbance of TNB. Results were compared to the 
concentration–response curve of standard GSH solutions and expressed as 
nanomoles of GSH/mL plasma. 
Thiobarbituric acid reactive substances (TBARS) level 
TBARS, the end-products of lipid peroxidation, were assayed as 
previously reported (Valli et al., 2012) with slight modification. Briefly, 100 μl of 
plasma diluted 1:10 in DPBS were added to a mixture containing 100 μl TCA 
(30% in 0.25N HCl), 100 μl TBA (0.75% in 0.25N HCl) and 3 μl BHT (1% in 
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ethanol). The mixture was heated for 10 min in a boiling water bath, allowed to 
cool and the TBA adducts were detected fluorimetrically (λex 535 nm; λem 595 
nm). TBARS level was expressed as relative fluorescence units (RFU). 
Cytokines production 
Cytokines (IFNα, IFNγ, IL-1β, IL-4, IL-6, IL-8, IL-10, and TNFα) 
production was evaluated by the Ciraplex® immunoassay kit following 
manufacturer’s instructions. Briefly, the assay is a multiplex sandwich ELISA 
where each well of the 96-well microplate is pre-spotted with protein-specific 
antibodies and these antibodies capture specific proteins from the standards 
and samples of interest. After unbound proteins are washed away, biotinylated 
detecting antibodies are added and bind to a secondary site on the target 
proteins. After the removal of excess detection antibody, 
streptavidinhorseradish peroxidase (SA-HRP) is added. HRP is an enzyme that 
reacts with a substrate to produce a luminescent signal that is detected by the 
Cirascan™ Imaging System. The intensity of the signal produced is directly 
proportional to the quantity of each protein in the standard or sample of 
interest. 
Digestive process investigation 
NMR spectra acquisition 
Fecal samples were prepared for proton nuclear magnetic resonance 
spectroscopy (1H-NMR) analysis by vortex mixing 40 mg of stool for 5 minutes 
with 800 μl of deionized water, followed by centrifugation for 15 minutes at 
15,000 rpm at 4°C. 700 μl of supernatant were added to 160 μl of a D2O 1M 
phosphate buffer at pH 7.00 solution of 3-(trimethylsilyl)-propionic-2,2,3,3-d4 
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acid sodium salt (TSP) 6.25 mM. The samples were stored at -20°C prior to 
analysis. Immediately before analysis the samples were thawed and centrifuged 
again. 1H-NMR spectra were recorded at 298 K with an AVANCE III 
spectrometer (Bruker, Milan, Italy) operating at 600.13 MHz.  
The HOD residual signal was suppressed by applying the first increment 
of the NOESY pulse sequence and a spoil gradient (Laghi et al., 2014). This was 
done by employing the NOESYGPPR1D sequence, part of the standard pulse 
sequence library. Each spectrum was acquired by summing up 256 transients 
using 32 K data points over a 7211.54 Hz spectral (for an acquisition time of 
2.27s). In order to apply NMR as a quantitative technique (Pauli, 2001), the 
recycle delay was set to 5s, keeping into consideration the longitudinal 
relaxation time of the protons under investigation. The signals were assigned by 
comparing their chemical shift and multiplicity with the Human Metabolome 
Database (Wishart et al., 2007) and Chenomx software data bank (Chenomx Inc., 
Canada, ver 8.1). 
Data analysis 
1H-NMR spectra baseline was adjusted by means of the simultaneous 
peak detection (Coombes et al., 2003) and baseline correction algorithm 
(SPDBC) implemented in the baseline R package (Liland et al., 2010). Briefly, the 
algorithm tries to iteratively locate peaks as consistent deviations from noise 
and interpolate over the spectra after peak removal. To each spectrum a linear 
correction was then applied to make the points pertaining to the baseline 
randomly spread around zero. The spectra were overall corrected for errors in 
chemical shift misalignments using an in-house modified version of Correlation 
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Optimized Shifting (i-Coshift) (Savorani 2010) able to perform the Co-shift in 
localized regions of the spectrum. As pigs ileal, duodenal and fecal metabolome 
have been rarely studied by NMR through a metabolomic approach, literature 
lacks a detailed description of the NMR spectra pre-processing pipeline. This 
applies in particular to signals alignment procedure by icoshift, with the 
following iCoshift NMR signals alignment procedure command string: 
 [Allin, intervals,indexes]=icoshift('median', b4f7.y,[9.14 9.118, 8.278 
8.259, 8.211 8.203, 8.112 8.087, 7.962 7.893, 7.879 7.861, 7.553 7.546, 7.54 
7.532, 7.125 7.1, 6.984 6.943, 6.426 6.375, 5.993 5.973, 5.641 5.606, 0.7055 
0.6133], 'b', [2,0,0,10,1], b4f7.x). 
Differences in soluble solids content among samples was taken into 
consideration by probabilistic quotient normalization (Dieterle et al., 2006). The 
signals were assigned by comparing their chemical shift and multiplicity with 
the Human Metabolome Database (Wishart et al., 2007) and Chenomx software 
data bank (Chenomx Inc., Canada, ver 8). Signals which significantly varied 
(P<0.05) among the samples groups under investigation were looked for by 
means of a Type II ANOVA test followed by TukeyHSD post hoc test. The 
assumptions of Anova normal distribution and equality of variance were tested 
by Shapiro and Bartlett tests respectively. 
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5.1.2 Results and Discussion 
 
Growth performance and clinical evaluation 
The daily observation of the animals showed that pigs housed in box A, B 
and D had diarrhea throughout the first two weeks and completely recovered 
within the second part of the trial. The pigs housed in the other three boxes 
preserved their normal gastrointestinal functions during the entire experiment. 
The humidity in the different samples of dried /grinded breads was very 
similar (9.37±0.53), so it was considered as negligible in the trials.  
The body weight of the animals for each group is presented in figure 13. 
No statistically significant differences were detected between the groups. We 
must consider that, due to experimental design, the pigs received fixed daily 
amount of experimental diet (2Kg) that was undersized for energy 
requirements. We than decide to analyze the data after normalization as body 
increment/initial weight ratio as shown in figure 14. A two way ANOVA for 
Flour*Fermentation was performed with a p<0.027 for Fermentation, post-hoc 
test HSD  
1 Sourdough Ancient Fermentation (groups E, F)   1.0341243  a 
2 Sourdough Standard  Fermetation  (groups C, D)  0.9932986 ab 
3 Conventional Fermentation (groups A, B) 0.8772724  b 
The diet E and F (SFSAF, AFSAF) did sustain better the growth of animals 
in comparison with diet A and B formulated with conventional fermentation. 
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Complete Blood Count (CBC) is shown in table 11. All CBC values fell 
within the physiological reference intervals, the differences between day 0 (T0) 
and day 30 (T30) were mainly related with the animal normal development 
stages. White Blood cells (WBC) count was decreasing from T0 to T30 in all 
groups; the decreasing was due to a cleaner environment of the ASA Unit 
compared to the standard commercial piggery where the animals were bred. 
The other differences between groups, T0 and T30 were not statistically or 
biologically significant and fell within the physiological reference intervals. 
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Figure 13. Body weight (kg) expressed as mean ±SD in the groups n= 6 
 
Figure 14. Body increment/initial weight ratio after normalization (mean ± SD) in 
the groups n=6 
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Table 11. Complete Blood Count (CBC) expressed as mean ± SD in the groups n=6 
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Gut microbiota evaluation 
A total of 8,493,063 sequence reads passing quality filtering (mean per 
sample, 81,664; range, 23,852-200,038) were obtained and analyzed. Reads 
were clustered into 5,516 non-singleton OTUs at 97% similarity. Alpha-
diversity was almost saturated for all samples, as revealed by the asymptotic 
shape of the rarefaction curves obtained with Shannon, Chao1, PD whole tree 
and observed species phylogenetic metrics (Fig. 15). 
Principal Coordinates Analysis of weighted UniFrac distances resulted in 
no significant segregation between the swine gut microbiota profiles at T0 and 
T30 for any diet group (Fig. 16). However, Procrustes similarity analysis of 
weighted UniFrac distances revealed that T30 profiles for each diet group 
partially converged, suggesting a diet-specific effect on the gut microbiota 
structure (Fig. 17). 
Analysis of the relative taxon abundance identified many notable 
differences before and after the different diet interventions at phylum, family 
and genus level. In particular, at the phylum level the relative abundance of 
Bacteroidetes significantly increased after B and C intervention, while it 
decreased after A intervention. Correspondingly, B and C diets were associated 
with significantly lower amounts of Firmicutes. D and F diets were specifically 
associated with an increase in Spirochaetes and a decrease in Proteobacteria, 
respectively 
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Figure 15. Rarefaction curves with different alpha diversity metrics: the Faith’s 
phylogenetic diversity (PD whole tree), the chao1 measure of microbial richness, 
number of observed species and the Shannon index of biodiversity.  
 
 
Figure 16. PCoA based on weighted UniFrac distances. 
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Figure 17. Procrustes similarity analysis combining weighted UniFrac distance 
PCoA of T0 (noncircle end of lines) and T30 profiles (circle end of lines) of the swine 
gut microbiota. Colors were assigned to each diet group. 
 
At the family level, the majority of diet groups were characterized by a 
significant enrichment in Bifidobacteriaceae (A, B, C, D), as well as unclassified 
members of Bacteroidales order (A, B, C, D, E). Most of the groups also showed a 
significant decrease in Streptococcaceae (A, D, E), Veillonellaceae (A, D, E, F), and 
Enterobacteriaceae (A, B, D, F). Despite these common features, some 
intervention-specific changes were identified. In particular, A diet was 
significantly associated with an increase in Clostridiaceae. C diet was associated 
with an increase of S24-7 and Desulfovibrionaceae, and a decrease in 
Lactobacillaceae. D diet was specifically characterized by an increase in 
Spirochetaceae and the Bacteroidetes families BS11, RF16 and p-2534-18B5, as 
well as by a decrease in Erysipelotrichaceae and Succinivibrionaceae. A 
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significant increase in Paraprevotellaceae and Lachnospiraceae was observed in 
E and F diet group, respectively. 
These differences were reflected at the genus level, where both common 
and unique patterns of variation were identified. In particular, the vast majority 
of diet groups were characterized by a significant decrease in Acidaminococcus 
(A, B, C, D) and Megasphaera (A, B, D, E, F). Moreover, A and F diets were 
similarly characterized by an increase in Oscillospira and Ruminococcus, 
whereas B and D diet groups were both enriched in Anaerovibrio. Among the 
specific effects of the different diets, it is noteworthy that D diet was associated 
with a significant increase in Treponema and a significant decrease in 
Phascolarctobacterium, Dialister, and Catenibacterium. B diet was specifically 
characterized by a decrease in Blautia, whereas C diet by an increase in 
Desulfovibrio. As anticipated by the family-level comparison, E diet was 
significantly associated with an increase in the Prevotella genus of the 
Paraprevotellaceae family, whereas F diet was associated with enrichment in 
Coprococcus, Dorea and Roseburia, which are all members of the 
Lachnospiraceae family. 
To better understand the gut microbiota modulation due to the different 
diets in terms of standard and ancient flour (diet A and B) the ileum and cecum 
microbiota was investigated.  
In the ileum statistical differences were observed (Fig. 18), more in detail 
the diet B lead to a decrease of Firmicutes and Sreprococcus concentration 
compared to diet A.  
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Figure 18. Beta diversity of ileum and cecum mucosae microbiota. Group A_ileum is 
orange; group B_ileum is red; group A_cecum is cyan; group B_cecum is blue 
 
In conclusion, the different diets were able to modulate the swine gut 
microbiota structure, resulting in both common and unique patterns of 
variations. Such variations may be related to functional differences in the 
microbiome with a different impact on host physiology. 
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Oxidative and inflammatory status evaluation 
In figure 19 the TAC (Fig. 19A), GSH content (Fig. 19B) and TBARS level 
(Fig. 19C) in the plasma of pigs fed the different diets are reported. Among the 
different dietary groups no significant differences in plasma TAC were detected 
either at the beginning (T0) or in the end (T30) of the trial. As well, within each 
group no significant differences between T0 and T30 were evidenced. 
At T0, plasma GSH content was similar in all groups (Fig. 19B). In pig fed 
the SFCF diet (A), plasma GSH concentration increased upon the dietary 
treatment, while no differences were detected in other groups. As well, plasma 
TBARS concentration was similar in all groups at T0 (Fig. 19C), and no 
significant modifications were observed upon the dietary treatment in all 
groups but group D (fed the AFSSF diet), which evidenced a significant decrease 
in TBARS level at T30. Overall, the herein reported results indicate that the 
dietary treatment did not modify the level of antioxidant defenses in pigs, apart 
from the increase in GSH level observed in animals fed the SFCF diet. The 
different dietary treatments did not modify the level of oxidative stress, 
measured as TBARS concentration in plasma, a part from the AFSSF diet. In fact, 
animals fed this diet showed a lower plasma TBARS concentration, which is 
suggestive for a reduced lipid peroxidation. 
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Figure 19. TAC (panel A), GSH content (panel B), and TBARS level (panel C) in 
plasma of pigs fed the different diets. Data are mean +/- SD of six samples, and are 
expressed as micromoles TE/mL (panel A), nanomoles/mL (panel B), and RFU (panel C). 
TAC, GSH content and TBARS level were detected at T0 (white bars) and T30 (black bars). 
Differences among groups at T0 and T30 were tested for statistical significance by the one 
way ANOVA (n.s.);  in the same dietary group differences between T0 and T30 were tested 
for statistical significance by unpaired Student’s t tests (# p<0.05). 
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In this study, using a multi-parametric immunoassay kit specific for 
porcine cytokines, IFNα, IFNγ, IL-4, IL-6, IL-10, and TNFα plasma concentration 
were under the limit of detection of the assay at both T0 and T30 in almost all 
animals. The limit of detection were 0.0878 pg/mL, 2.017 pg/mL, 1.435 pg/mL , 
0.458 pg/mL, 0.547 pg/mL, and 7.277 pg/mL for IFNα, IFNγ, IL-4, IL-6, IL-10, 
and TNFα, respectively. Before performing the assay, the calibration curve was 
run twice and fit with the concentrations used (0.99<r2<1 for all cytokines); in 
addition, in basal, not stressed condition the normal level of interleukins in pigs 
is reported to be 0-2 pg/mL (Byrami et al., 2013; Ciepielewski et al., 2013; Wyns 
et al., 2013),which is very close to the detection limits of the multiplex sandwich 
ELISA test used in the present study.  
Therefore it seems that the undetectability of cytokines but IL-1β and IL- 8 
was not due to technical problems but to a low inflammatory status of animals. 
At T0, both IL-1β and IL-8 were detected in plasma (Fig. 20A and 20B, 
respectively), and a huge variability was evidenced among animals within and 
among groups. A very high intra and inter groups variability was detected at 
T30, too. Due to this high variability among animals, no significant differences in 
IL-1β and IL-8 plasma concentration either comparing all groups at T0 or at 
T30, or comparing the same group before and after the dietary treatment were 
observed. 
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Figure 20. IL-1 β (panel A) and IL-8 (panel B)concentration in plasma pigs at T0 
(white bar) and T30 (black bar) of treatment. Data are mean +/- SD of six samples, 
and are expressed as pg/mL of plasma. Differences among groups at T0 and T30 were 
tested for statistical significance by the one way ANOVA (n.s.);  in the same dietary group 
differences between T0 and T30 were tested for statistical significance by unpaired 
Student’s t tests (n.s.). 
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Digestive process investigation 
We identified by NMR 83 signals. Among them, 68 were assigned to (and 
employed to quantify) molecules pertaining to the classes of organic acids and 
alcohols (Tab. 12 and 13), amino acids (Tab. 14), amines (Tab. 15), nitrogenous 
bases, mono- and di-saccharides (table 16), while 15 were identified but 
unassigned (Tab. 17).  
Table 12. Position in the NMR spectra of the signals employed for the 
quantification of organic acids and alcohols 
Molecule (Chemical shift) Spectral portion Signal protons 
Formate-8.460 8.444 - 8.476 1.00 
Oxypurinol-8.206 8.202 - 8.209 1.00 
Fumarate-6.524 6.517 - 6.531 2.00 
Lactate-4.120 4.096 - 4.143 1.00 
Glycerol-3.583 3.581 - 3.586 4.00 
Methanol-3.365 3.361 - 3.369 3.00 
2-oxoglutarate-2.999 2.996 - 3.002 0.25 
2-oxoisocaproate-2.623 2.617 - 2.628 1.00 
Citrate-2.560 2.556 - 2.564 1.00 
Succinate-2.410 2.406 - 2.413 4.00 
Butyrate-2.392 2.388 - 2.396 0.31 
Pyruvate-2.377 2.375 - 2.378 2.50 
Propionate-2.206 2.201 - 2.211 0.25 
Isovalerate-2.066 2.063 - 2.070 1.00 
Acetate-1.922 1.905 - 1.938 3.00 
Valerate-1.517 1.512 - 1.522 0.50 
Ethanol-1.188 1.184 - 1.192 1.50 
 
Table 13. Position in the NMR spectra of the signals employed for the 
quantification of nitrogenous compounds and bases 
Molecule (Chemical shift) Spectral portion Signal protons 
Nicotinate-8.944 8.927 - 8.961 1.00 
Adenine-8.218 8.211 - 8.225 1.00 
Xanthine-7.926 7.918 - 7.933 1.00 
Uracil-7.536 7.534 - 7.539 0.50 
Cytosine-7.501 7.496 - 7.506 0.50 
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Table 14. Position in the NMR spectra of the signals employed for the 
quantification of aminoacids 
Molecule (Chemical shift) Spectral portion Signal protons 
tyrosine-7.198 7.185 - 7.211 2.00 
Tryptophan-7.734 7.729 - 7.739 0.50 
Phenylalanine-7.434 7.416 - 7.452 2.00 
Histidine-7.891 7.889 - 7.893 1.00 
Glycine-3.566 3.565 - 3.568 2.00 
aspartate-2.804 2.795 - 2.813 3.00 
Methionine-2.648 2.642 - 2.654 1.00 
Glutamate-2.357 2.350 - 2.364 1.33 
proline-2.015 2.009 - 2.020 1.00 
lysine-1.727 1.699 - 1.755 1.00 
alanine-1.477 1.473 - 1.482 1.50 
isoleucine-1.013 1.004 - 1.022 1.00 
valine-0.993 0.983 - 1.003 3.00 
leucine-0.964 0.960 - 0.968 1.00 
 
Table 15. Position in the NMR spectra of the signals employed for the 
quantification of amines 
Molecule (Chemical shift) Spectral portion Signal protons 
Tyramine-7.230 7.224 - 7.235 2.00 
Histamine-7.117 7.112 - 7.121 1.00 
Ornitine-Putrescine-3.060 3.041 - 3.079 2.00 
Cadaverine-3.021 3.015 - 3.027 2.00 
TMA-2.883 2.877 - 2.890 9.00 
DMA-2.703 2.699 - 2.707 6.00 
Methylamine-2.608 2.600 - 2.617 3.00 
 
Table 16. Position in the NMR spectra of the signals employed for the 
quantification of saccharides 
Molecule (Chemical shift) Spectral portion Signal protons 
Glucose-1-Phosphate-5.462 5.446 - 5.478 1.00 
Maltose-5.416 5.406 - 5.426 1.00 
Galactose-5.270 5.266 - 5.273 0.50 
Glucose-5.270 5.266 - 5.273 1.00 
Ribose-5.259 5.256 - 5.262 1.00 
Trehalose-5.215 5.211 - 5.218 0.50 
xylose-5.200 5.197 - 5.203 0.50 
Galactose-4.598 4.595 - 4.601 0.50 
Fucose-4.554 4.551 - 4.558 1.00 
Arabinose-4.529 4.533 - 4.525 0.50 
Sucrose-4.230 4.225 - 4.235 0.50 
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Table 17. Position in the NMR spectra of the signals employed for the 
quantification of other molecules 
Molecule (Chemical shift) Spectral portion Signal protons 
Phenylacetate-7.305 7.292 - 7.319 2.00 
3-phenylpropionate-7.363 7.357 - 7.369 0.80 
Indole-3-lactate-7.174 7.172 - 7.177 0.50 
p-cresol-7.150 7.137 - 7.163 2.00 
1,3-Dihydroxyacetone-4.425 4.422 - 4.428 4.00 
Choline-3.204 3.199 - 3.209 9.00 
5-aminolevulinate-2.787 2.780 - 2.793 1.00 
2-aminoadipate-2.249 2.244 - 2.255 1.00 
Acetone-2-aminoadipate-2.237 2.233 - 2.242 6.00 
N-acetilglycine-2.044 2.041 - 2.048 1.00 
N-acetilglutamate-2.038 2.035 - 2.040 1.00 
2-hydroxy-3-methylvalerate-0.860 0.857 - 0.863 1.00 
Cholate-0.738 0.730 - 0.747 1.00 
Glycocholate-0.714 0.707 - 0.721 1.00 
 
To gain an insight of the effect of both the flour employed and the kind of 
leavening agent, we set up, and explored by ANOVA, a two-way model built on 
each of the 83 signals identified by NMR on the samples obtained at the final 
timepoint of the experiment. 
The leavening agent gave rise to statistically significant differences among 
the molecules quantified in table 18 A and summarized in table 19, while the 
flour employed to prepare the bread gave rise to significant differences among 
the molecules described in table 18 B. To be sure that the found differences 
could be ascribed to the tested conditions, they were looked for, without 
success, on samples collected from the same animals at the beginning of the 
experiment. 
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Table 18. A Molecules influenced by leavening agent. B Molecules influenced by 
employed flour 
 
Table 19. Statistically significant differences among the molecules of table 9 
Conv. Leav. agent Sourd. Ancient Sourd. Standard 
Cytosine ab b A 
Phenylalanine b a Ab 
Fumarate a ab B 
X-1.819 ab b A 
alanine b a Ab 
valine b a Ab 
isoleucine b a Ab 
leucine b a Ab 
Cholate a ab B 
A B 
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To obtain an overview of the changes of molecules influenced by 
leavening agent or employed flour, a principal component analysis (PCA) model 
was calculated on their concentration, as shown in figure 21. 
PC1, accounting for the 42.6% of the total variance, was mainly 
influenced by the flour employ, with short chain fatty acids showing higher 
concentrations in the faeces of pigs fed with standard flour based bred. PC2 was, 
at the contrary, mainly influenced by the leavening agent, with sourdough based 
on standard flour leading to the greatest differences from conventional 
leavening agent, and sourdough based on ancient flour showing intermediate 
characteristics. The samples pattern was strongly influenced by the amino acids 
leucine, isoleucine, valine, phenylalanine and alanine, each of them 
characterized by the highest values as a consequence of conventional leavening 
agent. 
Figure 21. Overview by PCA of pigs faecal metabolome influenced by flour and 
leavening agent of the bread. A) Dispersion scoreplot of the pigs fed with standard 
(black) and ancient (red) flour, divided in subgroups according to the leavening 
agent; B) Median of such subgroups; C) PCA loadingplot 
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5.1.3 Conclusions 
 
The pigs enrolled in the trial were feed with the experimental breads for 
50% of their daily food requirements; the percentage was chose to obtain 
significant impact on the animals without causing nutritional deficiency. T the 
end of trial all animals were in good clinical condition and did not displayed 
nutritional deficiency. The diet A (SFCF) was the less effective to sustain the 
growth of pigs while sourdough ancient fermentation (groups E, F) breads were 
the most effective.  
No significant segregation between the swine gut microbiota profiles at 
T0 and T30 for any diet group was recorded. However, Procrustes similarity 
analysis of weighted UniFrac distances revealed that T30 profiles for each diet 
group partially converged, suggesting a diet-specific effect on the gut microbiota 
structure. Some intervention-specific changes were identified; in particular, A 
diet was significantly associated with an increase in Clostridiaceae. C diet was 
associated with an increase of S24-7 and Desulfovibrionaceae, and a decrease in 
Lactobacillaceae. D diet was specifically characterized by an increase in 
Spirochetaceae and the Bacteroidetes families BS11, RF16 and p-2534-18B5, as 
well as by a decrease in Erysipelotrichaceae and Succinivibrionaceae. A 
significant increase in Paraprevotellaceae and Lachnospiraceae was observed in 
E and F diet group, respectively. 
At the genus level, both common and unique patterns of variation were 
identified. In particular, the vast majority of diet groups were characterized by a 
significant decrease in Acidaminococcus (A, B, C, D) and Megasphaera (A, B, D, E, 
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F). Moreover, A and F diets were similarly characterized by an increase in 
Oscillospira and Ruminococcus, whereas B and D diet groups were both enriched 
in Anaerovibrio. Among the specific effects of the different diets, it is noteworthy 
that D diet was associated with a significant increase in Treponema and a 
significant decrease in Phascolarctobacterium, Dialister, and Catenibacterium. B 
diet was specifically characterized by a decrease in Blautia, whereas C diet by an 
increase in Desulfovibrio. As anticipated by the family level comparison, E diet 
was significantly associated with an increase in the Prevotella genus of the 
Paraprevotellaceae family, whereas F diet was associated with enrichment in 
Coprococcus, Dorea and Roseburia, which are all members of the 
Lachnospiraceae family. 
Anyway, the different diet did not modify the level of antioxidant 
defenses in pigs, apart from plasma GSH concentration that increased upon the 
dietary treatment in pig fed the SFCF diet (A), and TBARS level which evidenced 
a significant decrease in group D (fed the AFSSF diet), which is suggestive for a 
reduced lipid peroxidation. 
All animals showed a low inflammatory status with IFNα, IFNγ, IL-4, IL-6, 
IL-10, and TNFα plasma concentration under the limit of detection of the 
multiplex sandwich ELISA test used in the study. At T0, both IL-1β and IL-8 
were detected in plasma with a huge variability among animals. A very high 
intra and inter groups variability was detected at T30, too. Due to this high 
variability among animals, no significant differences in IL-1β and IL-8 plasma 
concentration either comparing all groups at T0 or at T30, or comparing the 
same group before and after the dietary treatment were observed. 
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The metabolome approach by NMR identified 68 molecules on T30 fecal 
samples. The evolution of the animal metabolome as a consequence of the diet 
was best followed by focusing on the fecal metabolome. The choice to observe 
the consequences of the diets under investigation after 30 days of 
administration was therefore considered as appropriate. The concentration of 8 
molecules was found to be influenced by the flour, 5 of which being a short 
chain fatty acid. The univariate statistical analysis allowed to observe 9 
molecules with a concentration in the fecal metabolome influenced by the 
leavening agent. It is interesting to notice that 5 of them were amino acids, 
suggesting that the efficiency in the proteins dietary content could be finely 
influenced by the modulation of their source. 
Overall our know-how on the healthy and nutritional properties of 
einkorn flour and einkorn sourdough bread have been significantly increased 
and, even if a low number of statistically significant differences were found, 
many trends were detected (better ability to sustain the growth, modulation of 
the gut microbiota and the fecal metabolome). Results on potential anti-
inflammatory role of ancient flour were not univocal, further studies will be 
necessary to better identify the effects of such as modifications in a challenging 
condition (e.g. after an inflammatory stimulus) to detect a different level of 
competence in the response of the host after a different alimentary regime. 
The results indicate that the dietary treatment were able to modulate the 
swine gut microbiota structure, resulting in both common and unique patterns 
of variations. Such variations may be related to functional differences in the 
microbiome with a different impact on host physiology. 
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5.2 Experiment 2. Evaluation of the impact of novel 
ancient flour bakery products on the glycemic index 
 
Glucose is considered to be the primary trigger for postprandial changes 
in metabolic and endocrine functioning. As a consequence, defining the 
postprandial potential glucose response after a meal is of great interest 
(Giuberti et al., 2012). 
Elevated glucose and insulin excursions may induce oxidative stress and 
subclinical inflammation as well as insulin resistance. By counteracting these 
phenomena the risk of cardiovascular diseases (CVD) and type 2 diabete (T2D) 
can be lowered. Indeed, foods with low glycemic index (GI) and low insulin 
index (II) have been demonstrated to protect against T2D and CVD in 
observational studies (Rosén et al., 2011). 
A higher dietary glycemic index has been proposed as a risk factor for 
weight gain and obesity. This notion builds on findings from experimental 
studies that a high-glycemic-index meal may induce reactive hypoglycemia in 
the late postprandial phase, which may in turn lead to hunger and higher 
voluntary energy intakes. These adverse effects of a high-glycemic-index meal 
may only become relevant if long time intervals elapse between meals, allowing 
enough time for reactive hypoglycemia to develop (Cheng et al., 2009) 
The reason for differences in glycemic response appears to relate to the 
rate at which the foods are digested and the many factors influencing this. The 
glycemic index (GI) is a system of classification in which the glycemic responses 
of foods are indexed against a standard (white bread or glucose). Low GI foods 
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may influence amino acid metabolism although the implications of these are 
unknown. In addition, low GI foods increase colonic fermentation. The 
physiologic and metabolic implications of this relate to increased bacterial urea 
utilization, and to the production and absorption of short chain fatty acids in the 
colon. 
The aim of this trial was therefore to evaluate how glycemic index change 
between breads produced with different type of flour (ancient vs conventional) 
and different type of fermentation (yeast vs sourdough). In addition we evaluate 
the insulin level to better characterize the effects of einkorn and sourdough 
fermentation on the carbohydrates metabolism. 
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5.2.1 Materials & Methods 
 
Animals 
6 hybrid (LW x D) female pigs of 50Kg all coming from the same piggery 
were used in this study. The animals were delivered to the ASA Unit two at a 
time five days before the beginning of the experimental procedure and stabled 
in multiple boxes. 
The animals were cannulated in the jugular vein with a central 
permanent silicon catheter (BBraun, Bethlehem, USA) under general anesthesia 
and stabled in single overhead boxes for a week to recover before the beginning 
of the trial. For the surgery pigs were premedicated with an intramuscular (IM) 
bolus of ketamine (20 mg/kg) and medetomidine (0.03 mg/kg). Ten minutes 
after, when recumbent, a venous access was achieved through an auricular vein 
and animals were inducted with a bolus of tiopenthal (0,25 gr/animal). 
Orotracheal intubation was performed using a 8 mm ID endotracheal tube. 
Anesthesia was maintained with isoflurane (2-3%) in a mixture 1:1 of oxygen 
and air.  
Diet 
Although the experimental breads have excellent organoleptic 
characteristic, the pigs bred in standard commercial conditions were not use to 
their flavor. Therefore the animals have been trained to eat the experimental 
bread. During the training period the animals were fed with a Swine Standard 
Diet (SSD) and experimental bread mix, in a 1:1 ratio. After a week of training 
pigs were spontaneously eating the experimental breads by itself. In the 
morning, after 18 hours of fasting, pigs were feed with 50gr of one of the six 
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experimental breads, then the blood was sampled every 15 min for two hours. 
At the end of the experimental session the animals were fed with SSD to meet 
the daily nutritional requirements. The bread was changed with a Latin Square 
design (6 x 6). After 2 days of standard diet the challenge was repeated twice. 
Sampling 
Blood samples were collected from jugular vein 15 minute before the 
administration of the bread and every 15 minute for 2 hours to measure glucose 
and insulin level by standard clinical chemistry analysis (Fig. 22). For the blood 
glucose detection a rapid test glucometer (Contour Glucometer Xt, Bayer S.p.a., 
Leverkusen, Germany) was used while the blood for the insulin quantification 
was collected in a K3EDTA tube and stored at +4°C until the end of the post 
prandial sampling period. The K3EDTA tubes were then centrifuged (1000g x 
10min) and the plasma was stocked at -20°C. The insulin level was detected 
with a Ria Kit. 
 
Figure  22. A pig with a jugular cannula that allowed recurring blood samples and 
the rapid test glucometer used in the trial   
 
 
 
103 
 
5.2.2 Results and discussions 
 
All animals recovered completely from the surgery in about seven days, 
the food training was successful and the pigs ate the fixed experimental bread 
quantity within five minutes. The jugular catheters were constantly washed 
with saline during the trial and left with heparin to maintain patency and 
prevent thrombus formation at the catheter tip. Despite that, the catheters from 
two animals did not enable to standardize the blood sampling so we decide to 
exclude the subjects from the study.  
The data were analyzed dividing the initial groups in 4 groups as 
indicated in table 20.  The division was necessary to highlight the effect of 
different fermentation strategy and flours on the bread characteristics.  
Table  20. Groups Yeast, Sourdough, Standard (STD) four and Ancient (AN) flour 
characteristic.  
Experimental Bread Group Group on 
fermentation  
Group on 
flour 
SFCF = Bread made with Standard 
Flour + Conventional Fermentation  
A yeast STD flour 
AFCF = Bread made with Ancient 
Flour + Conventional Fermentation 
B AN flour 
SFSSF = Bread made with Standard 
Flour + Sourdough Standard 
Fermentation 
C sourdough STD flour 
AFSAF = Bread made with Ancient 
Flour + Sourdough Ancient 
Fermentation 
E AN flour 
 
Blood glucose and insulin curves are represented in figure 23 and 24.For 
Blood glucose no statistical differences were found between ST and AN flour 
and between Yeast and Sourdough fermentation, while all four differ from 
glucose after 15 minute from the feed.  
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The shape of blood glucose curve of einkorn flour and sourdough 
fermented breads suggest that the glucose level was more stable, but more 
subjects are needed to confirm it due to the extremely high variability of the 
carbohydrate metabolism within the same subject. 
Figure 23.  A. Glycaemia of yeast and sourdough fermentation breads compared to 
glucose. B. Glycaemia of standard (STD) and ancient (AN) flour breads compared to 
glucose. The data are presented as mean ± SD. Time is reported as minutes. At 15 minutes 
the glycemic level of glucose is statistically different (p < 0.001) from yeast and sourdough 
breads which are not different among each other (fig 23 A). At 15 minutes the glycemic 
level of glucose is statistically different (p < 0.001) from STD and AN flour breads which 
are not different among each other (fig 23 B).  
 
A 
B 
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Figure  24.  A. Insulin levels of yeast and sourdough fermentation breads compared 
to glucose. B. Insulin levels of standard (STD) flour and ancient (AN) flour 
compared to glucose. The data are presented as mean ± SD. Time is reported as minutes. 
In figure 24 A at 15 min insulin level of sourdough breads is statistically different (p < 
0.05) from glucose and yeast breads which are not different among each other; at 45 min 
Glucose insulin differ (p<0.001) from all the other. In figure 24 B at 30 min insulin level of 
ST flour breads and glucose are statistically different (p < 0.05) from AN flour breads; at 
45 min all insulin levels differ (p<0.001) with the glucose level highest, the AN flour lowest 
and the ST flour in the middle. 
 
The insulin plasma levels of yeast and sourdough fermented breads does 
not biologically differ, while there is an interesting differences between einkorn 
and standard flour. The insulin level of AN flour breads was stable for the entire 
A 
B 
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post prandial sampling period (120 min) suggesting that the einkorn does less 
stimulate the insulin release.    
Glycemic index (GI) for each diet was calculate as area under the curve 
(AUC) normalized on the glucose AUC. The GI of AN was lower compared to ST 
flour while GI of sourdough fermented bread was higher compared to yeast 
fermented bread. 
The glycemic load (GL) of the different breads was also calculated to take 
in account the amount of carbohydrates intake, but did not show any difference 
between diets (Fig. 25). 
Figure 25. A Glycemic loads (GL) of yeast and sourdough fermented breads 
compared to glucose. B. Glycemic loads of standard (STD) flour and ancient (AN) 
flour breads compared to glucose.  
 
A 
B 
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5.2.3 Conclusions 
The trial was conducted on jugular cannulated pigs, after a period of 
training all animals eat the experimental diet within 5 minutes leading to a 
standardized post prandial blood samples collection. The blood glucose and 
insulin spikes of glucose were coherent as the insulin spike followed the glucose 
spike after 30 minutes. Despite that some animals were excluded from the trial 
due to technical problem with the jugular cannula. 
Glycemic index (GI) and glycemic load (GL) were calculated.  
Einkorn (AN flour) breads and sourdough fermented breads GI and GL 
did not lead to a statistical differences compared with standard flour and 
standard fermented breads, but the trend of the blood glucose curves suggest 
that AN flour bread made with einkorn has a lower GI and GL that might be 
highlighted  by increasing the subjects enrolled in the study.  
This study confirms that whole flour bread compared to standard flour 
bread might protect against insulin spikes and subsequent hypoglycemia with 
the reactivation of the hunger and higher voluntary energy intakes in a pig 
model. 
Moreover the role of sourdough microbioma on the gut pig micriobiota 
and its role on the modulation of carbohydrate metabolism were studied. The 
results suggest that the sourdough fermentation can lead to a better 
exploitation of food carbohydrates.  This finding make the einkorn sourdough 
fermented bread a high nutritional value food.  
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5.3 Experiment 3. Evaluation of iron 
bioavailability and impact of novel bakery products 
enriched by microencapsulated iron on the intestinal 
microbiota, oxidative and inflammatory status 
 
 
Human beings are unable to excrete iron actively, so its concentration in 
the body must be regulated at the site of iron absorption in the proximal small 
intestine. Diets contain both haem and non-haem (inorganic) iron and each 
form has specific transporters (Zimmermann and Hurrell, 2007). In figure 26 
regulation of intestinal iron uptake is represented, haem iron is taken up by the 
haem iron transporter (HCP), undergoes endocytosis, and Fe²⁺ (ferrous iron) is 
liberated within the endosome or lysosome. Non-haem iron includes Fe²⁺ and 
Fe³⁺ (ferric iron) salts. Fe³⁺ is reduced to Fe²⁺ by ascorbic acid in the lumen or 
by membrane ferrireductases that include duodenal cytochrome B (DCYTB). At 
the apical membrane, the acid microclimate provides an H⁺ electrochemical 
gradient that drives Fe²⁺ transport into the enterocyte via the divalent metal-ion 
transporter (DMT1). At the basolateral membrane, iron transport to transferrin 
in the circulation is mediated by ferroportin 1, in association with hephaestin. 
Hepcidin, produced by the liver, binds to ferroportin 1, causing its 
internalisation and degradation and decreasing iron transfer into the blood. 
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Figure 26. Regulation of intestinal iron uptake. From Zimmermann and Hurrell, 2007 
 
Nutritional iron deficiency arises when physiological requirements 
cannot be met by iron absorption from diet. Dietary iron bioavailability is low in 
populations consuming monotonous plant-based diets with little meat 
(Zimmermann et al., 2005). In meat, 30–70% of iron is haem iron, of which 15–
35% is absorbed. However, in plant-based diets in developing countries most 
dietary iron is non-haem iron, and its absorption is often less than 10% (Hurrell, 
2002). The absorption of non-haem iron is increased by meat and ascorbic acid, 
but inhibited by phytates, polyphenols, and calcium. Iron deficiency affects 
predominantly infants, young children, adolescents, menstruating and pregnant 
woman when iron requirements are greater than energy needs; this condition 
has substantial health and economics costs. 
The main strategies to correct iron deficiency are supplementation and 
fortification. Although in industrialized countries, oral iron therapy is commonly 
associated with gastrointestinal side effects, it is not known to increase the 
burden of infection in this setting (Kortman et al., 2014) . In contrast, in an 
African region with high infection pressure (e.g. malaria) and low hygiene 
110 
 
standards, oral iron supplementation has been associated with increased 
morbidity and mortality of children (Goheen et al., 2016). Furthermore, oral 
administration can increase the incidence of diarrhea, which may partly be 
caused by the outgrowth of enteric pathogens. 
Fortification is probably the most practical and sustainable long-term 
solution to control iron deficiency, but often the iron compound react with other 
food components causing off-flavors, color changes and or fat oxidation 
(Spieldenner, 2016). 
Moreover accumulating evidence indicates that excess of unabsorbed 
iron that enters the colonic lumen causes unwanted side effects at the intestinal 
host–microbiota interface, a schematic overview of this process is exposed in 
figure 27 (Kortman et al., 2014). In their article review Kortman et al. described 
the dynamic effects and impact of oral administration on intestinal host-
microbiota interactions pointing out that oral iron administration changes the 
gut microbiota profile on several fronts and a shift towards a potentially 
pathogenic profile has been confirmed. 
The clinical relevance of these effects is not fully clear yet, but it is highly 
recommended that potentially pathogenic effects on the gut microbiota need to 
be avoided as much as possible.  
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Figure 27. Schematic overview of the main gut microbial factors that are 
influenced by oral iron administration and host iron status. This figure summarizes 
the main two iron-related components that influence the gut microbiota composition, 
virulence and metabolism. (1) Orally administered iron can have direct impact on the gut 
microbiota composition (and the ratio of pathogenic bacteria to beneficial bacteria) and 
metabolism and potentially on the virulence of enteric pathogens. (2) Host iron status is 
influenced by dietary iron uptake and infection; this in turn influences host immunity 
factors which can affect the gut microbiota. From (Kortman et al., 2014) 
 
To study the role of iron supplementation on gut microbiota and 
intestinal mucosa in vitro gut models and animal models that closely resemble 
the relevant in vivo conditions are needed.  
The suckling piglet is an optimal model for iron deficiency as this 
condition is particularly frequent and severe in pigs, regardless of the breed and 
the system of piglet rearing (Starzyński et al., 2013). 
The common reason for iron deficiency in newborn piglets is their rapid 
growth, particularly the increase in blood volume and the number of red blood 
cells (RBCs). Indeed, erythroid precursors in the bone marrow use most of the 
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iron found in the plasma for the synthesis of hemoglobin. As sow's milk largely 
provides piglets with iron below their daily requirements, an exogenous source 
of iron is essential to prevent the reduction in RBC hemoglobin level. 
Intramuscular administration of large amounts of iron dextran (FeDex) on days 
3 to 6 postpartum is current practice in the swine industry and has been proven 
to rectify the hematological status of piglets.  
The newborn piglet develop a para-physiological iron deficiency anemia 
that is comparable with human nutritional iron deficiency making the piglet 
without iron parenteral supplementation a feasible, rapidly inducible and cost-
effective model.  
The need for different approaches to iron supplementation or 
fortification able to protect the gut microbiota leads to the development of iron 
microencapsulation. This technology was used by Bake4Fun partners to 
produce an iron microencapsulate fortified bread that had similar organoleptic 
properties to the conventional breads.  
One of the aims of this study was to evaluate the effect of this novel 
bakery product on the gut microbiota and inflammatory status in a piglet model. 
Moreover we wanted to validate the iron microencapsulated fortification as 
possible strategy to contrast iron deficiency in a piglet model.  
In order to be able to compare iron fortification efficiency on the model, 
valuable references data for piglets at precise ages were needed. Moreover the 
bibliography lacks of hematology and clinical chemistry references to evaluate 
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iron profile in newborn piglets with and without iron exogenous 
supplementation. 
We therefore decide to create a dataset to improve current knowledge 
and to improve the Reduction in future animal experiments as suggested by the 
3Rs principle. 
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5.3.1 The biomedical piglet: establishing reference 
intervals for haematology and clinical chemistry parameters of 
two age groups with and without iron supplementation 
 
The similarities between swine and humans in physiological and 
genomic patterns, and the great correlation in size and anatomy, make pigs 
extremely useful in preclinical studies. New-born piglets can represent a model 
for congenital and genetic diseases in new-born children. It is known that 
piglets may have significant differences in clinicopathological results compared 
to adult pigs. Therefore, adult laboratory reference intervals cannot be applied 
to piglets. The aim of this study was to compare hematological and chemical 
variables in piglets of two ages and determinate age-related reference intervals 
for commercial hybrid young pigs. 
Blood samples were collected under general anesthesia from 130 
animals divided into five- (P5) and 30- (P30) day-old piglets. Only P30 animals 
were treated with parenteral iron after birth. Samples were analyzed using 
automated hematology (ADVIA 2120) and chemistry analyzers, and age-related 
reference intervals were calculated. 
Significant higher values of RBC, Hb and HCT were observed in P30 
animals when compared to P5, with an opposite trend for MCV. These results 
were associated with a reduction of the RBC regeneration process and the 
thrombopoietic response. The TSAT and TIBC were significantly higher in P30 
compared to P5; however, piglets remained iron deficient compared to adult 
reference intervals reported previously. 
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In conclusion, this paper emphasizes the high variability occurring in 
clinicopathological variables between new-born and 30-day-old pigs, and 
between piglets and adult pigs. This study provides valuable reference data for 
piglets at precise ages and could be used in the future as historical control 
improving the Reduction in animal experiments, as suggested by the 3Rs 
principle. 
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Background
The interest in the pig as an animal model for experi-
mental medicine can be traced back to Galen, in 1586
[1]. One reason for this interest is the strong similar-
ities between the pig and the human in both physio-
logical [2] and genomic [3] patterns. In addition, size
and anatomy can be easily related to the development
stages of people, making the pig the perfect preclinical
model for human diseases [4, 5], surgical techniques
and, more recently, for transplantation research [6–8].
When compared to other models such as mice or rats, the
pig has a longer lifespan of 10–15 years [9], so disease
progression is more similar to that seen in humans [1].
Furthermore, in the neonatal period, pigs represent an ac-
curate model for studying congenital and genetic diseases
in humans [10]. Piglets can even represent a good model
for the preterm neonate, as they show similar anthropo-
metric and physiological characteristics [11].
However, age differences, even within the same species,
significantly affect the comparison of some developmental
patterns, especially in extremely young subjects. There-
fore, these processes need to be thoroughly investigated in
order to create an accurate and standardised preclinical
model and to help reduce and refine experimental proto-
cols. As an important example, iron deficiency, which is
one of the most common nutritional defects during the
neonatal period in mammals [12, 13], is extremely com-
mon in swine, due to the high reproductive performance
required of these animals. Unless given iron supplements,
piglets may develop iron-deficiency a few days after birth
[14, 15]. This condition occurs regardless of the breed
and management system, and is the result of interac-
tions of several factors including low levels of iron
stores, increased requirements, poor exogenous supply
and immaturity of absorption mechanisms [15, 16].
Similarly, iron requirements cannot be completely ful-
filled by hepatic reserves and milk consumption due to
the constant request for larger litter sizes, higher birth
weights and faster growth that result in a greater blood
volume and red blood cell (RBC) count [17]. It is there-
fore mandatory to supplement piglets with exogenous
iron to prevent dangerous deficiency [18]. This proced-
ure may interfere with several clinical chemistry param-
eters [19] and is the reason why it is very inaccurate to
evaluate piglets based on the clinicopathological find-
ings of older pigs. Therefore, it is extremely important
to have specific age-related reference intervals for both
haematological and chemical variables for piglets. Some
values have been described in a single litter of Duroc x
Jersey piglets [20], but the small number of animals and
the lack of information about iron supplementation make
them hard to rely on.
The aim of this study was to evaluate haematological
and chemical variables in two groups of healthy hybrid
piglets of different ages. Secondary objectives were to
establish age-related reference intervals (RI) for both
haematology and clinical chemistry variables and to
evaluate the iron profile in new-born piglets without
exogenous supplementation (5 days old) and young pigs
administered with exogenous iron within 3 days after
birth (30 days old).
Methods
Animals
All of the animals were Italian Large White x Duroc x
Landrace commercial hybrids used in our facility. We only
selected control and/or pre-treated animals previously
enrolled in other experimental protocols and approved by
the local ethical committee to be part of this study. The
above mentioned protocols included blood tests to evalu-
ate the animals, and we decided to work on the obtained
data set of blood values.
We analysed piglets at two different time points: P5
were five-day-old piglets born in our facility that had not
received any iron supplementation before blood sam-
pling and were not neutered; P30 were 30-day-old pigs
that were transferred to our piggery on the day of wean-
ing (28th day of life) and were administered a single iron
injection (100 mg IM; Endofer, FATRO, Italy) within the
first 72 h after birth, and males were neutered. None of
the animals was included in both age groups. In order to
rule out any possible variation in genetic line and man-
agement, both pregnant sows and pigs were born and
raised in the same farm. All of the animals were housed
in multiple stalls and fed with a standard swine diet; P5
were housed in the farrowing crate with the sow until
weaning. Body weight (kg) was measured in P5 and P30
and recorded.
A total of one hundred-thirty animals were included
in the study; 74/130 (57%) were females, while 56/130
(43%) were males. Body weight was 2.3 (1.2–3.8) kg in
P5 and 8.0 (5.3–11.2) kg in P30. For haematologicalal
analyses, samples from 130 animals were available: 66 P5
and 64 P30. For chemistry evaluations, samples from
119 animals were available: 56 P5 and 63 P30.
Blood sample collection and analyses
Blood samplings were performed on day 5 (P5) or 30
(P30) under general anaesthesia, using an advanced an-
aesthesia delivery unit (Datex-Ohmeda ADU S/5, GE
Healthcare, USA), achieved by inhalation induction
with sevoflurane (Sevoflo, Abbott Laboratories, Chicago,
USA). No premedication was performed in order to
avoid blood alterations due to injected drug adsorption.
After oro-tracheal intubation, anaesthesia was main-
tained with 4 ± 0.5% sevoflurane in a 1:1 oxygen/air
mixture. Samples were obtained from the femoral ar-
tery using a 21 G butterfly needle and a vacuum system;
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tubes with K3EDTA anticoagulant, citrate and clot acti-
vator were used. The total volume of withdrawn blood
was approximately 10 ml, which was considered com-
pletely safe and negligible for these animals.
Blood samples (K3EDTA tubes) were analysed within
30 min from collection; serum (clot activator tubes) and
citrate plasma (citrate tubes) were obtained by centrifu-
gation (10 min at 3000 × g) within 1 h and analysed or
stored at −80 °C until analysis.
Complete blood count (CBC) was performed with a
new automated haematology analyser (ADVIA 2120,
Siemens Healthcare Diagnostics, Tarrytown NY, USA)
that combines classic haematological variables with
individual cell indices. The variables evaluated in our
study were haematocrit value (HCT), haemoglobin con-
centration (Hb), cellular haemoglobin content (CH),
cellular haemoglobin content of mature red blood cells
(CHm), red blood cells count (RBC), mean corpuscular
volume (MCV), mean corpuscular volume of mature
RBCs (MCVm), mean corpuscular haemoglobin con-
centration (MCHC), mean corpuscular haemoglobin
(MCH), corpuscular haemoglobin concentration mean
(CHCM), corpuscular haemoglobin concentration mean
of mature RBCs (CHCMm), haemoglobin concentra-
tion distribution width (HDW), haemoglobin concen-
tration distribution width of mature RBC (HDWm),
RBC distribution width (RDW) and mature RBC distri-
bution width (RDWm). Total white blood cell (WBC)
count and differential WBC count were also performed.
Platelet indices were analysed and included platelet
count (PLT), mean platelet volume (MPV), PLT volume
distribution width (PDW), plateletcrit (PCT), mean PLT
component (MPC), platelet component distribution width
(PCDW), mean PLT mass (MPM) and platelet mass distri-
bution width (PMDW).
In addition to the above mentioned variables, we
evaluated the following reticulocyte indices: absolute
reticulocyte count (Retic), percentage of reticulocytes
(%Retic), average size of reticulocytes (MCVr), average cell
haemoglobin concentration (CHCMr), average haemoglo-
bin content (CHr), distribution width of reticulocyte cell
size (RDWr), distribution width of CHCMr (HDWr), per-
centage of microcytic reticulocytes (%Micro-r), percentage
of macrocytic reticulocytes (%Macro-r), percentage of
hypochromic reticulocytes (%Hypo-r), percentage of
hyperchromic reticulocytes (%Hyper-r), percentage of re-
ticulocytes with a low CH (%LowCHr), percentage of re-
ticulocytes with a high CH (%HighCHr), CHr-CHm (CH
delta), CHCMr-CHCMm (CHCM delta), CHDWr-
CHDWm (CHDW delta), HDWr-HDWm (HDW delta),
MCVr-MCVm (MCV delta), and RDWr-RDWm (RDW
delta). The haematologicalal evaluation was completed
by a blood smear microscopic examination using
Romanovsky staining.
All chemistry analyses were carried out on an auto-
mated chemistry analyser (Olympus AU 400, Beckman
Coulter/Olympus) and included aspartate transaminase
(AST), alanine transaminase (ALT), alkaline phosphatase
(ALP), creatinine, urea, glucose, total proteins (TP), albu-
min, albumin to globulin ratio (A/G), sodium, potassium,
total iron (TI), unsaturated iron binding capacity (UIBC),
total iron binding capacity (TIBC) and TIBC saturation
(TSAT). Total iron and UIBC were measured using colori-
metric methods (Iron Ferene, KAL 002, Olympus/Sentinel
Diagnostics, Milan, Italy; UIBC OSR61205, Olympus/
Beckman Coulter, O’Callaghan’s Mills, Ireland). Total iron
binding capacity and TSAT were calculated as follows:
TIBC = TI + UIBC; TSAT = (TI × 100)/TIBC.
ADVIA 2120 erythrocytes, reticulocytes and platelet
indices, and other variables evaluated in the study are
reported in the Additional file 1, including their
abbreviations.
Statistical analyses
Statistical analyses were performed using MedCalc
statistical software (version 15.6; MedCalc Software,
Ostend, Belgium). The D’Agostino-Pearson test was used
to assess normal distribution of data. Data were reported
as mean ± SD or median (minimum-maximum) based
on their distribution. Comparisons between the two age
groups were performed using the Mann-Whitney U test
due to the non-Gaussian distribution of the majority of
the data. Reference intervals were obtained using the
2.5th – 97.5th percentiles method following the Clinical
and Laboratory Standards Institute (CLSI) guidelines for
estimating percentiles and their 90% confidence intervals
[21]. Outliers were identified with the Tukey test. Differ-
ences were considered to be statistically significant with
P < 0.05.
Results and discussion
For the haematological and chemical analyses, the num-
ber of samples available for each analyses, descriptive
statistics, differences between groups and estimated RI
in P5 and P30 are reported in Tables 1, 2 and 3. A
significant increase in the circulating erythrocyte mass
was detected in P30 compared to P5 as demonstrated by
the higher values of Hb, HCT and RBC count. This find-
ing was associated with a significant reduction in volume
(MCV, MCVm) and a significant increase in anisocytosis
(RDW, RDWm). Erythrocyte haemoglobin content indi-
ces (CH, CHm, MCH) were significantly lower in P30
compared to P5 with the exception of CHCM which was
significantly higher in P30, while MCHC and CHCMm
were not significantly different between groups (Table 1).
Absolute reticulocyte count and percentage of reticulo-
cytes were significantly lower in P30 compared to P5.
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Many other reticulocyte indices were significantly differ-
ent between age groups (Table 2).
Circulating platelet number (PLT, PCT) was signifi-
cantly decreased in P30 compared to P5; these results
were associated with a significant reduction in platelet
volume and mass (MPV, MPM) in P30 animals.
In the chemistry analysis, P5 subjects had significantly
lower values of creatinine, urea, ALT, albumin and A/G
and significantly higher ALP and potassium compared
to P30 animals. Total iron concentration and TSAT %
were significantly higher in P30 piglets compared to P5
(Table 3).
Table 1 Descriptive statistics, differences between groups and estimated reference intervals for haematological variables. Data are
expressed as mean ± SD or median (minimum-maximum)
Variable P5 P5 P5 P30 P30 P30 P-value
Descriptive data Reference Interval n Descriptive data Reference Interval n
Hb (g/dL) 6.03 ± 1.02 3.56-7.74 61 8.84 ± 2.0 4.32-13.31 64 <0.0001
HCT (%) 20 ± 3 13-25 61 29 ± 6 16-41 64 <0.0001
CH (pg) 16.85 (14.10–22.30) 14.30–21.82 66 14.0 (9.0–19.0) 9.3–18.9 64 <0.0001
CHm (pg) 18.3 (16.1–22.4) 16.27–22.01 50 15.4 ± 1.5 12.7–18.8 33 <0.0001
CHDW (pg) 3.72 (2.90–5.84) 3.01–5.71 66 3.99 ± 0.66 2.66–5.33 64 0.3541
CHDWm (pg) 3.36 (2.82–5.47) 2.83–5.34 50 4.78 (2.61–5.55) 2.61–5.50 33 <0.0001
RBC (106/μL) 3.26 ± 0.52 1.88–4.11 61 6.08 ± 0.93 4.08–8.17 64 <0.0001
MCV (fL) 61.97 ± 5.39 51.41–73.65 61 48.5 (32.4–61.5) 34.2–61.3 64 <0.0001
MCVm (fL) 65.9 ± 4.5 56.4–74.9 50 52.9 ± 3.9 45.3–60.5 33 <0.0001
MCHC (g/dL) 30.0. ± 1.6 26.1–32.7 61 29.9 ± 1.59 26.5–33.6 63 0.9606
MCH (pg) 18.50 ± 1.36 15.45–21.54 61 14.8 (9.1–20.2) 9.4–19.8 64 <0.0001
CHCM (g/dL) 27.35 ± 1.11 24.84–29.13 66 28.35 ± 1.60 25.13–31.62 64 0.0003
CHCMm (g/dL) 28.2 (26.7–30.8) 26.8–30.8 50 28.6 (26.8–30.9) 26.8–30.9 33 0.5389
RDW (%) 18.8 (15.8–25.7) 15.9–25.7 56 26.5 (13.5–38.5) 13.5–38.0 64 <0.0001
RDWm (%) 15.9 (14.2–25.7) 14.2–25.1 50 25.5 (12.7–32.2) 12.7–32.0 33 <0.0001
HDW (g/dL) 2.89 (2.28–4.13) 2.29–3.93 66 2.63 ± 0.40 2.02–3.50 64 <0.0001
HDWm (g/dL) 2.60 (2.14–3.68) 2.16–3.63 50 2.73 ± 1.99–3.28 1.99–3.28 33 0.1685
WBC (103/μL) 7.47 (4.39–12.58) 4.50–12.55 58 11.6 ± 3.2 5.6–18.5 58 <0.0001
neutrophil (%) 44.71 ± 9.66 22.77–61.33 60 35.3 ± 15.0 10.8–70.6 63 0.0001
lymphocyte (%) 49.30 ± 9.49 33.45–70.86 60 57.9 ± 14.5 26.2–82.9 64 0.0005
monocyte (%) 3.11 ± 1.13 1.10–5.85 59 4.4 ± 1.5 1.4–8.3 64 <0.0001
eosinophil (%) 0.5 (0.1–3.1) 0–2.3 57 0.6 (0.1–7.6) 0–1.9 64 0.5699
basophil (%) 0.41 ± 0.16 0–0.79 60 0.4 (0.2–1.2) 0–0.9 63 0.1183
neutrophil (103/μL) 3.17 ± 0.98 1.15–5.43 54 3.5 (0.8–9.9) 0.8–9.7 61 0.1472
lymphocyte (103/μL) 3.85 ± 1.11 1.91–6.45 58 6.6 ± 2.4 2.7–12.8 60 <0.0001
monocyte (103/μL) 0.23 (0.07–0.7) 0.075–0.68 59 0.4 (0.1–1.1) 0.1–1.1 59 <0.0001
eosinophil (103/μL) 0.04 (0.01–0.48) 0–0.28 60 0.07 (0.01–0.38) 0.00–0.20 63 0.0014
basophil (103/μL) 0.03 (0.01–0.2) 0–0.08 60 0.05 (0.02–0.33) 0.00–0.13 63 <0.0001
PLT (103/μL) 594 (219–1142) 253–1286 61 503 ± 141 192–832 63 <0.0001
MPV (fL) 17.84 ± 3.78 9.99–25.32 61 8.5 (6.2–13.0) 6.5–12.7 63 <0.0001
PDW (%) 84.22 ± 8.32 69.17–100.30 61 60.40 (17.90–106.60) 18.59–101.98 64 <0.0001
PCT (%) 1.20 ± 0.50 0.29–2.52 61 0.40 (0.12–0.94) 0.18–0.91 62 <0.0001
MPC (g/dL) 24.5 (17.2–26.3) 17.81–26.30 61 24.09 ± 0.96 21.69–26.50 64 0.0182
MPM (pg) 2.84 ± 0.34 2.10–3.44 61 1.96 ± 0.22 1.58–2.45 63 <0.0001
PCDW (g/dL) 4.6 (4.0–5.7) 4.0–5.6 66 4.6 (3.8–5.9) 3.9–5.9 64 0.4354
PMDW (pg) 1.45 (0.99–1.62) 0.99–1.61 66 0.87 (0.61–1.55) 0.62–1.54 64 <0.0001
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Table 2 Descriptive statistics, differences between groups and estimated reference intervals for reticulocyte indices. Data are
expressed as mean ± SD or median (minimum-maximum)
Variable P5 P5 P5 P30 P30 P30 P-value
Descriptive data Reference Interval n Descriptive data Reference Interval n
Retic (109cell/L) 369.3 ± 101.1 152.2–547.9 45 148.2 (53.4–554.5) 53.4–554.5 33 <0.000001
%Retic (%) 11.8 ± 3.8 4.6–20.7 49 2.5 (0.8–9.2) 0.8–9.2 33 <0.000001
MCVr (fL) 74.5 ± 7.3 60.7–89.4 48 56.5 ± 6.8 43.0–71.1 33 <0.000001
CHCMr (g/dL) 24.9 ± 0.9 23.4–27.0 48 26.1 ± 1.0 24.2–28.0 33 0.000008
CHr (pg) 18.1 (16.0–24.3) 16.2–23.8 48 14.6 ± 1.4 12.1–18.0 33 <0.000001
CHDWr (pg) 3.7 ± 0.3 3.1–4.4 48 3.5 (2.4–4.6) 2.4–4.6 33 0.166288
RDWr (%) 17.6 ± 2.1 14.2–20.7 48 19.5 (13.0–33.0) 13.0–33.0 33 0.055130
HDWr (g/dL) 3.36 ± 0.36 2.66–3.84 48 3.9 ± 0.62 2.7–5.1 33 0.000003
%Micro-r (%) 0.05 (0–0.8) 0.0–0.45 48 0.7 (0.0–15.5) 0.0–15.5 33 0.000005
%Macro-r (%) 26.5 (4.8–71.9) 6.7–70.7 48 2.6 (1.0–17.4) 1.0–17.4 33 <0.000001
%Hypo-r (%) 83.0 (62.8–94.3) 62.2–92.2 48 76.4 (57.2–85.8) 57.2–85.8 33 0.000036
%Hyper-r (%) 0.1 (0.0–0.3) 0.0–0.3 48 0.3 (0.0–2.7) 0.0–2.7 33 <0.000001
%LowCHr (%) 10.9 (0.5–35.4) 0.5–32.1 48 57.3 (6.0–76.8) 6.0–76.8 33 <0.000001
%HighCHr (%) 22.6 (9.2–76.3) 10.1–74.9 48 7.1 ± 2.5 3.3–13.0 33 <0.000001
CH delta (pg) −0.1 ± 1.6 −3.3–2.1 48 −0.7 ± 0.7 −2.4–0.7 33 0.012741
CHCM delta (g/dL) −3.4 ± 0.9 −5.2–(−1.8) 48 −2.6 ± 1.7 −5.3–0.8 33 0.075
CHDW delta (pg) 0.38 (−0.54–0.86) −0.33–0.67 48 −1.0 ± 0.6 −2.19–(−0.05) 33 <0.000001
HDW delta (g/dL) 0.66 ± 0.27 0.12–1.07 48 1.26 ± 0.46 0.18–2.06 33 <0.000001
MCV delta (fL) 8.9 ± 6.6 −3.4–18.3 48 3.6 ± 4.4 −3.8–12.5 33 0.000255
RDW delta (%) 1.4 (−7.4–5.2) −6.3–4.2 48 −3.8 ± 4.3 −12.6–3.0 33 <0.000001
Table 3 Descriptive statistics, differences between groups and estimated reference intervals for clinical chemistry. Data are
expressed as mean ± SD or median (minimum-maximum)
Variable P5 P5 P5 P30 P30 P30 P-value
Descriptive data Reference Interval n Descriptive data Reference Interval n
Glucose (mg/dL) 124 (69–200) 71–196 49 111 ± 26 34–159 62 0.0016
Urea (mg/dL) 12.4 (4.9–31.7) 5.0–30.8 55 17 (4–40) 4–39 59 0.0002
Creatinine (mg/dL) 0.65 (0.30–0.88) 0.38–0.85 56 1.09 (0.31–1.41) 0.51–1.39 62 <0.0001
AST (U/L) 29 ± 7 10–47 56 31 (11–68) 13–65 62 0.9915
ALT (U/L) 23 ± 6 5–38 56 30 (11–58) 14–54 60 <0.0001
ALP (U/L) 3773 ± 1017 1324–6031 56 770 ± 270 110–1292 61 <0.0001
TP (g/dL) 5.0 ± 0.5 3.7–6.2 54 4.8 (1.2–6.7) 2.5–6.6 59 0.4464
Albumin (g/dL) 1.8 ± 0.3 1.0–2.6 55 3.0 (1.8–4.0) 1.9–4.0 59 <0.0001
A/G 0.56 (0.36–0.99) 0.37–0.98 53 1.5 ± 0.3 0.7–2.2 60 <0.0001
TI (μg/dL) 15 (9–31) 9–30 49 34 (7–157) 7–151 60 <0.0001
UIBC (μg/dL) 338 ± 72 218–524 44 326 (40–1058) 63–980 62 0.2031
TIBC (μg/dL) 354 ± 72 230–542 44 397 (128–882) 142–877 60 0.0031
TSAT (%) 4.2 ± 1.2 1.3–6.7 42 8.6 (0.8–55.6) 0.9–54 61 0.0058
Potassium (mEq/L) 4 ± 0.5 2.8–5.1 54 3.7 ± 0.4 2.9–4.6 63 0.0252
Sodium (mEq/L) 135 (126–140) 126–140 53 136 ± 4.7 125–147 63 0.2448
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Swine are probably one of the most important models
for translational medicine [7], and therefore a complete
and accurate knowledge of their physiology should be
mandatory. This kind of knowledge would represent a big
improvement when it comes to refinement of animal ex-
periments. When using commercial hybrids for scientific
purposes, it is important to acknowledge that those ani-
mals are the products of strong zootechnical manipulation
that constantly requires higher breeding and production
performance [18]. Moreover, very young piglets (first
month of age) present high variability in many clinical and
clinicopathological variables due to rapid growth, nutri-
tion and other metabolic conditions, some which are po-
tentially related to iron status [15, 20]. As in other species,
new-born and young piglets are extremely different than
adult animals regarding laboratory results [20], thus, the
determination of reliable age-related reference intervals
for both haematology and chemistry variables in 5- and
30-day-old piglets is warranted. It is important to acknow-
ledge the fact that our results may not perfectly translate
to every other pigs’ breeds, but still represent a valid and
robust general reference especially because obtained by
one of the most common hybrid cross in Europe. Another
important issue to address, before the discussion of the re-
sults, is the feeding protocol: P5 only received milk from
the sows, while P30 were weaned at 28 days of life, there-
fore only ate solid feed for 2 days before blood sampling.
This difference in alimentation may have contributed to
some of the differences alongside with evolution of the
gastro-intestinal system.
The results reported in this study showed high vari-
ability in the blood profiles among P5 and P30 animals.
Unfortunately, it is hard to compare our data with the
ones previously described in the literature mainly be-
cause of the poor or absent age distinction and the dif-
ferent types of animals used. However, our P5 and P30
animals had lower Hb, HCT, RBC, MCV and MCH
values compared to animals of similar ages (days 6 and
36 from birth, respectively) [20].
In our study, P5 animals had a RBC regenerative re-
sponse that was significantly reduced in P30, as further
demonstrated by the results of reticulocyte indices (signifi-
cantly higher Retic, %Retic, MCVr, %Macro-r and MCV
delta). Similar findings have been reported previously and
could represent a physiological response in the new-born
pigs [15, 20]. However, a condition of iron deficiency
could not be excluded in our piglets. It is well known that
piglets can suffer from iron deficiency due to many causes
such as immature iron metabolism, decreased iron intake
or absorption and rapid growth. Iron deficiency can be as-
sociated with reduced weight gain, anaemia and even with
increased mortality in these animals [22]. For these rea-
sons, iron supplementation is highly recommended and
the benefit of this treatment is well documented [18]. The
role of iron deficiency in P5 animals, although sus-
pected based on haematological results, could not be
demonstrated with the current study design. In the ini-
tial phase, iron deficiency is characterised by enhanced
erythropoiesis and even a regenerative anaemia, while
microcytosis and hypochromasia (reduction of MCV
and MCHC) are late findings associated with iron defi-
ciency in animals and humans [23, 24]. The P30 ani-
mals that were supplemented with parenteral iron
within the first 72 h after birth had a decreased reticu-
locyte response compared to the new-born animals. In
addition, the results of iron profile parameters, particu-
larly TI and TSAT, supported the potential role of iron
deficiency in the piglets included in the present study.
Total iron and TSAT values in P5 and even P30 animals
were extremely decreased compared to the adult pig
values reported in the literature [25]. However, TI and
TSAT values were significantly higher at 30 days after
birth, compared to new-born piglets. A previous study,
using a different schedule of iron treatment, reported
different results with particular regard to the iron pro-
file parameters, compared to our study [15]. In our study,
the upper limit for TI in P30 animals was five times higher
than the P5 upper limit, however the lower limit was simi-
lar; the same happened for TSAT. The TIBC showed a
slightly different trend, with a wider interval and both
lower and higher values in P30 compared to P5. The over-
all pattern shown by iron-related parameters indicated
that circulating iron was very low in these healthy animals.
For this reason iron deficiency is hard to investigate in
piglets and the determination of other iron-related vari-
ables such as ferritin, which is considered the main iron
storage protein, may be helpful. Further studies on non-
treated animals should be performed in order to investi-
gate and quantify the physiological erythroid response of
growing pigs. However, it is possible that an enhanced
erythropoiesis accompanied by a relative iron deficiency
may be considered a paraphysiological condition for this
type of piglet in the first month after birth.
Swine are known to have an elevated platelet count
compared to other animals, with frequent platelet clump-
ing upon blood smear examination [20]. Although the
total platelet count at both experimental times was com-
parable to adult animal values available in the literature,
PLT, volume and mass were significantly reduced in P30
pigs compared to the new-born piglets. Similar data for
young pigs are lacking in veterinary medicine to the best
of our knowledge. Analogous to erythropoiesis, an en-
hanced thrombocytopoiesis that decreases shortly after
birth could be explained by the increased need for plate-
lets due to rapid growth or even iron deficiency. Iron defi-
ciency, in fact, is recognised as a stimulus for the bone
marrow to produce and release platelets, leading to
thrombocytosis in small animals and humans [26].
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The P5 and P30 total WBC count results in our study
were consistent with the literature: neutrophil percent-
age decreased from P5 to P30 while the neutrophil total
number did not differ significantly. On the contrary, the
lymphocyte count and percentage were significantly in-
creased in older animals, as previously reported [20].
Many chemistry variables evaluated were significantly
different between the two age groups. These differences
may impact the RI definition, however, it is difficult to
clarify the exact physiological significance of these changes
from an observational study. Interestingly, new-born
swine may have a very low concentration of albumin that
was significantly higher in 30-day-old animals, while TP
concentration did not differ significantly between groups.
As supported by the increase in A/G in P30 piglets, albu-
min concentration increased with the growth of these
animals and this process was associated with a progressive
reduction in the globulin fraction. Similar findings are
lacking in previous studies.
Creatinine and urea values were significantly higher
in P30 animals compared to P5, however both values
were fully comparable to the adult values available in
the veterinary literature [27]. In the authors’ opinion,
this is the result of the fast growing rate of pigs leading
to a rapid increase in muscle mass, helped by the grad-
ual supplementation of enriched solid diet throughout
the lactation period.
Another significant difference can be noticed in the
ALP concentration, which was extremely higher in youn-
ger animals. The literature suggests that this finding is
related to higher osteoblast activity in young, growing
animals; nevertheless the exact role of ALP in swine in
poorly understood, and its clinicopathological usefulness
needs to be clarified in further studies [28, 29].
Age-related reference intervals for haematological and
biochemical variables in wild boars have been recently
published [30]. Although a similar automated haematol-
ogy system (ADVIA 120) was used in that study, animals
from zero to six months were referred to as piglets, and
therefore a comparison of their data with our results
would not be accurate or reliable. This different stratifi-
cation of the population in their study design reflects
changes in chemical variables as well, and their data
seem to be more comparable to our P30 results.
Conclusions
In conclusion, this paper highlights the high variability in
haematological and chemistry variables between new-born
and 30-day-old pigs, and between these animals and adult
pigs. Moreover, our study provides specific age-related ref-
erence intervals for healthy commercial hybrid piglets that
can be used as physiological standards for both transla-
tional and swine medicine. Age-related reference intervals
will help in the correct interpretation of experimental
results and should be considered an important step to-
wards a more in-depth knowledge and standardisation of
the swine animal model.
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5.3.2 Bioavailability of Microencapsulated Iron from 
Fortified Bread Assessed Using Piglet Model. 
 
The aim of this study was to investigate the influence of oral iron 
supplementation, in the form of fortified breads, on the growth performance, 
health, iron status parameters, and fecal metabolome of anemic piglets. A study 
was conducted on 24 hybrid (Large White × Landrace × Duroc) piglets. From 
day 44, the post-natal 12 piglets were supplemented with 100 g of one of two 
experimental breads, each fortified with 21 mg of ferrous sulphate, either 
encapsulated or not. After one week of oral supplementation, hematological 
parameters (hematocrit value, hemoglobin, and red blood cells) showed 
statistically significant differences (p ≤ 0.05). Piglets fed with the fortified 
breads had higher iron concentrations in the heart, liver, and intestinal mucosa 
compared to anemic piglets fed with control bread. Gene expression of hepcidin, 
iron exporter ferroportin (IREG1), and divalent metal transporter 1 (DMT1), 
together with concentrations of plasma ferritin, showed no significant statistical 
differences between groups. Both fortified breads could be used as sources of 
bioavailable iron. The seven-day intervention trial showed microencapsulation 
to have only a mild effect on the effectiveness of iron supplementation in the 
form of fortified bread. 
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Abstract: The aim of this study was to investigate the influence of oral iron supplementation, in the
form of fortified breads, on the growth performance, health, iron status parameters, and fecal
metabolome of anemic piglets. A study was conducted on 24 hybrid (Large White × Landrace
× Duroc) piglets. From day 44, the post-natal 12 piglets were supplemented with 100 g of one of
two experimental breads, each fortified with 21 mg of ferrous sulphate, either encapsulated or not.
After one week of oral supplementation, hematological parameters (hematocrit value, hemoglobin,
and red blood cells) showed statistically significant differences (p≤ 0.05). Piglets fed with the fortified
breads had higher iron concentrations in the heart, liver, and intestinal mucosa compared to anemic
piglets fed with control bread. Gene expression of hepcidin, iron exporter ferroportin (IREG1),
and divalent metal transporter 1 (DMT1), together with concentrations of plasma ferritin, showed no
significant statistical differences between groups. Both fortified breads could be used as sources of
bioavailable iron. The seven-day intervention trial showed microencapsulation to have only a mild
effect on the effectiveness of iron supplementation in the form of fortified bread.
Keywords: microencapsulated iron; fortified bread; iron bioavailability; piglet model; iron deficiency;
anemia; metabolome
1. Introduction
Iron is an essential metalloelement for the physiology and biochemistry of most forms of living
organism [1]. Well-nourished people generally have 4 to 5 grams of iron in their bodies, making it the
most abundant trace element in the human body [2,3]. The functional iron pool consists of structural
components in heme proteins—hemoglobin, myoglobin, and cytochrome-dependent proteins [3].
Approximately 2 grams of iron is stored by adult men in proteins such as ferritin and hemosiderin,
and somewhat less by women of childbearing age. Both the functional and stored iron pools are
maintained by the balance between intestinal absorption of dietary iron and iron losses via the
gastrointestinal tract, loss of blood (e.g., menstruation), sweat, skin, or urine [4,5].
The absorption of dietary iron is regulated by physiological factors such as bioactive hepcidin
peptide, iron importer divalent metal transporter 1 (DMT1), and the cellular iron exporter ferroportin
(IREG1) [6]. The molecular target of hepcidin is IREG1, which supplies iron to plasma from duodenal
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enterocytes engaged in dietary iron adsorption, from macrophages of the spleen and liver which recycle
old red blood cells, and from hepatocytes involved in iron storage [7,8]. The interaction of hepcidin and
IREG1 results in the internalization and degradation of the ligand-receptor complex, which decreases
the delivery of iron to plasma. DMT1 is the most important apical uptake transporter of inorganic iron
in enterocytes, which import ferrous iron. DMT1 is essential for normal iron homeostasis [6].
Iron deficiency is the most common nutritional disorder, affecting people of all ages worldwide,
and mammals in general [9,10]. According to the WHO, nutritional iron deficiency affects 1.5–2 billion
people worldwide [11,12]. Iron deficiency is associated with diminished work productivity,
lower immunity, and impaired cognitive development. Iron deficiency can be caused by inadequate
iron intake, compromised bioavailability, and increased iron losses, or a combination of these.
The predominant dietary form of iron is non-heme iron, which accounts for 70%–90% of dietary
iron intake in the world, with higher intake in the developing world than in developed countries [13].
Non-heme iron absorption is in the range of 5%–15%. The two major dietary inhibitors of absorption
are phytates and polyphenols [14]. The most significant enhancer of iron bioavailability is ascorbic
acid, which both reduces and chelates iron, rendering it soluble and available for absorption in the
gut [15].
Iron deficiency can be treated using oral iron supplements, such as ferrous sulfate,
ferrous gluconate, and ferrous fumarate [16]. However, inorganic iron supplements have limitations,
including poor bioavailability and potential adverse effects in the gastrointestinal tract, primarily due
to the oxidative toxicity of ferrous iron [17]. New types of iron supplements with minimal side effects
and dietary sources with high absorption efficiency, such as fortified foods, are therefore needed.
Food fortification is considered the most cost-effective population-based strategy in the long-term to
combat micronutrient malnutrition, effective with no or fewer side effects than supplementation [18].
This study set out to investigate the effects of two experimental breads—each fortified with
ferrous sulphate, either encapsulated or not—on iron status indicators, with piglets used as models.
Iron encapsulation was chosen because of its potential to help overcome unwanted sensory changes in
fortified food, reduce interactions of Fe with food components, and increase Fe bioavailability [19,20].
Swine provide possibly the best preclinical animal model for investigating the gastrointestinal system
and its functions [21,22]. New piglet models are constantly emerging [23]. Iron deficiency is extremely
common in pigs, and is considered to be a para-physiological condition by zootechnical standards.
Indeed, it is mandatory to supplement piglets with exogenous iron within few days of birth, in order
to compensate for poor iron storage by the mothers and the immaturity of the piglets’ absorption
mechanisms [24]. This species is therefore extremely useful for use in preclinical trials concerning iron
deficiency and food supplementation.
2. Material and Methods
2.1. Experimental Breads and Diet of Piglets
The control bread (CB) and iron fortified breads (FeMB and FeSB) were made according to
a procedure developed and optimized at the University of Bologna (UNIBO). The breadmaking
process was based on dried compressed yeast (Lesaffre, San Quirico, Italy). The dough was fermented
for 45 min at a controlled temperature (30 ◦C) and then portioned. The pieces were fermented for
another 45 min under the same conditions, then baked at 195 ◦C for 45 min. All samples were obtained
from the same batch.
The fortified bread was made from an iron fortified mix of white wheat flour (type 650) and
encapsulated ferrous sulphate supplied by EPSA (Valencia, Spain). The experimental breads were
produced in the form of sandwich loafs, sliced, and fresh frozen. Each morning, a small aliquot was
thawed and given to the animals after crumbling.
Analysis of the humidity, fat content, and content of soluble sucrose/saccharose in the breads
was performed according to Polish standard norm ref. no PN-A-74108:1996, Bakery products—testing
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methods. Protein content was calculated based on nitrogen content, determined using the Kjeldahl
method (AOAC 950.36-1950, Protein in bread). The ash residue of the flour was measured using
AOAC Official method 923.03. Total dietary fiber was quantified using an assay kit (Sigma, St. Louis,
MO, USA).
A low iron swine diet (LISD), providing the lowest possible amount of iron, was designed for
the purposes of the experiment. The standard commercial swine feed could not be used as the basal
diet, due to its iron content equivalent to dietary requirements. The LISD was composed of corn flour
(40%), barley flour (10%), barley flakes (20%), soybean flour (20%), and bran (10%). The iron content
.in this diet formula was one tenth of that found in standard commercial swine feed.
2.2. Animals
Twenty-four commercial hybrid (Large White × Landrace × Duroc) piglets, born within the
ASA Unit (DIMEVET, UNIBO), were enrolled in the study. Twelve of the animals were born of one
sow, and the other 12 to two different sows 4 days later. All of the sows were inseminated using
artificial insemination doses from the same boar, in an attempt to standardize the piglets as much
as possible. The animals were monitored daily to assess their clinical condition. All of the activities
performed on the animals were approved by the Local Ethics Committee and the Italian Ministry of
Health (Legislative Decree 116/92, protocol number 10-75-2013).
2.3. Trial Design and Feeding Protocol
Five days after birth (P5), the animals were randomly assigned to four groups (six piglets in
each group, n = 6). Only one of the four groups received regular intramuscular (IM) supplementation
with 1 mL iron dextran (Endofer, Fatro IT, 100 mg·iron·mL−1). Groups are represented in Table 1.
The experiment was divided into two identical blocks to guarantee better management of the animals
and to ensure that they were of the same age at the starting point. During their first 14 days of life,
the piglets were suckled on sow milk only. During the last phase of lactation (P14), LISD was placed in
the mangers of the farrowing crates to accustom the animals to solid feed. The same diet was then left
in quantities sufficient for the piglets to eat ad libitum throughout the rest of the trial.
Table 1. Experimental groups.
Treatments
Piglets Group
FeMB-G1 FeSB-G2 CB-G3 CB-G4
Intramuscular iron
supplementation No No No Yes
Administered
Bread
Microencapsulated
Iron Bread
Non-Microencapsulated
Iron Bread Control Bread Control Bread
In order to start training the piglets to eat the experimental breads, control bread (CB) was added
to the LISD until weaning. After weaning (P28), the piglets were individually fed with 50 g of CB each
day. Starting on day 44 (P44), the animals were individually fed 100 g of either the control or fortified
bread, depending on the experimental group, for 7 days until the end of the trial (P51).
Two groups were fed with iron fortified experimental breads. One group was fed
microencapsulated iron bread (FeMB-G1), the other was fed bread containing the same quantity
of iron sulphate, starch and citric acid (FeSB-G2). The remaining two groups were the control groups.
One (CB-G3) ate control bread, while the other (CB-G4) ate control bread and was given IM iron
supplements from P5.
To guarantee that the piglets ingested the required quantity of bread, it was mixed with water
(100 g of bread, 130 mL−1 water) and fed to the piglets through a 50 mL syringe connected to
a silicon tube, which the animals were given to suck. Vanilla extract was added to improve the flavor.
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The weight of individual piglets was monitored periodically (P5, P28, P44, and P51) using a livestock
scale (CO.BA di Melloni Giuseppe e C. SNC, Pieve di Cento IT).
2.4. Sampling Protocol
Blood samples were collected at P5, P44, and P51. Fecal samples were collected from the rectum
at P44 and P51. Urine and tissue samples were collected only at P51, upon euthanasia.
Blood samples were collected under general anesthesia via the femoral artery, using a 21G
butterfly needle and a vacuum system. Tubes with K3EDTA anticoagulant and clot activator were
used (Venosafe®, Terumo, Leuven, Belgium). Samples in K3EDTA for a complete blood count (CBC),
and serum (obtained by 1000 g × 10 min centrifugation) for biochemical profiling, were analyzed by
the Veterinary Clinical Pathology Service of DIMEVET (UNIBO).
At the end of the trial, the animals were sedated by an intramuscular (IM) injection of
Tiletamine-Zolazepam (Zoletil, Virbac, Praga) (5 mg·kg−1). General anesthesia was induced 10 min
later, using an intravenous (IV) bolus of Thiopental sodium (Pentothal, MSD Animal Health s.r.l.)
(10 mg·kg−1). After blood and urine had been collected, the animals were euthanized by an IV bolus
of Tanax (0.3 mL·kg−1, Intervet, Milano, Italy) for extensive sampling.
Immediately after euthanasia, the digestive tract was removed and separated into its anatomical
parts. Mucosal scraping of the stomach wall (lower body part, near pyloric antrum) was performed
using a glass microscope slide, and the mucosa was flash frozen in liquid nitrogen. A 25 cm long
segment of the small intestine (beginning ~10 cm distal to the pyloric sphincter) was removed, cut open
longitudinally, and rinsed with PBS [25]. Duodenal scrapings from the first 10 cm of exposed mucosa
were taken and the tissue was immediately frozen in liquid nitrogen for gene expression analysis.
The second 15 cm of mucosa was scraped and frozen for total iron content analysis. Samples of organs
(liver, heart, spleen, and kidney) were in part conserved for gene expression analysis using RNAlater
(Ambion, ThermoFisher, Waltham, MA, USA) and in part flash frozen in liquid nitrogen for iron
determination. Stomach contents, feces, and urine were collected in sterile tubes, frozen immediately,
and stored at −20 ◦C.
2.5. Hematological Tests
CBC was performed using an automated hematology analyzer (ADVIA 2120, Siemens Healthcare
Diagnostics, Tarrytown, NY, USA). All of the classic hematological variables were analyzed, along with
relatively new platelet and reticulocyte indices.
Biochemical analyses were performed on an automated chemistry analyzer (Olympus AU 400,
Beckman Coulter/Olympus, Brea, CA, USA), including analyses of total iron (TI) and unsaturated iron
binding capacity (UIBC). TI and UIBC, analyzed using a colorimetric method, were used to further
calculate the total iron binding capacity (TIBC) and the TIBC saturation percentage (TSAT).
2.6. Total Iron and Fe(II)
The concentration of iron in wet-digested samples of organs (liver, spleen, heart, and kidney),
whole blood, diets, and feces was determined using atomic absorption spectrophotometry.
The Standard Berghof (Berghof Products + Instruments GmbH Labor Technik, Eningen, Germany)
method for microwave digestion of wheat was applied to the gastric content and whole blood samples.
Briefly, 1 g or 0.5 mL (blood) samples were digested in 10 mL of concentrated nitric acid and 2 mL
hydrogen peroxide using a three-step digestion program, with the temperature raised to 170 ◦C and
a total digestion time of 25 min. For the intestinal mucosa samples, the volume of acid and hydrogen
peroxide was reduced by half. Before digestion, the samples of gastric content were homogenized
using a Glas Col GKH Control Stirrer Mixer.
The digested samples were diluted with deionized water and the iron content was determined by
AAS using a GBC 932 spectrophotometer (GBC Scientific Equipment Pty Ltd., Braeside, Australia),
with a hollow cathode lamp for iron, at 248.3 nm. Acetylene and air flow were fine-tuned daily.
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Standard curves were prepared daily by diluting iron standard reference materials (1000 µg·cm−3;
JT Baker®Chemicals, Phillipsburg, NJ, USA) with deionized water to concentrations of between 0 and
10 µg·cm−3. Certified reference material, whole blood L-1 (Seronorm™ Trace Elements Serum L-1),
was used to test the accuracy of the methods. Iron recovery from whole blood was 97%. During analysis,
precautions were taken to avoid contamination of the iron samples. A ceramic cutter was used.
The glassware was washed in 10% HCl and rinsed three times in ultrapure water.
The presence of Fe(II) was determined through the reaction of formation blue coordinating
compound, formed by chelation of Fe(II) with Ferene S reagent (3-(2-pyridyl)-5,6-difurylsulfonic
acid-1,2,4-triazine sodium salt) under acidic conditions [26].
2.7. RNA Isolation and Quantitative Real Time PCR (qPCR) for HAMP, IREG1, and DMT1
Total RNA was isolated from liver and duodenal mucosa samples using a NucleoSpin®RNA Kit
(Macherey-Nagel GmbH & Co. KG, Düren, Germany). One microgram of total high quality RNA
(A260/A280 ratio above 2.0) was reverse-transcribed in cDNA using an iScript cDNA Synthesis Kit
(Bio-Rad Laboratories Inc., Hercules, CA, USA), with a final volume of 20 µL. Real-time quantitative
PCR was carried out using a CFX 96 Real Time System (Bio-Rad) and iTaq Universal SYBR Green
Supermix (Bio-Rad). All samples were analyzed in duplicate (10 µL/well). The amplification reaction
(20 µL) contained 10 µL of iTaq Universal SYBR Green Supermix, 0.8 µL of each forward and reverse
primer (5 µM), and 2 µL of cDNA. All samples were performed in duplicate. Controls lacking a cDNA
template were included to determine the specificity of target amplification. The real-time program
included an initial denaturation period of 1 min 30 s at 95 ◦C, 40 cycles at 95 ◦C for 15 s, and 60 ◦C
for 30 s, followed by a melting step with ramping from 55 ◦C to 95 ◦C at a rate of 0.5 ◦C/10 s.
The specificity of the amplified PCR products was confirmed by melting curve analysis and agarose
gel electrophoresis. The expression of the hepcidin gene (HAMP, hepcidin antimicrobial peptide) was
evaluated on cDNA derived from liver tissue, while the gene expression of iron transporters (IREG1
and DMT1) was assessed on cDNA derived from duodenum. The swine primer sequences are reported
in Table 2.
The relative expressions of the studied genes were normalized based on the geometric mean
of two reference genes (GAPDH, glyceraldehyde-3-phosphate dehydrogenase and RPL35 ribosomal
protein L35). The relative mRNA expression of the tested genes was evaluated in relation to the control
group (CB-G4) using the 2−∆∆Ct method [27].
Table 2. Primer sequences used for quantitative real-time polymerase chain reaction analysis.
Gene Sequence (5′-3′) PCR ProductLength (bp)
Gene Bank
Accession Number Reference
HAMP
For: TCTCCCATCCCAGACAAGAC
123 NM_214117
Hansen et al.,
2009 [25]Rev: AAGATGCAGATGGGGAAGTG
IREG1
For: CTCTATGGAAACAGCCTTCTC
158 XM_003359590.1 Present studyRev: AGGATGACCGAAACATTCTG
DMT1
For: AGGATCTAGGGCATGTGGTG
124 NM_001128440.1 Present studyRev: CCACAGTCCAGGAAGGACAT
GAPDH
For: TGGTGAAGGTCGGAGTGAAC
120 AF017079
Dall’Aglio et al.,
2011 [28]Rev: TGTAGTGGAGGTCAATGAAGGG
RPL35
For: AACCAGACCCAGAAAGAGAAC
145 NM_214326
Alexander et al.,
2012 [29]Rev: TTCCGCTGCTGCTTCTTG
2.8. Ferritin in Plasma
The specific Pig Ferritin Sandwich ELISA (Cod. LS-F6483, LifeSpan BioScience, Inc., Seattle, WA,
USA) was used for the ferritin assay. Plasma ferritin concentrations were extrapolated from a standard
curve, as described in the manufacturer’s protocol.
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2.9. Metabolomics of Feces
Fecal samples were prepared for proton nuclear magnetic resonance spectroscopy (1H-NMR)
analysis by vortex mixing 80 mg of stool for 5 min with 1 mL of deionized water, followed by
centrifugation, for 15 min at 18,630 g and 4 ◦C. Seven hundred microliters of supernatant was added
to 100 µL of a 10 mM solution of 3-(trimethylsilyl)-propionic-2,2,3,3-d4 acid sodium salt (TSP) in
D2O, buffered at pH 7.00 with 1 M phosphate buffer. Immediately before analysis, the samples were
centrifuged again. 1H-NMR spectra were recorded at 298 K using an AVANCE III spectrometer (Bruker,
Milan, Italy) operating at 600.13 MHz.
The HOD residual signal was suppressed by applying the first increment of the NOESY pulse
sequence and a spoil gradient [30]. The NOESYGPPR1D sequence, part of the standard pulse sequence
library, was used. Each spectrum was acquired by summing up 256 transients using 32 K data
points over 7211.54 Hz (for an acquisition time of 2.27 s). To apply NMR as a quantitative technique,
the recycle delay was set to 5 s, taking into consideration the longitudinal relaxation time of the
protons [31]. The signals were assigned by comparing their chemical shift and multiplicity with the
Human Metabolome Database and Chenomx software data bank (Chenomx Inc., Edmonton, AB,
Canada, ver 8.1) [32].
The 1H-NMR spectra were pre-processed for quantitative analysis following a method already
described in literature [30]. Briefly, the spectra were baseline-adjusted by means of simultaneous peak
detection and a baseline correction algorithm (SPDBC) implemented in the baseline R package [33].
The spectra were corrected for errors in chemical shift misalignments using an in-house modified
version of Correlation Optimized Shifting (i-Coshift) [34].
2.10. Statistical Data Analysis
The data were analyzed using a Student’s t-test and one-way analysis of variance (ANOVA),
followed by a Tukey post hoc comparison test (SPSS program version 13.0; SPSS Inc., Chicago, IL, USA).
Differences of at least p ≤ 0.05 were considered significant. Iron concentration underwent statistical
analysis in R computational language. In each group, data were considered as probable outliers when
they exceeded by 1.5 times the 0.25–0.75 percentile range. Metabolomics data were analyzed in R,
with sparse principal component analysis (sPCA) performed using a mixOmics package, applying the
sparsity principle as detailed by Shen and Huang [35].
3. Results and Discussion
3.1. Experimental Bread
Three types of experimental bread were prepared, using conventional yeast fermentation:
microencapsulated iron fortified bread (FeMB), ferrous sulphate fortified bread (FeSB), and control
bread (CB) without any iron supplementation. The formula of the FeSB was based on that of
FeMB, but instead of microencapsulated iron an equivalent amount of modified starch, ascorbic acid,
and ferrous sulphate was used, in the form of individual compounds. The content of iron in the
fortified breads was 21 mg Fe 100 g−1·WM (Wet Mass), ten times higher than that in the control bread.
To meet WHO recommendations for cereal flour fortification, ferrous sulphate was selected as the iron
source [36]. The presence of ferrous ions in the final experimental breads was determined, as ferrous
ions are easily oxidized to ferric ions, especially under the conditions used in the baking process
(high temperature and humidity), which may accelerate the reaction. The presence of Fe(II) in the
experimental breads was confirmed in a reaction with Ferene S. During the trial period, the daily iron
intake of each piglet was 21 mg. This dose complies with experimental findings and recommendations.
According to the National Research Council’s current guidelines, neonatal pigs require 7 to 16 mg of
iron per day for normal growth [37]. Table 3 presents the composition of the experimental breads.
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Table 3. Component analysis of breads administered to the pigs. All values are given in respect to
the fresh bread mass. (FeMB: bread with microencapsulated iron; FeSB: bread with free iron; CB:
control bread).
Sample/Breads FeMB FeSB CB
Humidity (g 100 g−1) 38.90 ± 0.83 38.11 ± 0.19 41.27 ± 0.77
Proteins (g 100 g−1) 7.62 ± 0.53 8.10 ± 0.57 7.55 ± 0.53
Fat (g 100 g−1) 1.76 ± 0.20 1.43 ± 0.05 1.78 ± 0.42
Carbohydrates
Total (g 100 g−1) 45.59 46.56 44.01
Soluble (Sucrose/Saccharose) (g 100 g−1) 1.35 1.00 0.69
Insoluble (fiber) (g 100 g−1) 1.61 1.61 1.61
Ash (g 100 g−1) 1.71 ± 0.04 1.73 ± 0.04 1.62 ± 0.05
NaCl (g 100 g−1) 1.47 1.47 1.47
Total Fe (mg 100 g−1) 21.10 ± 0.82 21.20 ± 0.63 2.80 ± 0.20
3.2. Body Weight and Blood Analyses
The body weights of the piglets and their main blood parameters are reported in Table 4.
Table 4. Effect of bread administration on growth performance and blood parameters. Value are
means ± SD. Means with different superscripts differ p < 0.05. Capital superscripts represent
differences within the same group between P44 and P51. Lowercase superscript represent differences
between the groups at the same experimental time. (BW: body weight; HCT: hematocrit; Hb:
hemoglobin; RBC: red blood cells; WBC: white blood cells; RET: reticulocytes; GGT: gamma
glutamyltransferase; TIBC: total iron binding capacity; UIBC: unsaturated iron binding capacity;
TSAT: TIBC saturation percentage).
Intramuscular Iron Supplementation
Piglets Group
FeMB-G1 FeSB-G2 CB-G3 CB-G4
no no no yes
Body weight (kg) P44 6.9 ± 1.33
a 7.2 ± 1.5 a 7,6 ± 1.0 a 10.5 ± 1.5 b
P51 6.8 ± 1.1 a 6.3 ± 1.4 a 7.0 ± 1.6 a 10.5 ± 1.9 b
Hb (g/dL) P44 6.1 ± 2.0 aA 6.0 ± 2.5 aA 5.3 ± 1.5
a 8.8 ± 1.7 b
P51 7.2 ± 2.2 abB 8.0 ± 2.5 abB 6.3 ± 2.4 a 9.3 ± 1.7 b
HCT (%) P44 21.7 ± 5.6
a 21.1 ± 6.5 aA 20.2 ± 4.8 a 29.7 ± 3.6 b
P51 23.5 ± 5.5 ab 25.5 ± 6.7 abB 21.7 ± 5.9 a 29.1 ± 4.1 b
RBC (106/mm3)
P44 5.10 ± 0.9 a 4.59 ± 1.18 aA 5.26 ± 1.68 a 7.37 ± 0.86 b
P51 5.8 ± 0.9 a 5.60 ± 1.12 aB 5.78 ± 1.70 a 7.27 ± 0.40 b
WBC (103/mm3)
P44 14.3 ± 2.2 11.5 ± 3.4 11.5 ± 1.6 17.5 ± 4.1
P51 10.3 ± 3 8.1 ± 3.9 8.2 ± 2.5 14.1 ± 4.6
RET (103/mm3)
P44 415.5 ± 189.2 634.1 ± 171.7 503.3 ± 64.5 299.1 ± 93.7
P51 86.6 ± 57.9 112.4 ± 48.9 95.8 ± 28.5 58.6 ± 18.3
Glucose (mg/dL) P44 107.3 ± 17.2 104.5 ± 9 112.5 ± 15.7 104 ± 7.3
P51 162.2 ± 33.2 136.3 ± 26.9 150.8 ± 52.1 145.7 ± 27.3
GGT (U/L) P44 32.5 ± 5.2 30.1 ± 3.5 28.3 ± 5.3 36.9 ± 4.2P51 38.4 ± 8.1 37.3 ± 8.3 29.3 ± 4.4 36.8 ± 5.5
Iron (serum) (µg/dL) P44 97.2 ± 81.5 83.8 ± 59.1 41.8 ± 30.6 85 ± 47.2
P51 66.3 ± 54.1 69.7 ± 47.8 39.8 ± 44 88.5 ± 42.5
TIBC (µg/dL) P44 507 ± 51 528.5 ± 79.1 532.5 ± 118.9 455.7 ± 38.1
P51 402.8 ± 53.5 412.5 ± 60.2 388.3 ± 59.6 399 ± 60.4
UIBC (µg/dL) P44 409.8 ± 75.3 444.7 ± 117 490.8 ± 144.1 370.7 ± 76.2
P51 336.5 ± 84.9 342.8 ± 99.7 348.5 ± 91.8 310.5 ± 101
Iron (whole blood) (mg/L) P51 229.7 ± 64.2 a 253.2 ± 65.8 ab 215.7 ± 63.1 a 284.3 ± 49.2 b
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Parameters showing statistical differences and their correlations are reported in the upper part
of the table. All piglets were of similar weight on day 5 (data not shown) and analysis showed that
all of the animals enrolled in the study were healthy. The group that received IM iron supplements
subsequently gained significantly more weight than those which did not receive the experimental
diet. This might be explained by the fact that animals that received the IM supplementation at 5 days,
had more time (from P5 to P44) to restore and correct anemia and balance all of the physiological
gastrointestinal mechanisms. Their weight is indeed significantly higher since the beginning of the
trial P44. Over the week of the trial, the differences were maintained between the live body weights of
the piglets in the positive control group (CB-G4) and those of the piglets in all other groups.
Episodes of diarrhea were reported from the second day of the experimental diet. However,
none of the four groups showed a higher incidence of diarrhea than the others. Thomaz et al. [38]
report that animals fed diets supplemented with trace minerals in inorganic form suffer higher rates of
diarrhea than animals fed diets without mineral supplements. However, this was not confirmed in the
present study.
Levels of variables such as hematocrit (HCT), hemoglobin (Hb), and red blood cells (RBC) seem to
have been influenced by the kind of bread administered (Table 4). Groups that received iron fortified
breads (FeMB-G1; FeSB-G2) showed significant increases in these parameters (p≤ 0.05) as compared to
piglets fed with the control bread (CB-G3 and CB-G4). At the beginning of the experiment, the FeSB-G2
group was classified as anemic, whereas after the treatment they showed only borderline anemia [39].
The impact of iron microencapsulation on Hb was not as marked as that of unencapsulated ferrous
sulfate, although there was no significant difference between the treatments (p > 0.05).
No changes in levels of leukocytes were observed in any of the groups over the course of the
experiment. Clinical chemistry analyses did not reveal significant variations at different times or
between groups, proving that the animals were healthy. CB-G4 showed the highest concentrations of
Gamma-glutamyl transferase (GGT) at P44. By the end of the trial, GGT had increased in the groups fed
with iron fortified breads (FeMB-G1 and FeSB-G2), reaching or exceeding the level observed previously
for CB-G4, while it remained stable in group CB-G3 (the lowest noted concentration). Therefore,
this parameter seems to be directly related to iron supplementation, since it increased after both IM
and oral administration. In all of the groups, the glucose concentration in the blood was higher on
day 51 than on day 44. This is related to the fact that the animals were fed 1 hour before euthanasia in
order to collect gastric content. The iron content in serum varied widely between animals. Despite this
large individual variation, it can be noted that the iron levels in orally supplemented groups (FeMB-G1
and FeSB-G2) decreased, while they remained stable in groups fed with control bread (CB-G3 and
CB-G4). Our hypothesis is that the increase in nutritional iron availability may stimulate iron storage
or tissue-binding mechanisms, therefore lowering the UIBC (Unsaturated Iron Binding Capacity) and
TIBC (Total Iron Binding Capacity). TSAT (TIBC Saturation Percentage) appears to have remained
stable, with minimal variations.
CB-G4 did not show large differences for the main indices of hematopoiesis and anemia.
The probable reason is that the diet used (LISD) was designed to have a low iron content. Whereas,
a normal farm practice is IM supplementation and the use of specific iron-rich diets.
Overall, all of the blood parameters fell within the physiological reference intervals available
in the literature for piglets. Therefore, despite some differences between the groups at P44 and P51,
the trial did not determine any dangerous or important alterations in the animals, which remained
healthy throughout the trial [40].
3.3. Relative Expression of HAMP, IREG1, and DMT1
The effects of the different bread types on mRNA of hepcidin (HAMP) in the liver, and on IREG1
and DMT1 at the duodenal level, did not differ in a statistically significant manner (Figure 1). Moreover,
the gene expression of HAMP calculated with reference to CB-G4 shows a progressively decreasing
trend, starting from the group of anemic piglets fed bread with microencapsulated iron (FeMB-G1),
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followed by the group given non-encapsulated iron bread FeSB-G2 and finally the anemic group,
CB-G3, which was fed with control bread (Figure 1A). This trend, showing a slight up-regulation
in groups with iron fortified bread in respect to the anemic group, can be explained by the fact that
iron is the most important proven biological factor for inducing hepcidin expression, while there
is also evidence that both iron saturation of plasma and hepatic iron loading stimulate hepcidin
synthesis [25,29].
The relative gene expression of IREG1 (Figure 1B) and DMT1 (Figure 1C) in relation to the group
with encapsulated iron supplementation (CB-G4) showed a relatively higher value for piglets in
FeSB-G2. The increasing trend in intestinal DMT1 mRNA (Figure 1C) for piglets fed with FeMB-G1
and FeSB-G2 is likely due to the animals’ anemic status and increased need for dietary Fe to meet
erythropoietic demands. The increasing trend in IREG1 expression observed for animals fed with
FeMB-G1 and FeSB-G2 as compared with CB-G4 corresponds to the opposite trend observed for
HAMP expression. Hepcidin binds to IREG1, causing internalization and degradation of the protein
and decreasing cellular Fe export [7,41].
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3.4. Ferritin Determination
Although ferritin is mainly found as a cytosolic protein, small amounts of ferritin are secreted
into serum, in amounts closely reflecting the size of the body’s iron stores [42,43]. Plasmatic ferritin
can be used to identify differences within the physiological range, reflecting non-heme iron levels in
the liver and spleen more than other blood values [44].
The effects of consuming the different types of bread on the piglets’ plasmatic levels of ferritin are
presented in Figure 2. There were no statistically significant differences between the groups in terms of
the amounts of ferritin detected in the plasma samples using a specific ELISA kit, although the group
fed with FeMB-G1 had the highest ferritin levels. This lack of significant differences may be due to the
short duration of the experiment.
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Figure 2. Effect of consuming different breads on plasmatic levels of ferritin in piglets.
3.5. Iron Absorption and Storage
The total iron content in the intestinal mucosa and internal organs after 51 days of life is
shown in Table 5. The iron content in the intestines of the animals which did not receive iron
supplementation was 18.4 ± . · e·kg−1. This was significantly lower (p < 0.05) than in CB-G4.
In t, the iron content in the in estinal muc sa of the animals that rec ved either oral or IM
iron supplementation ranged from 25.0 to 28.0 (mg/kg·WM), and did not diff r from the CB-G4
group (p > 0.05). Iron cont nt in the intestinal mucosa is known to be controlle tightly by d uble
regulation [3]. The first regulatory mechanism controls the passage of iro into intestinal mucosal
absorptive cells (enterocytes). Iron transfer from the basal surface into the blood is then regulated
according to the body’s needs at the time. Excess iron entering the mucosal cells can be incorporated
into ferritin, stored in the intestinal cells for 2–3 days, and finally lost by exfoliation and apoptosis of
the cell [37]. The iron levels of the piglets fed with iron fortified breads were close to iron adequate
status. This suggests that iron absorbed from lumen was not stored in the epithelial cell, but uptaken
by transferrin and transported systemically to the body.
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Table 5. Effects of dietary iron supplementation in the form of iron fortified bread and intramuscular
injection on iron concentration (mg·kg−1·WM) in organs of post-weanling piglets. Values are expressed
as means ± SD; Values in the same row with different superscripts differ significantly p < 0.05 (n = 6).
Samples
Piglets Group
FeMB-G1 FeSB-G2 CB-G3 CB-G4
Intestinal mucosa P51 25.0 ± 8.1 a 28.0 ± 11.5 a 18.4 ± 4.6 b 27.2 ± 4.4 a
Liver P51 29.0 ± 7.6 b 30.3 ± 10.1 b 20.0 ± 6.9 c 56.2 ± 24.7 a
Heart P51 33.0 ± 9.9 b 35.4 ± 8.1 b 26.3 ± 8.4 c 46.0 ± 12.4 a
Spleen P51 9.4 ± 2.0 ab 10.1 ± 1.2 ab 8.3 ± 1.6 b 10.5 ± 2.4 a
kidney P51 28.2 ± 8.6 ab 27.3 ± 8.0 ab 24.5 ± 7.3 b 33.0 ± 8.6 a
Feces
P44 130.4 ± 39.7 a 84.2 ± 17.2 a 98.2 ± 31.3 a 119.9 ± 27.3 a
P51 324.4 ± 129.5 b 168.8 ± 83.7 ab 58.5 ± 18.5 a 139.2 ± 92.4 a
Oral supplementation with iron in FeMB or FeSB forms resulted in a statistically significant
increase in the iron content of the liver, by up to 51.6% and 53.9%, respectively, with respect to the
CB-G3 group. The concentration of Fe showed a clear tendency to increase in orally supplemented
groups compared to CB-G3, confirming the positive effect of this Fe source on absorption and storage
in the body.
To understand the extent to which oral supplementation moved iron content away from
typical levels for anemic non-supplemented piglets, we calculated the differences shown by each
supplemented piglet from those of the piglets in groups CB-G3 and CB-G4. We then set up a paired
comparison between the distances, using Welch’s t-test. [45] The supplemented piglets, independent of
the kind of supplementation, showed an intermediate iron content in relation to the CB-G3 and CB-G4
groups in each of the studied body organs with the exception of liver, where the iron content was
closer to that of CB-G3.
Piglets given increased daily iron intake in the form of FeMB-1 or FeSB-2 showed significantly
higher iron content in their hearts in comparison with CB-G3 (p < 0.05), but did not reach the level
observed in piglets given IM supplementation from day 5 of life. In both orally supplemented
groups, iron accumulation in the heart and liver, the organs most commonly affected by iron overload,
remained below the values observed in CB-G4. At the end of the intervention trial, there were no
statistical differences in terms of iron content in the spleens of supplemented animals, where iron
content reached similar levels of around 10 mg·g−1. The iron content in the spleens of animals not
given supplementation was lower, although the increase caused by one week of oral supplementation
was not statistically significant.
A comparison of the iron content in feces from individual animals showed a broad range of
variation. In the feces of the FeMB-1 group, iron content varied from 94 to 180 mg/kg on 44 day and
from 282 to 485 mg/kg on day 51. However, with increased iron intake there was an up to twofold
increase in excretion. At the same time, in the CB-G3 iron excretion decreased by half.
Pigs fed with FeSO4 or microencapsulated FeSO4 had higher iron concentrations in the heart, liver,
and intestinal mucosa compared with iron-deficient pigs, indicating that iron supplementation was
effective at improving the iron status of the tested organs. These results are in agreement with those
obtained by Fang et al., [46] who observed that 10 days of supplementation in the form of ferrous sulfate
or iron glycine chelate increased iron content in the heart, liver, and lungs of iron-deficient piglets.
3.6. Fecal Metabolome
To provide an overview of the changes that occurred over the course of the experiment in the
intestinal environments of piglets in different test groups, the metabolome of feces collected at the
beginning and at the end of the experiment was investigated by means of high-resolution proton
magnetic resonance spectroscopy (1H-NMR) and multivariate analysis. In several related studies,
these methods have been found optimal for following the possible consequences of inflammation
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caused by exogenous agents [47–49]. Sixty-six molecules were quantified, mainly pertaining
to amino acids, short chain fatty acids and organic acids. Fifteen other signals were detected,
pertaining to different unknown molecules. The underlying structure of the data was represented in
a multidimensional space using principal component analysis (Figure 3). The score plot highlighted
the differences between the samples, while the loading plot provided a visual representation of the
most important molecules that determined those differences. Along the first principal component
(PC1), accounting for 23.5% of the total variance, the samples collected at P44 are grouped around
negative values, while the samples collected at P51 are grouped around positive values. The linear
combination of the molecules giving rise to PC1 therefore provides a superbly concise representation
of the growth of the animals. Piglets belonging to group CB-G4 appear at P44 with less negative values
than the others, which are closer to CB-G4 animals at P51, as a one tail Wilcox test confirmed. This was
not unexpected, as such piglets were anticipated to be characterized by a more balanced physiological
condition than those in any other group, with positive consequences for the overall development of
the animals. The relative position of samples collected at P51 is remarkably different from the position
of samples obtained at P44, as revealed by an ANOVA test. In fact, the CB-G4 samples are flanked
by FeMB-G1, which has the highest PC1 values, by FeSB-G2 with intermediate values, and by CB-G3
which has the lowest values.
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Figure 3. Score l t ( ) of a PCA analysis of fecal metabolome. To facilitate the visualization
of the differences of the samples at P51, their scores along PC1 are summarized by boxplots (C);
Corresponding loading plot (B), in which only the 10 most important variables, as calculated by sPCA,
are reported. The 81 loadings are also summarized by the molecular group in panel (D). In panels
(C,D), different lowercase letters indicate statistically different groups (p < 0.05). (G1, G2, G3, G4 refer
respectively to the groups fed with: microencapsulated iron bread (FeMB-G1); bread containing the
same quantity of iron sulphate; starch and citric acid (FeSB-G2); control bread (CB-G3), and control
bread with IM iron supplements at P5 (CB-G4)).
A recent work on human subjects showed that s me iron replaceme t ther pies ay cause
inflam ation accompanied by dra c modifica ion f gut microbiota and metabolome [50].
Prompted by these findings, we investigated the intra-group distances of the piglet at P44 and
P51, by considering the Euclidean space cons ituted by the concentration of all the mol cules studied
by NMR, scaled to unit variance. FeSB treatment caused a si nificant (p < 0.05) increase in the
variability of the metabolome, with the average distance between FeSB-G2 piglets increasing by
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175% after iron supplementation. This trend was confirmed when the samples were observed
in the principal component space shown in Figure 3, or in the space of intermediate complexity.
In contrast, groups FeMB-G1, CB-G3, and CB-G4 showed no statistical differences between P44 and
P51, suggesting that iron supplementation through microcapsules had a milder effect on gut microbiota
and metabolome than did fortification with iron sulphate.
The loading plot of the PCA model reveals that the metabolic cycles mostly responsible for the
highlighted trends involved the production of amino acids and decarboxylation. In fact, amino acids
appear significantly more concentrated in samples located around positive PC1 values, while molecules
belonging to the chemical group of amines appear more concentrated in samples with negative
PC1 values.
4. Conclusions
This study has shown that bread fortified with ferrous sulphate or encapsulated ferrous sulphate
provided effective treatment of anemia in piglets. Indeed, after a relatively short treatment time
(7 days), animals initially classified as anemic, due to lack of exogenous iron supplementation,
showed noticeable signs of improvement regarding hematological indicators of anemia. Fortified bread
could therefore also provide a source of bioavailable iron for humans, which should be of interest to the
functional foods industry. However, little difference was observed during the seven-day intervention
trial between using microencapsulated iron or the same amount of ferrous sulphate. It might be
expected that over the course of a longer study iron microencapsulation could obviate the negative
effects of free iron supplementation, and this should be the focus of further research.
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6 Morpho-functional 
characterization of the visual pathways 
in the iodoacetic acid (IAA) pig model  
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Photoreceptors degeneration is the major cause of adult blindness in 
industrialized countries,  retinitis pigmentosa (RP) and age-related macular 
degeneration (AMD) are the most common.(Ting et al., 2009; Wright et al., 
2010) Typically RP results from a primary defect in rods leading to diminished 
night vision and progressive narrowing of the visual field as vision becomes 
totally dependent on cones, but this almost invariably induce a  secondary cone 
loss (rod–cone degeneration) with consequent visual loss up to complete 
blindness.(Hamel, 2006) AMD is a multifactorial cause of photoreceptor 
degeneration that is becoming a growing health problem as the segment of the 
population aged 60 and older will experience a demographic growth.(Smith, 
2010; Velez-Montoya et al., 2014) Different animal models have been used to 
study genotype-phenotype correlation and to evaluate new therapeutic 
strategies for photoreceptor degeneration. Spontaneous animal model are 
available for retinal degeneration, but their repertoire is limited and still many 
models has to be found.(Chader, 2002) Thanks to the great progress in genetic 
engineering over the last few years an increasing number of transgenic model 
are available, small animals might be very useful for the earlier phase of 
investigation, but before embarking on human clinical trials it is imperative to 
demonstrate both efficacy and safety in a large animal model. The pig is an 
excellent retinal model as with humans, the swine retina contains a cone-
dominant central visual streak with rods enriched in the peripheral 
retina,(Chandler et al., 1999; Hendrickson and Hicks, 2002; Kostic and 
Arsenijevic, 2016) and the eye is comparable in size to the humane eye (Prince 
and Ruskell, 1960) . Different transgenic pig model have been created for 
studying the cone degeneration,(Petters et al., 1997; Ross et al., 2012) and 
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macular degeneration.(Sommer et al., 2011; Colella et al., 2014) Despite the 
clear advantages, those models share slow time course of disease progression 
and can only features a specific gene defect while the photoreceptor 
degeneration is a multifactorial disease. This could be a deterrent for their use 
in many cases when a rapidly inducible swine model of photoreceptor damage 
would be advantageous. Iodoacetic acid (IAA) was proved to blocks glycolysis 
and to be  toxic to neurons which depend upon this pathway.(Orzalesi et al., 
1970; Winkler et al., 2003; Liang et al., 2008) The degeneration of 
photoreceptors and in particular of the rods in the pig by IAA have been 
described.(Scott et al., 2011; Wang et al., 2011; Noel et al., 2012) The IAA swine 
model could be a useful model to study biocompatibility, surgical approach and 
efficacy of new artificial retinal prosthesis. In the last twenty years indeed many 
research groups worked on this new rising technology (Zrenner, 2002; 
Bertschinger et al., 2008; Ghezzi et al., 2013) proving its feasibility in micropigs 
(Schwahn et al., 2001). The IAA pig model has been described but the lack of 
information regarding the functionality of the entire visual pathways does not 
allow its use in this field. Our aim is to characterize the IAA swine model visual 
pathways to enlarge the use of this low cost and rapidly inducible model.  
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6.1 Materials and Methods 
 
 
Animals and study design 
The use of animals in this study was regulated by two protocols 
approved by the Italian Ministry of Health, one with D.Lgs 116/92 and the other 
with the new low  D.Lgs 26/2014. 
Eighteen commercial hybrid pig [(Large White x Landrance) x Duroc] 
were enrolled in the study and stable in multiple boxes according to their origin 
dominance group to reduce stress and aggressiveness.  The animals (male and 
female, 32 ± 12 Kg bodyweight) were anesthetized, a group was treated with 
iodoacetic acid (IAA) (IAA group n=11), the other group was injected with saline 
(Control group n=7). Before and a month after treatment animals were 
evaluated with a panel of functional and morphological test, full-field and 
pattern electro-retinography (ffERGs and pERG),  Flash Visual Evoked Potential 
(fVEP) and behavioral tests. At the end of the trial animals were put under 
general anesthesia and euthanized with 0.3 ml/kg of a compound containing 
embutramide 200 mg/ml, mebenzonio iodide 50 mg/ml, tetracaine 
hydrochloride 5 mg/ml (Tanax, Intervet Italia srl, Milan, Italy)  for the 
anatomical and pathological study of the retina and the visual pathways. 
Anesthesia protocol and IAA treatment  
Animals were weight and sedated with an intramuscular (IM) injection of 
Tiletamine-Zolazepam (Zoletil, Virbac, Prague) (5mg/Kg). General anesthesia 
was induced and maintained with sevoflurane (SevoFlo, Esteve, Barcelona, 
Spain). During anesthesia hematic and biochemical analysis were performed as 
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previously described.(Ventrella et al., 2017) The IAA group piglets received an 
intravenous injection, in the auricular vein, of 12 mg/kg body weight of sterile, 
pH balanced, iodoacetic acid (ICH2CO2H) lot n. BCBQ7348V and BCBS2675V 
(CAS Number: 64-69-7, Sigma Chemical Corp., St Louis, MO), the administration 
last five minutes. The IAA was freshly prepared the day of the administration 
with saline solution (NaCl 0,9%) and use at the concentration of 12 mg/ml. 
Electrophysiological (ffERG, pERG and fVEP) analysis 
The analysis was performed with the animals under general anesthesia, 
to maintain the eye in a central and stable position atracurium besylate 
(Tracrium, GlaxoSmithKline, Bredford, United Kingdom) 0.25mg/kg was 
injected every 30 min. Two drops of oxybuprocaine hydrochloride (Novesina, 
Visufarma s.r.l. Rome, Italy) were used as a local anesthetic for the corneal 
surface and a barraquer blepharostat and the electrodes were positioned. 
Contact lenses electrodes (ERG-jet®, Universo Plastique, Switzerland) as active 
electrodes during ffERG and pERG and sub dermal needle electrodes as 
reference near the ipsilateral and the controlateral ear were used. For fVEP a 
dermal needle was placed close to the occipital protuberance as active 
electrode. A drop of 3% carbomel (Dacriogel, Alcon, Fort Worth, Texas, USA) 
was also applied to the inner surface of the lens electrode to protect the cornea 
and to ensure good electrical contact. The pERG was performed before pupillary 
dilatation; maximal pupillary dilation was obtained by applying 2 drops of 
tropicamide phenylephrine hydrochloride (Visumidriatic fenilefrina 10% + 
0.5%, Visufarma s.r.l. Rome, Italy) 15 min prior to the beginning of the ffERGs 
session. The International Society for Clinical Electrophysiology of Vision 
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(ISCEV) Standards for ffERGs, pERG and fVEP (Bach et al., 2013; McCulloch et al., 
2015; Odom et al., 2016) were used with the settings adjusted for the swine 
species displayed in table 21 A and B. Both eyes were investigated separately 
and the contralateral eye was covered to reduce contamination. The ffERG 
stimuli were produce by a Ganzfeld dome and pattern stimuli by a screen 
connected to a pattern generator. The data were amplified and acquired by 
WinAverager Software. The Ganzfeld dome, the pattern screen and generator, 
the amplifier and the Software used were part of the BM6000-MAXI 
Electrophysiology Unit shown in figure 28 (Biomedica Mangoni, Pisa, Italy). Data 
were acquire as single waves and filtered with OriginPro 9.1. A FFT filter low 
pass 50 Hz was used for the ffERGs  and fVEP waves while pattern ERG were 
filtered with a band pass 5-20 Hz FFT filter.  
Figure 28 BM6000-MAXI Electrophysiology Unit 
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Table 21.  A. Stimulus and recording parameters for swine adapted ISCEV Standard 
ERGs. * Dark-adapted ERGs are recorded sequentially without further dark adaptation. 
Thus, only the 0.01 ERG is a fully dark-adapted response 
B. Stimulus and recording parameters for swine adapted ISCEV Standard pERG and 
fVEP 
 
A B 
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Behavioral Vision Assessment 
Two week after treatment pigs (IAA group n=11 and C group n=7) were 
evaluated with a behavior test proposed for cats in 2013 (Nan et al., 2013) with 
some modifications. The testing course was 10 meter long and 2 meter wide, 
with 10 obstacles every meter randomly positioned on the right, the left or the 
center to obtain 4 configurations (Fig. 29). In the morning before food 
administration the animals were tested with artificial light condition and 
semidarkness condition. Time to complete the course and number of collision 
with the obstacles were recorded by two different operators at the same time. 
The test was performed twice a week for 8 replicates to reduce errors due to 
smells and noises, to reduce the possibility that the animals where learning the 
obstacles position, configuration was changed every time the test was 
performed.  
Figure 29. Clinical vision evaluation testing course design 
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Retinal histology 
The eye globes from two C and two IAA animals were enucleated after 
suppression and immediately put in Ambion™ PBS Phosphate-Buffered Saline 
(10X) pH 7.4 precooled at 4°C (Fisher Scientific, Waltham, Massachusetts, 
United States). The eyes were prepared for the shipment to the Department of 
Biotechnological and Applied Clinical Science, University of L’Aquila, with the 
following protocol: a cut near to the corneal limbus was performed to expose 
the posterior chamber, that the eyes were perfixed in 4% paraformaldehyde for 
24 hours. At the Department of Biotechnological and Applied Clinical Science 
the samples were dehydrated in an increasing concentration solution of sucrose 
(10-20-30%), each step last 24 hours. 
The retinas were than orientated cut and stained for the 
immunohistochemistry analyzes with the protocols of the Department of 
Biotechnological and Applied Clinical Science of University of L’Aquila. 
Visual pathways (anatomical and pathological) evaluation 
Five pigs were submitted to necroscopic and histologic investigations, 
focusing on the study of the optic tracts, IAA n=3 and C n=2. 
After opening of the skull the CNS tissues were gently removed; the 
cerebral ventricles were opened and the tissue exposed to favour the 
subsequent fixation. (In case of detection grossly), the optic chiasm and the 
optic nerve were sampled and put in a plastic biocassette (Bio-Optica, Milan). 
Then, cerebrum cerebellum and pons and the tissues within the biocassettes 
were in toto in formalin fixed (10%).  
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Brains samples were fixed in 4% paraformaldehyde for at least 72 h. The 
lateral geniculate bodies and adjacent diencephalon were isolated and postfixed 
in the same fixative for 4 h. After rinsing in phosphate buffer saline (PBS, pH 
7.4), the tissue was cryoprotected in 30% sucrose solution in PBS (pH 7.4) at 
+4°C, and cut on a sliding freezing microtome in serial coronal sections (50 μm). 
The sections were stored in PBS (pH 7.4) containing sodium azide (0.01%). 
Samples of the optic chiasm, optic nerve, the left and right optic tracts, 
the left and right lateral geniculate bodies were routinely processed, embedded 
in paraffin, cut into 4-μm thick sections and stained with Haematoxylin–Eosin 
(H&E). 
Thionin staining 
To identify cytoarchitectonic features of the lateral geniculate nucleus, 
sections were stained with thionin as follows. Sections were taken out of the 
PBS, mounted on gelatin-coated slides, and dried overnight at 37 ◦C. Sections 
were defatted 1 h in a mixture of chloroform/ethanol 100% (1:1), and then 
rehydrated through a graded series of ethanol,2×2 min in 100% ethanol, 2 min 
in 96% ethanol, 2 min in 70% ethanol, 2 min in50% ethanol, 2 min in dH2O, and 
stained 30 s in a 0.125% thionin (Fisher Scientific)solution, dehydrated and 
coverslipped with DPX (BDH Laboratory Suplies Poole,England). 
Analysis of sections 
Sections were analyzed using a Leica DMRB microscope. Brightfield 
images were acquired by means of a Polaroid DMCdigital camera (Polaroid 
Corporation, Cambridge, MA, USA) and DMC 2 software. Contrast and brightness 
150 
 
were adjusted to reflect the appearance of the labeling seen through the 
microscope using Adobe Photoshop CS3 Extended 10.0 software 
(AdobeSystems, San Jose, CA). Data concerning the percentage of the image 
covered by neurons and glial cells in lateral geniculate nucleus were obtained 
using the automatic threshold algorithm of ImageJ (version IJ 1.46r downloaded 
from http://imagej.nih.gov/ij/download.html). For this analysis images were 
taken using a Leica DMRB microscope under identical acquisition parameters 
from control and treated pigs. For each pig, 5 sections were analyzed. All data 
are given as mean ± standard deviation and differences between controls and 
treated were evaluated using Student’s t-test, with a significance level of p < 
0.05. 
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6.2 Results and discussions 
 
Electrophysiological (ffERGs, pERG and fVEP) analysis 
The animals were tested before and four weeks after IAA treatment (12 
mg/kg). The recording of ffERG and fVEP stimuli was reproducible amplitudes 
of b-wave are shown in figure 30. The data were analyzed for pair data in 
animals treated with the IAA and for in comparison with the control group. In 
both analyzes the data confirmed the complete degeneration of rod 
photoreceptor while few cones were still able to react to light. As previously 
describe by Weng, Noel and Scott the 12 mg/kg IAA concentration lead to 
severe photoreceptor degeneration. The fVEP stimuli are were reduced but not 
completely extinguished, as we can see in figure 31D the shape of the wave after 
IAA treatment is maintained suggesting that the visual pathways are still intact 
and able to conduct the stimuli from photoreceptor to visual cortex. 
Figure 30.  B wave amplitudes of ffERG in C and IAA pigs four week after treatment. 
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In figure 31 (A, B, C and D) an example wave for each of the full field flash 
ERGs stimulus and fVEP is reported. It is important to notice that the waves are 
well characterized and comparable to the one described for humans (McCulloch 
et al., 2015; Odom et al., 2016). FVEP wave (fig 31 D) has a different y axis scale 
to allow a better visualization of the wave; the fVEP amplitude is indeed smaller 
compared to ffERG waves. 
Figure 31. ffERGs and fVEP waves shape in IAA (green) and C (black) animals. A 
light adapted fERG 3.0 expressing the cones response. B dark adapted fERG 10.0 
expressing the rods response. C dark adapted fERG 3.0 expressing both cones and rods 
response. D fVEP expressing the activation of visual cortex in response to flash stimuli.  
 
The pERG arises largely in the ganglion cells, driven by the 
photoreceptors and corresponding retinal cells. Since the pERG (in contrast to 
the flash ERG) is a local response from the area covered by the retinal stimulus 
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image, it can be used as a sensitive indicator of dysfunction within the macular 
region and it reflects the integrity of the optics, photoreceptors, bipolar cells 
and retinal ganglion cells.  
To evaluate the ganglion cells functionality pERG was evaluated. We start 
from the ISCEV protocol parameters for reconding pPERG in human as very 
little is described in swine (Janknecht et al., 2001) and we end up with the 
setting displayed in table 21 B.  
PERGs are small signals, typically around 2–8 µV in normal humans, 
making pERG recording more technically demanding than standard flash ERGs 
(Fig. 32) (Bach et al., 2013). 
Figure 32. A typical 
standard pERG. The 
amplitude of the P50 is 
typically between 2.0 and 
8.0 µV.  
From Bach et al., 2013 
 
 
 
 
Therefore, obtaining reliable results requires careful attention to 
technique, including stimulus and electrode quality as well as to sources of 
extraneous noise.  
We recorded pattern ERGs in normal pigs (Fig. 33), but we were not able 
to recorder it after IAA treatment. Most probably the very high technical 
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demanding to record pattern ERG requires a faraday cage to maintai the noises 
under control and enable investigators to recorder a decrease signal. 
 
Figure 33. pERG waves of three pigs without IAA treatment. Data of right and left 
eye are reported, each animal is assigned to a different color, and at least two 
replicates were made for each animal. 
 
The pERG presented  show a high variability between subject (inter 
variability) but a reduced intra subject variability confirming the reproducibility 
of the records.  The tested animals (Fig. 32) have different age, black and red 
color was assigned to 80 days old pigs while the green color refear to a six 
mounth old pig. We can notice that their might be a difference in pERG 
amplitude due to the animal development, but more studies are necessaty to 
confirm this hypotesis. 
 
Behavioral vision assessment   
The animals were easily trained to complete the trial within 20 ± 5 
seconds in four days. All animals were than tested before treatment. After 
treatment the IAA group showed a statistically significant increase in the time 
needed to complete the trial and in the number of collision with the obstacles 
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(Fig. 34) compared with C group in both light and semidarkness conditions. In 
semidarkness condition IAA treated animals had more collision with obstacle 
compared with the same group in light condition. The results confirm that 
vision can be assessed with behavioral test in pigs, endorsing the hypotheses 
obtained from electrophysiology.   
Figure 34. Behavioral vision assessment. A. Time (s) in light and 
semidarkness condition to finish the path in control (C) and iodoacetic acid 
treated (IAA) groups. B. numbers of hit obstacles in light and semidarkness 
condition in control (C) and iodoacetic acid treated (IAA) groups. * for 
p<0.05; † for p<0.001  
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Retina histology 
The eyes were macroscopically evaluated (Fig. 35), all samples were in 
good conditions and no inflammation or alterations were observed. 
Figure 35. Macroscopic views of IAA and C eyes after ablation of the cornea, 
anterior chamber and the crystalline during the processing. The red line indicates 
were the retina was cut for the histology. 
 
The photoreceptors from the central cone rich horizontal band were 
completely degenerated in IAA treated retinas as shown in figure 36.  
As previously described the 12 mg/kg IAA concentration lead to a severe 
photoreceptors degeneration affecting both rods and cones (Wang et al., 2011).  
Figure 36.  Immunohistochemistry of the retina showing the differences within the 
IAA and C retinas. 
 
IAA C 
C  IIA 
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The thickness of retinal layers was evaluated (Fig. 37 A, B and C). The 
ganglion cell layer (GCL) and the inner layer (INL) were found relatively 
increased in IAA group due to the outer layer (ONL) degeneration. The data are 
confirming previously findings of hypertrophy and swelling of Müller cells 
(Scott et al., 2011). 
Figure 37.  Retinal Thickness measures in C and IAA retina samples.  A GCL thickess 
to inner retina thickness ratio. B INL thickness to inner retina thickness ratio. C ONL over 
total retinal thickness ratio. 
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The data suggest a mild anatomical alteration of GCL layer that is 
however not compromising the optic nerve anatomy.  
Visual pathways histo-morphological evaluation 
Histology of the optic/visual tracts 
A mild satellitosis of the optic chiasm along with a mild to moderate 
gliosis of the optic nerve were detected. Glial cells immunohistochemistry is 
ongoing; the results could help to investigate a possible inflammation reaction 
toward the treatment. 
Histology of the lateral geniculate nucleus 
In thionin preparations, the neuronal population of the lateral geniculate 
nucleus was made up in its grater part of polygonal neurons, but also included 
fusiform and spheroidal neurons. Although the lateral geniculate nucleus had a 
rather striated appearance, it was difficult to recognize the existence of a clear 
laminar organization. As reported in table 22, the average area covered by 
neurons and glial cells was significantly larger in C than in IAA animals.  
Table 22.  Average percentage (± standard deviation) of the image area covered by 
neurons and glial cells (nuclei) in lateral geniculate nucleus (LGN) of control (C) 
and treated (IAA) groups 
Group Right and left LGN Right LGN Left LGN 
C 25,6 ± 4,7* 27,8 ± 3,4§ 21,5 ± 3,9 
IAA 23,2 ± 3,3* 23,2 ± 2,8§ 23,3 ±3,8 
* P < 0.05 at the t-test, C versus IAA 
§ P< 0.001 at the t-test, C versus IAA 
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Histopathological extra-CNS findings were enzootic pneumonia (one 
case of necro-suppurative bronchio-alveolar pneumonia), inguinal 
lymphadenomegaly (chronic follicular hyperplasia, subcapsular histiocytosis, 
and eosinophilic lymphadenitis), and multifocal chronic hepatitis (“white spot 
liver disease”). Those findings were compatible with a standard pig farming 
health condition.    
 
6.3 Conclusions 
 
We evaluate morpho-functional characteristic of the visual pathways in a 
IAA pig model of photoreceptor degeneration. The project is not concluded, 
more histological and electrophysiological investigations are indeed necessary 
to better characterize the visual pathways.  
Behavioral visual functional test were assessed for the first time in pigs. 
The test was easily conduced on animals and was able to discriminate between 
C and IAA groups. We can therefore state that the proposed pig behavioral 
vision assessment test is validated and can be applied to any research that 
involves the pig as animal model. Moreover it can be adopted as clinical 
evaluation of pig vision acuity as the pig, and in particular minipig, is becoming 
more frequently a domestic pet. 
The full field ERG was recorded and waves were described; the 
differences between groups were strong as the IAA concentration of 12 mg/kg 
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lead to a complete rods and severe cones degeneration mimic the late stage of 
retinitis pigmentosa. 
The IAA concentration dependent pig model was reproduced and 
innovative investigations were proposed to better characterize the model.   The 
components of optic tract following the retina up to the visual cortex were 
indeed never investigated in IAA pig model.  
The morphological investigation suggest that a 12 mg/kg of IAA 
administration can cause reorganization in the structure of lateral geniculate 
nucleus (LGN) as a possible consequence of decreased incoming inputs due to 
photoreceptor degeneration. None the less the optic investigated tract did not 
show any pathological status, a very mild gliosis was observed, but further 
investigations are needed to understand this phenomenon.   
We can therefore state that the IAA pig model is an easy reproducible, 
costs-effective model. At the concentration of 12mg/Kg the IAA treatment lead 
to anatomical and functional findings comparable with the late stage of retinitis 
pigmentosa. 
The 12mg/kg IAA pig model of photoreceptors degeneration could 
therefore be a suitable model for the study of bioprosthetic devices that are one 
of the only treatment choices for end stage photoreceptors degeneration 
diseases. 
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The role of veterinarians in biomedical science is increasing 
and becoming fundamental due to the awareness that more efforts 
are needed to increase translational value of animal models. 
  Deep knowledge of the physiology of the chosen species 
combined with the etiopatological knowhow of human diseases 
could be the right path to take.  
The new findings in science concerning the role of microbiota 
on the host health increased the need for comparable animal models 
to allow more in deep investigations and to test microbiota 
associated treatments.  
The pig full fields this need, as it is a widespread and validated 
model of gastro enteric and metabolic system.  
The Bake4fun project aimed to investigate the impact of highly 
nutritional value foods on the gut microbiota and the potential 
benefits to the human health on a pig model. At the same time the 
piglet was chosen for its Para physiological iron deficiency to 
investigate microencapsulated iron fortification as potential 
treatment for human iron nutritional deficiency.  
The results lead to a thorough understanding of pig gut 
microbiota and its modulation to nutritional changes, these 
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understandings are fundamental for the interpretation of data when 
experiments are conducted on animals.  
The potential role in reduction and refinement is clear 
especially considering the pig as the emerging gold standard model 
for gastro intestinal research. 
The microencapsulation of iron was found to be protective 
against the side effects of iron dietary supplementation maintaining 
the healing effect, opening a new prospective on iron fortified foods. 
The pig model is also very important in ophthalmology. 
The human vision is based on three photo sensible cells and 
the most important are cones. The cones are responsible for day 
light color vision and visual acuity therefore the loss of cone system 
is dramatic in our highly technological world.  
The rich cone pig retina is therefore an extremely important 
model for the study of cones degeneration mechanisms and the 
examination of innovative therapeutic strategies. 
A rapidly inducible costs-effective chemical pig model of 
photoreceptor degeneration was investigated. New tools have been 
established for the assessment of vision in a pig model. An easy 
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visual evaluation behavioral test has been validated, giving to 
researchers and clinicians the opportunity to assess vision in a 
sentient pig model.  
Moreover the pattern electroretinogram (pERG) was recorded 
for the first time in pigs. The pERG is a sensitive indicator of 
dysfunction within the macular region and it reflects the integrity of 
the optics, photoreceptors, bipolar cells and retinal ganglion cells. 
The advance in ophthalmology research given by the above 
described results is enormous and leads to a better use of the pig 
model in retinal research.  
Hopefully this work will contribute to the translational value 
of the pig model, which in my opinion is the future gold standard 
model for gastro-intestinal and vision systems and will completely 
replace the use of dogs and non-humane primates in biomedical 
science. 
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